<SEC-DOCUMENT>0001104659-24-071756.txt : 20240614
<SEC-HEADER>0001104659-24-071756.hdr.sgml : 20240614
<ACCEPTANCE-DATETIME>20240614161050
ACCESSION NUMBER:		0001104659-24-071756
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20240812
FILED AS OF DATE:		20240614
DATE AS OF CHANGE:		20240614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001649989
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				383982704
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37759
		FILM NUMBER:		241044857

	BUSINESS ADDRESS:	
		STREET 1:		111 S. WOOD AVENUE
		STREET 2:		UNIT #100
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830
		BUSINESS PHONE:		6096193990

	MAIL ADDRESS:	
		STREET 1:		111 S. WOOD AVENUE
		STREET 2:		UNIT #100
		CITY:			ISELIN
		STATE:			NJ
		ZIP:			08830

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncobiologics, Inc.
		DATE OF NAME CHANGE:	20150804
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>tm2417053-1_pre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<html>
  <head>
    <title>tm2417053-1_pre14a - none - 6.5156583s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.24pt;">SECURITIES AND EXCHANGE COMMISSION </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Washington, D.C. 20549</font><font style="font-weight:normal;font-size:12pt;">&#8203;<font style="letter-spacing:0.24pt;"> </font></font>
        </div>
        <div style="margin-top:18.833pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">SCHEDULE 14A</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(RULE 14a-101)</font>
          <br >
          <font style="letter-spacing:-0.2pt;">SCHEDULE 14A INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proxy Statement Pursuant to Section&#160;14(a) of the</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Securities Exchange Act of 1934</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by the Registrant&nbsp;&nbsp;&nbsp;&#9746; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by a Party other than the Registrant&nbsp;&nbsp;&nbsp;&#9744; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Check the appropriate box: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Preliminary Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Additional Materials </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Soliciting Material Pursuant to &#167;240.14a-12 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">OUTLOOK THERAPEUTICS, INC.</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:3.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Registrant as Specified In Its Charter) </font>
        </div>
        <div style="margin-top:16.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payment of Filing Fee (Check the appropriate box): </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No fee required. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee paid previously with preliminary materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules 14a6(i)(1) and 0-11</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">PRELIMINARY PROXY STATEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;">, </font><font style="letter-spacing:-0.2pt;">SUBJECT TO COMPLETION </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DATED JUNE 14, 2024</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_outlooktherapeutics-4clr.jpg" alt="[MISSING IMAGE: lg_outlooktherapeutics-4clr.jpg]" height="77" width="261" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(609) 619-3990</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dear Stockholder: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You are cordially invited to attend a special meeting of the stockholders, the Special Meeting, of Outlook Therapeutics, Inc., a Delaware corporation. The meeting will be held on Monday, August&#160;12, 2024 at 9:00&#160;a.m. Central Time at the offices of Cooley LLP, 110 N. Wacker Drive, Suite 4200, Chicago, Illinois 60606. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You are being asked to vote on the following matters: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To approve the Outlook Therapeutics, Inc. 2024 Equity Incentive Plan; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To conduct any other business properly brought before the Special Meeting and any adjournment or postponement thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These items of business are more fully described in the Proxy Statement accompanying this Notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The record date for the Special Meeting is June&#160;17, 2024. Only stockholders of record as of the close of business on that date may vote at the Special Meeting or any adjournment or postponement thereof. </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; text-align:justify; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By Order of the Board of Directors, </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Lawrence A. Kenyon </font>
        </div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lawrence A. Kenyon</font>
          <br >
          <font style="font-style:italic;letter-spacing:0.2pt;">Corporate Secretary</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Iselin, New Jersey</font> <br ><font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2024 </font></div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;min-height:92pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="border-bottom:0.75pt solid #000000; ;padding:4.167pt 0pt 4pt 0pt; width:444pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.2pt;">You are cordially invited to attend the Special Meeting in person. Whether or not you expect to attend </font>
                <br >
                <font style="letter-spacing:-0.2pt;">the Special Meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the Special Meeting. Even if you have voted by proxy, you may still vote in person if you attend the Special Meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the Special Meeting, you must obtain a proxy issued in your </font>
                <br >
                <font style="letter-spacing:-0.2pt;">name from that record holder.</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:269pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:322pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tQAAA"><font style="letter-spacing:0.2pt;">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQAAA">1</a></font> <a href="#tQAAA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.96pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tPN1O"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 1 APPROVAL OF OUTLOOK THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN1O">5</a></font> <a href="#tPN1O"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWYSV"><font style="letter-spacing:0.2pt;">Why You Should Vote for the 2024 Plan </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYSV">5</a></font> <a href="#tWYSV"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tDOT2"><font style="letter-spacing:0.2pt;">Description of the 2024 Plan </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOT2">8</a></font> <a href="#tDOT2"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNPBU"><font style="letter-spacing:0.2pt;">New Plan&#160;Benefits under 2024 Plan </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNPBU">17</a></font> <a href="#tNPBU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tECPI"><font style="letter-spacing:0.2pt;">Equity Compensation Plan&#160;Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tECPI">18</a></font> <a href="#tECPI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSOOC"><font style="letter-spacing:0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSOOC">20</a></font> <a href="#tSOOC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXCO"><font style="letter-spacing:0.2pt;">EXECUTIVE COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXCO">24</a></font> <a href="#tEXCO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tSCT"><font style="letter-spacing:0.2pt;">Summary Compensation Table </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSCT">24</a></font> <a href="#tSCT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNTSC"><font style="letter-spacing:0.2pt;">Narrative to Summary Compensation Table </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNTSC">25</a></font> <a href="#tNTSC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tOEAA"><font style="letter-spacing:0.2pt;">Outstanding Equity Awards at Fiscal Year End </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOEAA">27</a></font> <a href="#tOEAA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tM2OA"><font style="letter-spacing:0.2pt;">March&#160;2024 Option Awards </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tM2OA">28</a></font> <a href="#tM2OA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tCLPO"><font style="letter-spacing:0.2pt;">Clawback Policy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCLPO">28</a></font> <a href="#tCLPO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tHETR"><font style="letter-spacing:0.2pt;">Hedging Transactions </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHETR">29</a></font> <a href="#tHETR"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDICO"><font style="letter-spacing:0.2pt;">DIRECTOR COMPENSATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDICO">30</a></font> <a href="#tDICO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tNDCP"><font style="letter-spacing:0.2pt;">Non-Employee Director Compensation Policy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNDCP">30</a></font> <a href="#tNDCP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPVP"><font style="letter-spacing:0.2pt;">PAY VERSUS PERFORMANCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPVP">33</a></font> <a href="#tPVP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tAOTI"><font style="letter-spacing:0.2pt;">Analysis of the Information Presented in the Pay versus Performance Table </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAOTI">35</a></font> <a href="#tAOTI"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tHOPM"><font style="letter-spacing:0.2pt;">HOUSEHOLDING OF PROXY MATERIALS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHOPM">37</a></font> <a href="#tHOPM"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOTMA"><font style="letter-spacing:0.2pt;">OTHER MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOTMA">38</a></font> <a href="#tOTMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.96pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAATI"><font style="letter-spacing:0.2pt;">APPENDIX A OUTLOOK THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAATI">A-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tQAAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OUTLOOK THERAPEUTICS, INC.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(609) 619-3990</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROXY STATEMENT FOR THE</font>
          <br >
          <font style="letter-spacing:-0.2pt;">SPECIAL MEETING OF STOCKHOLDERS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO BE HELD ON AUGUST 12, 2024</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why am I receiving these materials?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have sent you this proxy statement and the Proxy Card, or collectively, the Proxy Materials, because the Board of Directors, or the Board, of Outlook Therapeutics, Inc., sometimes referred to as the Company or Outlook Therapeutics, is soliciting your proxy to vote at the special meeting of stockholders, or the Special Meeting, including any adjournment or postponement thereof. This proxy statement summarizes the information you will need to know to cast an informed vote at the Special Meeting. You are invited to attend the Special Meeting to vote on the proposal described in this proxy statement. However, you do not need to attend the Special Meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed Proxy Card, or follow the instructions below to submit your proxy over the telephone or through the internet. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We intend to begin mailing these Proxy Materials on or about &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;&#8201; &#8199;&#8199;&#8199;&#8199;, 2024 to all stockholders of record entitled to vote at the Special Meeting. </font>
        </div>
        <div style="margin-top:11.52pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do I attend the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Special Meeting will be held on Monday, August&#160;12, 2024, at 9:00&#160;a.m. Central Time, at the offices of Cooley LLP, 110 N. Wacker Drive, Suite 4200, Chicago, Illinois 60606. Information on how to vote in person at the Special Meeting is discussed below. </font>
        </div>
        <div style="margin-top:11.52pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who can vote at the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Only stockholders of record at the close of business on June&#160;17, 2024, or the Record Date, will be entitled to vote at the Special Meeting. On the Record Date, there were &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock outstanding and entitled to vote. </font>
        </div>
        <div style="margin-top:11.52pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If on the Record Date your shares of common stock were registered directly in your name with Outlook Therapeutics&#8217; transfer agent, Equiniti Trust Company, LLC, or Equiniti, then you are a stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the Special Meeting, we urge you to fill out and return the enclosed Proxy Card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </font>
        </div>
        <div style="margin-top:11.51pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of a Broker or Bank</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If on the Record Date your shares of common stock were held not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name,&#8221; and these Proxy Materials are being forwarded to you by that organization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The organization holding your account is considered to be the stockholder of record for purposes of voting at the Special Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, because you are not the stockholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent. </font>
        </div>
        <div style="margin-top:11.41pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What am I voting on?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There is one matter scheduled for a vote: the approval of the Outlook Therapeutics, Inc. 2024 Equity Incentive Plan, which we refer to as the 2024 Plan (Proposal No. 1). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How does the Board recommend that I vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board recommends that you vote &#8220;For&#8221; the approval of the 2024 Plan (Proposal No. 1). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What if another matter is properly brought before the meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board knows of no other matters that will be presented for consideration at the Special Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do I vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For Proposal No. 1, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Please note that by casting your vote by proxy you are authorizing the individuals listed on the Proxy Card to vote your shares in accordance with your instructions and in their discretion with respect to any other matter that properly comes before the Special Meeting or any adjournments or postponements thereof. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The procedures for voting are fairly simple: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a stockholder of record as of the Record Date, you may vote in person during the Special Meeting or you may vote by proxy using the enclosed Proxy Card, over the telephone or through the internet. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Whether or not you plan to attend the Special Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To vote in person, come to the Special Meeting and we will give you a ballot when you arrive. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To vote using the Proxy Card, simply complete, sign and date the enclosed Proxy Card and return it promptly in the envelope provided. If you return your signed Proxy Card to us before the Special Meeting, we will vote your shares as you direct. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To vote over the telephone, dial toll-free 1-800-PROXIES (1-800-776-9437) using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the enclosed Proxy Card. Your telephone vote must be received by 11:59&#160;p.m., Eastern Time on August&#160;11, 2024 to be counted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">To vote through the internet, go to http://www.voteproxy.com to complete an electronic Proxy Card. You will be asked to provide the company number and control number from the enclosed Proxy Card. Your internet vote must be received by 11:59&#160;p.m., Eastern Time on August&#160;11, 2024 to be counted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.02pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a voting instruction form with these Proxy Materials from that organization rather than from Outlook Therapeutics. Simply complete and mail the voting instruction form to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker or bank. To vote in person at the Special Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker or bank included with these Proxy Materials or contact your broker or bank to request a proxy form. </font>
        </div>
        <table style="width:456pt;height:57pt;margin-top:10pt;border-collapse: collapse;border:0.75pt solid #000000; font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;min-height:56pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="border-bottom:0.75pt solid #000000; ;padding:4.167pt 0pt 4pt 0pt; width:444pt;">
              <font style="letter-spacing:-0.2pt;">Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.</font>
            </td>
            <td style="padding:0pt;border-bottom:0.75pt solid #000000; ; width:6pt;">&#8203;</td>
            <td style="width:0.25pt;padding:0pt;font-size:0pt;line-height:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How many votes do I have?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On each matter to be voted upon, you have one vote for each share of common stock you own as of the close of business on the Record Date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What happens if I do not vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a stockholder of record and do not vote by completing your Proxy Card, by telephone, through the internet or in person at the Special Meeting, your shares will not be voted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of Broker or Bank (Broker non-votes)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you are a beneficial owner and do not instruct your broker, bank, or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether the New York Stock Exchange, or NYSE, deems the particular proposal to be a &#8220;routine&#8221; matter. Brokers and nominees can use their discretion to vote &#8220;uninstructed&#8221; shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the NYSE, &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders. Proposal No. 1 is considered to be a &#8220;non-routine&#8221; matter and, accordingly, your broker or nominee may not vote your shares on Proposal No. 1 without your instructions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What if I return a Proxy Card or otherwise vote but do not make specific choices?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you return a signed and dated Proxy Card or otherwise vote without marking voting selections on matters on which you are entitled to cast votes, your shares will be voted &#8220;For&#8221; Proposal No. 1. If any other matter is properly presented at the Special Meeting, your proxyholder (one of the individuals named on your Proxy Card) will vote your shares using his best judgment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who is paying for this proxy solicitation?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will pay for the entire cost of soliciting proxies. In addition to these Proxy Materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding Proxy Materials to beneficial owners. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What does it mean if I receive more than one set of Proxy Materials?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you receive more than one set of Proxy Materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Proxy Cards in the Proxy Materials to ensure that all of your shares are voted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Can I change my vote after submitting my proxy?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stockholder of Record: Shares Registered in Your Name</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Yes. You can revoke your proxy at any time before the final vote at the Special Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You may submit another properly completed Proxy Card with a later date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You may grant a subsequent proxy by telephone or through the internet. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You may send a timely written notice that you are revoking your proxy to Outlook Therapeutics&#8217; Corporate Secretary at 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">You may attend the Special Meeting and vote in person. Simply attending the Special Meeting will not, by itself, revoke your proxy. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your most current Proxy Card or telephone or internet proxy is the one that is counted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Beneficial Owner: Shares Registered in the Name of Broker, Bank or Other Agent</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">When are stockholder proposals and director nominations due for next year&#8217;s annual meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To be considered for inclusion in next year&#8217;s annual meeting proxy materials, your proposal must be submitted in writing by October&#160;15, 2024 to Outlook Therapeutics&#8217; Corporate Secretary at 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830. If you wish to submit a proposal (including a director nomination) at the meeting that is not to be included in next year&#8217;s proxy materials, you must provide specified information in writing to our Corporate Secretary at the address above not later than the close of business on December&#160;7, 2024 nor earlier than the close of business November&#160;7, 2024. You are also advised to review our Bylaws, which contain a description of the information required to be submitted, as well as additional requirements about advance notice of stockholder proposals and director nominations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How are votes counted?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Votes will be counted by the inspector of election appointed for the Special Meeting, who will separately count votes &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and broker non-votes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How many votes are needed to approve the proposal?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the minimum vote needed to approve the proposal and the effect of abstentions and broker non-votes. </font>
        </div>
        <table style="width:458.53pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Proposal </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:113pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Proposal Description </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:168pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Vote Required for Approval </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:39.08pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Effect of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Abstentions </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:54.45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Effect of Broker </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Non-Votes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:113pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Approval of the 2024 Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:168pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">&#8220;For&#8221; votes from the holders of a majority of the voting power of the shares present in person or represented by proxy at the Special Meeting and voting affirmatively or negatively (excluding abstentions and broker non-votes) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:39.08pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">No effect </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.167pt 0pt; width:54.45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">No effect</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the quorum requirement?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least a majority of the voting power of the outstanding shares entitled to vote at the Special Meeting are present at the meeting in person or represented by proxy. On the Record Date, there were &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#160;of common stock outstanding and entitled to vote. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Thus, shares representing &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; votes must be present in person or represented by proxy at the Special Meeting to have a quorum.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Special Meeting. Abstentions will also count towards the quorum requirement. Broker non-votes will not be counted for purposes of calculating whether a quorum is present at the Special Meeting as Proposal No. 1 is considered a non-routine matter on which brokers are not entitled to vote without instructions. If there is no quorum, the chairman of the Special Meeting may adjourn the meeting to another date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How can I find out the results of the voting at the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Preliminary voting results will be announced at the Special Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Special Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the Special Meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What proxy materials are available on the internet?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This proxy statement and the Proxy Card will be available at https://www.astproxyportal.com/ast/27823/. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN1O">&#8203;</a><a name="tWYSV">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSAL NO. 1 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">APPROVAL OF OUTLOOK THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board is asking our stockholders to approve an amendment and restatement of the Outlook Therapeutics, Inc. 2015 Equity Incentive Plan, which was previously amended as of September&#160;21, 2018, September&#160;12, 2019, and September&#160;17, 2020, or the 2015 Plan. On June 13, 2024, our Board approved the amendment and restatement of the 2015 Plan, subject to approval by our stockholders at the Special Meeting. In connection with amending and restating the 2015 Plan, the name of the 2015 Plan was updated to the Outlook Therapeutics, Inc. 2024 Equity Incentive Plan, and we refer to the 2015 Plan, as amended and restated, as the 2024 Plan throughout this proxy statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The adoption of the 2024 Plan is necessary to allow us to continue to make our customary annual long-term incentive awards and other equity awards to attract, retain, and motivate our employees, directors, and consultants, and to continue to link the interests of participants to those of our stockholders. If this Proposal No. 1 is approved by our stockholders, the 2024 Plan will become effective as of the date of the Special Meeting. In the event our stockholders do not approve this Proposal No. 1, the 2024 Plan will not become effective, and the 2015 Plan will continue in its current form. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Why You Should Vote for the 2024 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan&#160;Combines Compensation and Governance Best Practices</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan allows us to provide a broad array of equity incentives, including stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, and other stock awards, to our employees, directors, and consultants. By providing this flexibility, we can quickly and effectively react to trends in compensation practices and continue to offer competitive compensation arrangements to attract and retain the talent necessary for the success of our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan includes provisions, summarized below, that are designed to protect our stockholders&#8217; interests and to reflect corporate governance best practices. The plan features discussed below do not purport to be complete and are qualified by the full text of the 2024 Plan, which is attached as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Appendix&#160;A</font><font style="letter-spacing:0.2pt;"> to this proxy statement and incorporated by reference herein. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Stockholder approval is required for additional shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2024 Plan does not contain the annual &#8220;evergreen&#8221; provision that was in the 2015 Plan. The 2024 Plan authorizes a fixed number of shares, so that stockholder approval is required to issue any additional shares under the 2024 Plan in excess thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">No liberal share counting</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2024 Plan eliminates the provision in the 2015 Plan that allowed for shares withheld to cover taxes or the exercise price of awards to reenter the share reserve. Accordingly, the following shares will not become available again for issuance under the 2024 Plan: (i)&#160;shares that are reacquired or withheld (or not issued) by Outlook Therapeutics to satisfy the exercise, strike or purchase price of an award granted under the 2024 Plan; (ii)&#160;shares that are reacquired or withheld (or not issued) by Outlook Therapeutics to satisfy a tax withholding obligation in connection with an award granted under the 2024 Plan; (iii)&#160;shares repurchased by Outlook Therapeutics on the open market with the proceeds of the exercise, strike or purchase price of an award granted under the 2024 Plan; and (iv)&#160;in the event that a stock appreciation right granted under the 2024 Plan is settled in shares, the gross number of shares subject to such stock appreciation right. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">New minimum vesting requirement</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2024 Plan provides that no award granted on or after August&#160;12, 2024 may vest until at least 12&#160;months following the date of grant of such award (excluding (i)&#160;any award granted in connection with a merger or acquisition as permitted by applicable listing rules and (ii)&#160;any award granted to a non-employee director that vests on the earlier of the first anniversary of the date of grant or Outlook Therapeutics&#8217; next annual meeting of stockholders), except that shares up to 5% of the share reserve of the 2024 Plan may be issued pursuant to awards granted on or after August&#160;12, 2024 that do not meet such vesting requirements. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Repricing is not allowed</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2024 Plan amends the 2015 Plan to prohibit the repricing of stock options and stock appreciation rights without prior stockholder approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:50pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Limit on non-employee director compensation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The aggregate value of all compensation paid or granted by us to any individual for service as a non-employee director with respect to any fiscal year of Outlook Therapeutics, including awards granted under the 2024 Plan and cash fees paid by Outlook Therapeutics to such non-employee director, will not exceed $1,000,000 in total value (increased from $400,000 in the 2015 Plan), or in the event such non-employee director is first appointed or elected to the Board during such fiscal year, $1,500,000 in total value. For purposes of this limitation, the value of any equity-based awards is calculated based on the grant date fair value of such awards for financial reporting purposes. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Restrictions on dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2024 Plan adds explicit restrictions on the payment of dividends and dividend equivalents with respect to any shares of our common stock subject to an award granted under the 2024 Plan, providing that (i)&#160;no dividends or dividend equivalents may be paid with respect to any such shares subject to an option or stock appreciation right award, (ii)&#160;no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested, (iii)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of the applicable award agreement (including any vesting conditions), and (iv)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to us on the date such shares are forfeited to or repurchased by us due to a failure to vest. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Specific disclosure of equity award vesting upon a corporate transaction or change in control</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the 2015 Plan, at the time of a corporate transaction or a change in control (each referred to in this Proposal No. 1 as a Transaction), the Board had broad discretion to determine how outstanding awards would be treated. The 2024 Plan specifically provides that if a Transaction occurs and the surviving or acquiring corporation (or its parent company) does not assume or continue outstanding awards under the 2024 Plan or substitute similar stock awards for such outstanding awards, then with respect to any such awards that have not been assumed, continued or substituted and that are held by participants whose continuous service has not terminated prior to the Transaction, the vesting of such awards will be accelerated in full (and with respect to any such awards that are subject to performance-based conditions or requirements, vesting will be deemed to be satisfied at the greater of (x)&#160;the target level of performance or (y)&#160;the actual level of performance measured in accordance with the applicable performance goals as of the date of the Transaction). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">No liberal change in control definition</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The change in control definition in the 2024 Plan is not a &#8220;liberal&#8221; definition. A change in control transaction must actually occur in order for the change in control provisions in the 2024 Plan to be triggered. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">No discounted stock options or stock appreciation rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All stock options and stock appreciation rights granted under the 2024 Plan must have an exercise price equal to or greater than the fair market value of our common stock on the date the stock option or stock appreciation right is granted. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;letter-spacing:0.2pt;">Administrative changes.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2024 Plan also makes certain changes to the 2015 Plan for administrative ease and to reflect changes in applicable law, including, without limitation, updating language allowing for a delegation of authority to approve awards that will be made to non-executive officers, eliminating the requirement that shares withheld to cover taxes must not exceed the minimum statutory tax withholding rate, and adding language regarding the treatment of certain payments or benefits received in connection with a change in control. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overhang</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table provides certain information regarding our equity incentive program. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:158.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.14pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of June&#160;17, 2024</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Record Date) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:344.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock subject to outstanding stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average exercise price of outstanding stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted-average remaining term of outstanding stock options </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8199;&#8199;&#8199;&#8199;years</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock subject to outstanding full value awards</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:344.14pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock available for grant under the 2015 </font>
                <br >
                <font style="letter-spacing:0.2pt;">Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:344.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Per-share closing price of common stock as reported on Nasdaq Stock Market LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.425pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.21pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.21pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">A &#8220;full value award&#8221; is any award other than a stock option or stock appreciation with respect to which the exercise or strike price is at least 100% of the fair market value of our common stock on the date of grant. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.91pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">We Manage Our Equity Award Use Carefully</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We continue to believe that equity awards such as stock options and restricted stock unit awards are a vital part of our overall compensation program. Our compensation philosophy reflects broad-based eligibility for equity awards, and we grant equity awards to substantially all of our employees. However, we recognize that equity awards dilute existing stockholders, and, therefore, we must responsibly manage the growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, including our &#8220;burn rate,&#8221; in a manner intended to maximize stockholders&#8217; value by granting the appropriate number of equity awards necessary to attract, reward, and retain employees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Size of Our Share Reserve Request Is Reasonable</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If this Proposal No. 1 is approved by our stockholders, then subject to adjustment for certain changes in our capitalization, we will have 4,800,000 new shares available for grant under the 2024 Plan after our Special Meeting, plus the Returning Shares (as defined in the 2024 Plan and described below), as such shares become available from time to time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Burn Rate</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table provides detailed information regarding the activity related to our equity incentive program for fiscal&#160;years 2023, 2022 and 2021. On March&#160;14, 2024, we effected a reverse stock split, which we refer to as the Reverse Split, whereby every twenty shares of our issued and outstanding common stock were automatically combined into one issued share of common stock, with corresponding adjustments to all issued and outstanding options. All equity-related information presented in the table below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:416pt;height:104.5pt;margin-left:20pt;margin-top:10.0000000000001pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:248.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:248.76pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock subject to stock </font>
                <br >
                <font style="letter-spacing:0.2pt;">options granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">251,576</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">296,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">673,072</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:248.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Total number of shares of common stock subject to full value awards granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:248.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Weighted-average number of shares of common stock outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12,508,832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">10,603,974</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,633,807</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:248.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Burn Rate</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2.01<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2.80<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8.82<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Burn Rate is calculated as (shares of common stock subject to stock options granted + shares of common stock subject to full value awards granted) / weighted-average shares of common stock outstanding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOT2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Description of the 2024 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A summary of the principal features of the 2024 Plan follows below. The summary does not purport to be complete and is qualified by the full text of the 2024 Plan, which is attached as </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Appendix&#160;A</font><font style="letter-spacing:0.2pt;"> to this proxy statement and incorporated by reference herein. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Purpose</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan is designed to secure and retain the services of our employees, directors, and consultants, to provide incentives for our employees, directors, and consultants to exert maximum efforts for the success of Outlook Therapeutics and its affiliates, and to provide a means by which our employees, directors, and consultants may be given an opportunity to benefit from increases in the value of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Types of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance stock awards, and other stock awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Shares Available for Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may be issued under the 2024 Plan will not exceed the sum of (i)&#160;4,800,000 shares and (ii)&#160;the number of Returning Shares (as defined in the 2024 Plan and described below), as such shares become available from time to time. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The share reserve of the 2024 Plan will not be reduced by any of the following common shares and such shares will remain available for issuance under the 2024 Plan: (i)&#160;any shares subject to an award granted under the 2024 Plan that are not issued because such award or any portion thereof expires or otherwise terminates without all of the shares covered by such award having been issued; and (ii)&#160;any shares subject to an award granted under the 2024 Plan that are not issued because such award or any portion thereof is settled in cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any common stock issued pursuant to an award granted under the 2024 Plan that are forfeited back to or repurchased by Outlook Therapeutics because of a failure to vest, or the Returning Shares, will revert to the share reserve of the 2024 Plan and become available again for issuance under the 2024 Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following common shares will not revert to the share reserve of the 2024 Plan or become available again for issuance under the 2024 Plan: (i)&#160;any shares that are reacquired or withheld (or not issued) by Outlook Therapeutics to satisfy the exercise, strike or purchase price of an award granted under the 2024 Plan (including any shares subject to such award that are not delivered because such award is exercised through a reduction of shares subject to such award (i.e., &#8220;net exercised&#8221;)); (ii)&#160;any shares that are reacquired or withheld (or not issued) by Outlook Therapeutics to satisfy a tax withholding obligation in connection with an award granted under the 2024 Plan; (iii)&#160;any shares repurchased by Outlook Therapeutics on the open market with the proceeds of the exercise, strike or purchase price of an award granted under the 2024 Plan; and (iv)&#160;in the event that a stock appreciation right granted under the 2024 Plan is settled in common shares, the gross number of common shares subject to such award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the 2024 Plan described in this Proposal No. 1 is approved by stockholders, we will file a Registration Statement on Form S-8 with the SEC with respect to the shares of common stock to be registered pursuant to the 2024 Plan as soon as reasonably practicable following stockholder approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Eligibility</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of our (including our affiliates&#8217;) employees, non-employee directors, and consultants are eligible to participate in the 2024 Plan and may receive all types of awards other than incentive stock options. Incentive stock options may be granted under the 2024 Plan only to our (including our affiliates&#8217;) employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of June&#160;17, 2024, the Record Date, we (including our affiliates) had approximately &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; employees, &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; non-employee directors, and &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; consultants. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Administration</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan will be administered by our Board, which may in turn delegate authority to administer the 2024 Plan to a committee of our Board. Our Board has delegated concurrent authority to administer the 2024 Plan to our Compensation Committee, but may, at any time, re-vest in itself some or all of the power delegated to our Compensation Committee. Our Board and our Compensation Committee are each considered to be a Plan&#160;Administrator for purposes of this Proposal No. 1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms of the 2024 Plan, the Plan&#160;Administrator may determine the recipients, the types of awards to be granted, the number of shares of our common stock subject to or the cash value of awards, and the terms and conditions of awards granted under the 2024 Plan, including the period of their exercisability and vesting. The Plan&#160;Administrator also has the authority to provide for accelerated exercisability and vesting of awards. Subject to the limitations set forth below, the Plan&#160;Administrator also determines the fair market value applicable to an award and the exercise or strike price of stock options and stock appreciation rights granted under the 2024 Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Compensation Committee may also delegate to one or more persons or bodies the authority to designate recipients (other than officers) of awards, the number of shares of our common stock subject to such awards, and certain terms of such awards in a manner permitted by applicable law (including the General Corporation Law of the State of Delaware). Any person or body who is delegated such authority may not grant an award to themselves. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Repricing; Cancellation and Re-Grant of Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the 2024 Plan, the Plan&#160;Administrator does not have the authority to reprice any outstanding stock option or stock appreciation right by reducing the exercise or strike price of the stock option or stock appreciation right or to cancel any outstanding stock option or stock appreciation right that has an exercise or strike price greater than the then-current fair market value of our common stock in exchange for cash or other awards without obtaining the approval of our stockholders. Such approval must be obtained within 12&#160;months prior to such an event. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Minimum Vesting Requirements</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the 2024 Plan, no award granted on or after August&#160;12, 2024 may vest until at least 12&#160;months following the date of grant of such award (excluding (i)&#160;any award granted in connection with a merger or acquisition as permitted by applicable listing rules and (ii)&#160;any award granted to a non-employee director that vests on the earlier of the first anniversary of the date of grant or Outlook Therapeutics&#8217; next annual meeting of stockholders), except that shares up to 5% of the share reserve of the 2024 Plan may be issued pursuant to awards granted on or after August&#160;12, 2024 that do not meet such vesting requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Dividends and Dividend Equivalents</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan provides that dividends or dividend equivalents may be paid or credited with respect to any shares of our common stock subject to an award, as determined by the Plan&#160;Administrator and contained in the applicable award agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;no dividends or dividend equivalents may be paid with respect to any such shares subject to an option or stock appreciation right award, (ii)&#160;no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested, (iii)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of the applicable award agreement (including any vesting conditions), and (iv)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to us on the date such shares are forfeited to or repurchased by us due to a failure to vest. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Limit on Non-Employee Director Compensation</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The aggregate value of all compensation paid or granted by us to any individual for service as a non-employee director with respect to any fiscal year of Outlook Therapeutics, including awards granted under the 2024 Plan and cash fees paid by Outlook Therapeutics to such non-employee director, will not exceed </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">$1,000,000 in total value, or in the event such non-employee director is first appointed or elected to the Board during such fiscal year, $1,500,000 in total value. For purposes of this limitation, the value of any equity-based awards is calculated based on the grant date fair value of such awards for financial reporting purposes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stock Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock options may be granted under the 2024 Plan pursuant to stock option agreements. The 2024 Plan permits the grant of stock options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The exercise price of a stock option granted under the 2024 Plan may not be less than 100% of the fair market value of our common stock on the date of grant and, in some cases (see &#8220;&#8212; Limitations on Incentive Stock Options&#8221; below), may not be less than 110% of such fair market value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The term of stock options granted under the 2024 Plan may not exceed 10&#160;years from the date of grant and, in some cases (see &#8220;&#8212; Limitations on Incentive Stock Options&#8221; below), may not exceed five&#160;years from the date of grant. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s service relationship with us or any of our affiliates (referred to in this Proposal No. 1 as &#8220;continuous service&#8221;) terminates (other than for cause and other than upon the participant&#8217;s death or disability), the participant may exercise any vested stock options for up to three&#160;months following the participant&#8217;s termination of continuous service. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service terminates due to the participant&#8217;s disability or death (or the participant dies within a specified period, if any, following termination of continuous service), the participant, or his or her beneficiary, as applicable, may exercise any vested stock options for up to 12&#160;months following the participant&#8217;s termination due to the participant&#8217;s disability or for up to 18&#160;months following the participant&#8217;s death. Except as explicitly provided otherwise in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service is terminated for cause (as defined in the 2024 Plan), all stock options held by the participant will terminate upon the participant&#8217;s termination of continuous service and the participant will be prohibited from exercising any stock option from and after such termination date. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, the term of a stock option may be extended if the exercise of the stock option following the participant&#8217;s termination of continuous service (other than for cause and other than upon the participant&#8217;s death or disability) would be prohibited by applicable securities laws or if the sale of any shares of our common stock received upon exercise of the stock option following the participant&#8217;s termination of continuous service (other than for cause) would violate our insider trading policy. In no event, however, may a stock option be exercised after its original expiration date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Acceptable forms of consideration for the purchase of our common stock pursuant to the exercise of a stock option under the 2024 Plan will be determined by the Plan&#160;Administrator and may include payment: (i)&#160;by cash, check, bank draft or money order payable to us; (ii)&#160;pursuant to a program developed under Regulation&#160;T as promulgated by the Federal Reserve Board; (iii)&#160;by delivery to us of shares of our common stock (either by actual delivery or attestation); (iv)&#160;by a net exercise arrangement (for NSOs only); or (v)&#160;in other legal consideration approved by the Plan&#160;Administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock options granted under the 2024 Plan may vest and become exercisable in cumulative increments, as determined by the Plan&#160;Administrator at the rate specified in the stock option agreement (subject to the limitations described in &#8220;Minimum Vesting Requirements&#8221; above). Shares covered by different stock options granted under the 2024 Plan may be subject to different vesting schedules as the Plan&#160;Administrator may determine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan&#160;Administrator may impose limitations on the transferability of stock options granted under the 2024 Plan in its discretion. Generally, a participant may not transfer a stock option granted under the 2024 Plan other than by will or the laws of descent and distribution or, subject to approval by the Plan&#160;Administrator, pursuant to a domestic relations order or an official marital settlement agreement. However, the Plan&#160;Administrator may permit transfer of a stock option in a manner that is not prohibited by applicable tax and securities laws. In addition, subject to approval by the Plan&#160;Administrator, a participant </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">may designate a beneficiary who may exercise the stock option following the participant&#8217;s death. Notwithstanding the foregoing, no option may be transferred to any financial institution without prior stockholder approval. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Limitations on Incentive Stock Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to ISOs that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or otherwise fail to qualify as ISOs are treated as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any affiliate unless the following conditions are satisfied: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the exercise price of the ISO must be at least 110% of the fair market value of our common stock on the date of grant; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the term of the ISO must not exceed five&#160;years from the date of grant. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of ISOs under the 2024 Plan is 14,400,000 shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Stock appreciation rights may be granted under the 2024 Plan pursuant to stock appreciation right agreements. Each stock appreciation right is denominated in common share equivalents. The strike price of each stock appreciation right will be determined by the Plan&#160;Administrator, but will in no event be less than 100% of the fair market value of our common stock on the date of grant. The term of stock appreciation rights granted under the 2024 Plan may not exceed 10&#160;years from the date of grant. The Plan&#160;Administrator may also impose restrictions or conditions upon the vesting of stock appreciation rights that it deems appropriate (subject to the limitations described in &#8220;Minimum Vesting Requirements&#8221; above). The appreciation distribution payable upon exercise of a stock appreciation right may be paid in shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan&#160;Administrator and set forth in the stock appreciation right agreement. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on transfer as stock options under the 2024 Plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Stock Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restricted stock awards may be granted under the 2024 Plan pursuant to restricted stock award agreements. A restricted stock award may be granted in consideration for cash, check, bank draft or money order payable to us, the participant&#8217;s services performed for us or any of our affiliates, or any other form of legal consideration acceptable to the Plan&#160;Administrator. Shares of our common stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan&#160;Administrator (subject to the limitations described in &#8220;Minimum Vesting Requirements&#8221; above). Rights to acquire shares of our common stock under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that no restricted stock award may be transferred to any financial institution without prior stockholder approval. Upon a participant&#8217;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not vested as of such termination date may be forfeited to or repurchased by us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Stock Unit Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Restricted stock unit awards may be granted under the 2024 Plan pursuant to restricted stock unit award agreements. Payment of any purchase price may be made in any form of legal consideration acceptable to the Plan&#160;Administrator. A restricted stock unit award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan&#160;Administrator and set forth in the restricted stock unit award agreement. Restricted stock unit awards </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">may be subject to vesting in accordance with a vesting schedule to be determined by the Plan&#160;Administrator (subject to the limitations described in &#8220;&#8212; Minimum Vesting Requirements&#8221; above). Except as otherwise provided in a participant&#8217;s restricted stock unit award agreement or other written agreement with us or one of our affiliates, restricted stock&#160;units that have not vested will be forfeited upon the participant&#8217;s termination of continuous service for any reason. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Performance Stock Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A performance stock award is a stock award that is payable (including that may be granted, may vest, or may be exercised) contingent upon the attainment of pre-determined performance goals during a performance period. A performance stock award may require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Plan&#160;Administrator (subject to the limitations described in &#8220;&#8212; Minimum Vesting Requirements&#8221; above). In addition, to the extent permitted by applicable law and the performance stock award agreement, the Plan&#160;Administrator may determine that cash may be used in payment of performance stock awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance goals under the 2024 Plan will be based on any one or more of the following performance criteria: (i)&#160;earnings (including earnings per share and net earnings); (ii)&#160;earnings before interest, taxes and depreciation; (iii)&#160;earnings before interest, taxes, depreciation and amortization; (iv)&#160;earnings before interest, taxes, depreciation, amortization and legal settlements; (v)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation, other non-cash expenses and changes in deferred revenue; (ix)&#160;total stockholder return; (x)&#160;return on equity or average stockholder&#8217;s equity; (xi)&#160;return on assets, investment, or capital employed; (xii)&#160;stock price; (xiii)&#160;margin (including gross margin); (xiv)&#160;income (before or after taxes); (xv)&#160;operating income; (xvi)&#160;operating income after taxes; (xvii)&#160;pre-tax profit; (xviii) operating cash flow; (xix)&#160;sales or revenue targets; (xx)&#160;increases in revenue or product revenue; (xxi)&#160;expenses and cost reduction goals; (xxii)&#160;improvement in or attainment of working capital levels; (xxiii) economic value added (or an equivalent metric); (xxiv)&#160;market share; (xxv)&#160;cash flow; (xxvi)&#160;cash flow per share; (xxvii) cash balance; (xxviii) cash burn; (xxix)&#160;cash collections; (xxx)&#160;share price performance; (xxxi)&#160;debt reduction; (xxxii) implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals, new and supplemental indications for existing products, and product supply); (xxxiii) stockholders&#8217; equity; (xxxiv) capital expenditures; (xxxv)&#160;debt levels; (xxxvi) operating profit or net operating profit; (xxxvii)&#160;workforce diversity; (xxxviii) growth of net income or operating income; (xxxix) billings; (xl) bookings; (xli) employee retention; (xlii) initiation of phases of clinical trials and/or studies by specific dates; (xliii)&#160;acquisition of new customers, including institutional accounts; (xliv) customer retention and/or repeat order rate; (xlv) number of institutional customer accounts (xlvi) budget management; (xlvii) improvements in sample and test processing times; (xlviii) regulatory milestones; (xlix) progress of internal research or clinical programs; (l)&#160;progress of partnered programs; (li) partner satisfaction; (lii) milestones related to samples received and/or tests run; (liii) expansion of sales in additional geographies or markets; (liv) research progress, including the development of programs; (lv) submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product; (lvi) timely completion of clinical trials; (lvii) milestones related to samples received and/or tests or panels run; (lviii)&#160;expansion of sales in additional geographies or markets; (lix) research progress, including the development of programs; (lx) patient samples processed and billed; (lxi) sample processing operating metrics (including, without limitation, failure rate maximums and reduction of repeat rates); (lxii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; and (lxiii) other measures of performance selected by the Plan&#160;Administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance goals may be based on a company-wide basis, with respect to one or more business&#160;units, divisions, affiliates or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The Plan&#160;Administrator is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">authorized to make appropriate adjustments in the method of calculating the attainment of performance goals for a performance period as follows: (i)&#160;to exclude restructuring and/or other nonrecurring charges; (ii)&#160;to exclude exchange rate effects, as applicable, for non-U.S. dollar denominated performance goals; (iii)&#160;to exclude the effects of changes to generally accepted accounting principles; (iv)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (v)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; and (vi)&#160;to make other appropriate adjustments determined by the Plan&#160;Administrator. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Plan&#160;Administrator retains the discretion to reduce or eliminate the compensation or economic benefit due upon the attainment of any performance goals and to define the manner of calculating the performance criteria it selects to use for a performance period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Other Stock Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other forms of awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted either alone or in addition to other awards under the 2024 Plan. Subject to the terms of the 2024 Plan (including the limitations described in &#8220;&#8212; Minimum Vesting Requirements&#8221; above), the Plan&#160;Administrator will have sole and complete authority to determine the persons to whom and the time or times at which such other stock awards will be granted, the number of shares of our common stock to be granted, and all other terms and conditions of such other stock awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Clawback/Recoupment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Awards granted under the 2024 Plan will be subject to recoupment in accordance with the following, as applicable: (i)&#160;the Outlook Therapeutics, Inc. Incentive Compensation Recoupment Policy; (ii)&#160;any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law; and (iii)&#160;any other clawback policy that we adopt and maintain from time to time. In addition, the Plan&#160;Administrator may impose other clawback, recovery or recoupment provisions in an award agreement, including a reacquisition right in respect of previously acquired shares or other cash or property upon the occurrence of cause. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Changes to Capital Structure</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of certain capitalization adjustments, the Plan&#160;Administrator will appropriately adjust: (i)&#160;the class(es) and maximum number of securities subject to the 2024 Plan; (ii)&#160;the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs; and (iii)&#160;the class(es) and number of securities and price per share of stock subject to outstanding awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Corporate Transaction and Change in Control</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following provisions will apply to outstanding awards under the 2024 Plan in the event of a corporate transaction (as defined in the 2024 Plan and described below) or a change in control (as defined in the 2024 Plan and described below) unless otherwise provided in the instrument evidencing the award, in any other written agreement between us or one of our affiliates and the participant, or in any director compensation policy we adopt. For purposes of this Proposal No. 1, the term &#8220;Transaction&#8221; will mean such corporate transaction or change in control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of a Transaction, any surviving or acquiring corporation (or its parent company) may assume or continue any or all outstanding awards under the 2024 Plan, or may substitute similar stock awards for such outstanding awards (including, but not limited to, awards to acquire the same consideration paid to the stockholders of Outlook Therapeutics pursuant to the Transaction), and any reacquisition or repurchase rights held by Outlook Therapeutics in respect of stock issued pursuant to any outstanding awards under the 2024 Plan may be assigned by Outlook Therapeutics to the surviving or acquiring corporation (or its parent company). The terms of any such assumption, continuation or substitution will be set by the Plan&#160;Administrator. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of a Transaction in which the surviving or acquiring corporation (or its parent company) does not assume or continue outstanding awards under the 2024 Plan, or substitute similar stock awards for such outstanding awards, then with respect to any such awards that have not been assumed, continued or substituted and that are held by participants whose continuous service has not terminated prior to the effective time of the Transaction, or the Current Participants, the vesting (and exercisability, if applicable) of such awards will be accelerated in full (and with respect to any such awards that are subject to performance-based vesting conditions or requirements, vesting will be deemed to be satisfied at the greater of (i)&#160;the target level of performance or (ii)&#160;the actual level of performance measured in accordance with the applicable performance goals as of the date of the Transaction) to a date prior to the effective time of the Transaction (contingent upon the closing or completion of the Transaction) as the Plan&#160;Administrator will determine (or, if the Plan&#160;Administrator does not determine such a date, to the date that is five days prior to the effective time of the Transaction), and such awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Plan&#160;Administrator, and any reacquisition or repurchase rights held by Outlook Therapeutics with respect to such awards will lapse (contingent upon the closing or completion of the Transaction). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event of a Transaction in which the surviving or acquiring corporation (or its parent company) does not assume or continue outstanding awards under the 2024 Plan, or substitute similar stock awards for such outstanding awards, then with respect to any such awards that have not been assumed, continued or substituted and that are held by participants other than the Current Participants, such awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Plan&#160;Administrator; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that any reacquisition or repurchase rights held by Outlook Therapeutics with respect to such awards will not terminate and may continue to be exercised notwithstanding the Transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing, in the event any outstanding award under the 2024 Plan held by a participant will terminate if not exercised prior to the effective time of a Transaction, the Plan&#160;Administrator may provide that the participant may not exercise such award but instead will receive a payment, in such form as may be determined by the Plan&#160;Administrator, equal in value to the excess, if any, of (i)&#160;the value of the property the participant would have received upon the exercise of such award immediately prior to the effective time of the Transaction, over (ii)&#160;any exercise price payable by the participant in connection with such exercise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise provided in the instrument evidencing the award, in any other written agreement between us or one of our affiliates and the participant, or in any director compensation policy we adopt, awards granted under the 2024 Plan will not be subject to additional acceleration of vesting and exercisability upon or after a change in control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the 2024 Plan, a corporate transaction generally will be deemed to occur in the event of the consummation of: (i)&#160;a sale or other disposition of all or substantially all of our consolidated assets; (ii)&#160;a sale or other disposition of at least 50% of our outstanding securities; (iii)&#160;a merger, consolidation or similar transaction following which we are not the surviving corporation; or (iv)&#160;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to the transaction are converted or exchanged into other property by virtue of the transaction. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the 2024 Plan, a change in control generally will be deemed to occur in the event: (i)&#160;a person, entity or group acquires, directly or indirectly, our securities representing more than 50% of the combined voting power of our then outstanding securities, other than by virtue of a merger, consolidation, or similar transaction; (ii)&#160;there is consummated a merger, consolidation, or similar transaction and, immediately after the consummation of such transaction, our stockholders immediately prior thereto do not own, directly or indirectly, more than 50% of the combined outstanding voting power of the surviving entity or the parent of the surviving entity in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction; (iii)&#160;there is consummated a sale or other disposition of all or substantially all of our consolidated assets, other than a sale or other disposition to an entity in which more than 50% of the entity&#8217;s combined voting power is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such sale or other disposition; or (iv)&#160;individuals who, on the date the 2024 Plan was adopted by our Board, are members of our Board, or the Incumbent Directors, cease for any reason to constitute at least a majority of the members of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">our Board; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority of the Incumbent Directors then still in office, such new member will be considered as an Incumbent Director; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that no individual initially elected or nominated as a member of our Board as a result of an actual or threatened election contest with respect to Board membership or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than our Board will be deemed to be an Incumbent Director. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Plan&#160;Amendments and Termination</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan&#160;Administrator has the authority to amend or terminate the 2024 Plan at any time. However, except as otherwise provided in the 2024 Plan or an award agreement, no amendment or termination of the 2024 Plan may materially impair a participant&#8217;s rights under his or her outstanding awards without the participant&#8217;s consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will obtain stockholder approval of any amendment to the 2024 Plan as required by applicable law and listing requirements. No incentive stock options may be granted under the 2024 Plan after June 13, 2034, which is the tenth anniversary of the date the 2024 Plan was adopted by our Board. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. Federal Income Tax Consequences</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in the 2024 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#8217;s tax adviser regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired under the 2024 Plan. The 2024 Plan is not qualified under the provisions of Section&#160;401(a) of the Internal Revenue Code of 1986, as amended, or the Code, and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974, as amended. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness, the provisions of Section&#160;162(m) of the Code, and the satisfaction of our tax reporting obligations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Nonstatutory Stock Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain holding period for those shares will begin on that date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Incentive Stock Options</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The 2024 Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in Section&#160;422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two&#160;years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax basis in that share will be long-term capital gain or loss. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Stock Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30&#160;days following his or her receipt of the award, to recognize ordinary income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for the stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of stock acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Restricted Stock Unit Awards</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Generally, the recipient of a restricted stock unit award structured to comply with the requirements of Section&#160;409A of the Code or an exemption to Section&#160;409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section&#160;409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exemption to the requirements of Section&#160;409A of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of stock acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNPBU">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Stock Appreciation Rights</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Section&#160;162(m) Limitations</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Section&#160;162(m) of the Code, or Section&#160;162(m), compensation paid to any publicly held corporation&#8217;s &#8220;covered employees&#8221; that exceeds $1&#160;million per taxable year for any covered employee is generally non-deductible. Awards granted under the 2024 Plan will be subject to the deduction limit under Section&#160;162(m) and will not be eligible to qualify for the performance-based compensation exception under Section&#160;162(m) pursuant to the transition relief provided by the Tax Cuts and Jobs Act. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New Plan&#160;Benefits under 2024 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:146.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:305.57pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:98.43pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:305.57pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">C. Russell Trenary III</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President and Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0.5pt 0.833pt 0pt; width:98.43pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:305.57pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jeff Evanson</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Commercial Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.833pt 0pt; width:98.43pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font> <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font></div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:305.57pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Terry Dagnon</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Former Chief Operations Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 0.833pt 0pt; width:98.43pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font> <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)(2)</font></div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:305.57pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt; width:98.43pt;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font> <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font></div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:305.57pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current directors who are not executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:98.43pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">430,000 shares per year </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:305.57pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">All employees, including all current officers who are not executive officers, as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0.5pt 1.5pt 0pt; width:98.43pt;white-space:nowrap;text-align:right;">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;</font> <font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font></div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Awards granted under the 2024 Plan to our executive officers and other employees are discretionary and are not subject to set benefits or amounts under the terms of the 2024 Plan, and our Board and our Compensation Committee have not granted any awards under the 2024 Plan subject to stockholder approval of this Proposal No. 1. Accordingly, the benefits or amounts that will be received by or allocated to our executive officers and other employees under the 2024 Plan are not determinable. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On December&#160;6, 2023, Mr.&#160;Dagnon ceased to serve as our Chief Operations Officer and an executive officer. Mr.&#160;Dagnon was appointed as Senior Advisor and served in such role until April&#160;11, 2024. As of such date, Mr.&#160;Dagnon would no longer be eligible to receive awards under the 2024 Plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Plan&#160;Benefits under 2015 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth, for each of the individuals and various groups indicated, the total number of shares of our common stock subject to awards that have been granted under the 2015 Plan as of June&#160;17, 2024. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tECPI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:176.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:343.53pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:60.47pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:343.53pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">C. Russell Trenary III </font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President and Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:343.53pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Jeff Evanson </font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Commercial Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:343.53pt;">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Terry Dagnon </font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Former Chief Operations Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.53pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.53pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current directors who are not executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.53pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each associate of any executive officers or current directors </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.53pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each other person who received or is to receive 5% of awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:343.53pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">All employees, including all current officers who are not executive officers, as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60.47pt;white-space:nowrap;text-align:center;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Compensation Plan&#160;Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table provides certain information with respect to all of our equity compensation plans in effect as of September&#160;30, 2023. All equity-related information presented in the table below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:456pt;height:171pt;margin-top:9.99999999999997pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:203.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Plan&#160;Category </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities to be</font>
                <br >
                <font style="letter-spacing:-0.16pt;">issued upon exercise of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">outstanding options,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">warrants and rights</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(a)(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted-average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise price of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">outstanding options,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">warrants and rights</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(b)($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">remaining available for</font>
                <br >
                <font style="letter-spacing:-0.16pt;">issuance under equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">compensation plans</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(excluding securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reflected in column</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(a))(c)(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.5pt 0pt; width:203.13pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Equity compensation plans approved by security holders: </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:203.13pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2011 Stock Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">123</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">999.40<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:203.13pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2015 Equity Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">1,232,774</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">28.72<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">870,754<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:203.13pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">2016 Employee Stock Purchase Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">36,407<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:1.667pt 0pt 1.333pt 0pt; width:203.13pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Equity compensation plans not approved by security holders </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 1.333pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:203.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:33.75pt; text-align:right; white-space:nowrap;">1,232,897</td>
            <td style="padding:0pt;padding-left:17.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.47pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">907,161</td>
            <td style="padding:0pt;padding-left:21.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.41pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents the base price per outstanding performance stock unit, or PSU, award at September&#160;30, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Upon approval of the 2015 Plan, no additional options or awards were granted under the 2011 Stock Incentive Plan; all outstanding stock awards continue to be governed by their existing terms. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.31pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.31pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Number of securities to be issued upon exercise of outstanding options, warrants and rights outstanding at September&#160;30, 2023 under the 2015 Plan comprises option awards only. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.3pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The number of shares of our common stock reserved for issuance under the 2015 Plan automatically increases on January&#160;1st of each year continuing through January&#160;1, 2026, in an amount equal to the lesser of (A)&#160;3% of the total number of shares of our common stock outstanding on December&#160;31st of the immediately preceding calendar year and (B)&#160;a number determined by our board of directors. Accordingly, on January&#160;1, 2024, an additional 390,386 shares were automatically added to the 2015 Plan reserve. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.3pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The number of shares of our common stock reserved for issuance under the 2016 Employee Stock Purchase Plan, or ESPP, automatically increases on January&#160;1st each year continuing through January&#160;1, 2026, by the lesser of (i)&#160;one&#160;percent (1%) of the total number of shares of our common stock outstanding on December&#160;31st of the preceding calendar year, (ii)&#160;11,000 shares of our common stock and (iii)&#160;a number determined by our board of directors. Accordingly, on January&#160;1, 2024, an additional 11,000 shares were automatically added to the ESPP reserve. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:524pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The affirmative vote of the holders of a majority of the voting power of the shares present in person or represented by proxy at the Special Meeting and voting affirmatively or negatively (excluding abstentions and broker non-votes) will be required to approve the 2024 Plan. Abstentions and broker non-votes will have no effect on this proposal. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">THE BOARD OF DIRECTORS RECOMMENDS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">A VOTE &#8220;FOR&#8221; PROPOSAL NO. 1.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSOOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth certain information relating to the beneficial ownership of our common stock as of June&#160;17, 2024, by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our outstanding shares of common stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of our directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of our named executive officers; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all of our directors and executive officers as a group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise indicated, the address for each of the stockholders in the table below is c/o&#160;Outlook Therapeutics, Inc., 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830. Except for information based on Schedules 13G and 13D and information collected in connection with our filing of the Registration Statement on Form S-3 (Registration No. 333- 278209) on March&#160;25, 2024, as indicated in the footnotes, beneficial ownership is stated as of June&#160;17, 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules of the SEC and includes any shares over which a person exercises sole or shared voting or investment power. Applicable&#160;percentage ownership and total voting power are based on &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock outstanding as of June&#160;17, 2024. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown beneficially owned by them, subject to applicable community property laws. Shares of common stock issuable upon vesting, exercise or conversion of outstanding equity awards or warrants that are exercisable, subject to vesting or convertible within 60&#160;days after June&#160;17, 2024 are deemed beneficially owned and such shares are used in computing the&#160;percentage ownership of the person holding such securities, but are not deemed outstanding for the purpose of computing the&#160;percentage ownership of any other person. The information contained in the following table is not necessarily indicative of beneficial ownership for any other purpose, and the inclusion of any shares in the table does not constitute an admission of beneficial ownership of those shares. </font>
        </div>
        <table style="width:456pt;height:304pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Five Percent Stockholders (other than directors and officers):</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">GMS Ventures and Investments</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,266,645</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Syntone Ventures, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,776,867</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with Great Point Partners LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,231,324</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Tang Capital Partners, LP</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,215,851</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">9.9<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Armistice Capital, LLC</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,785,712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Entities affiliated with Sphera</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,458,192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Velan Capital Master Fund&#160;LP</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,250,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Named Executive Officers and Directors:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">C. Russell Trenary III, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director, President and Chief Executive Officer</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jeff Evanson, </font><font style="font-style:italic;letter-spacing:0.2pt;">Chief Commercial Officer</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ralph H. &#8220;Randy&#8221; Thurman, </font><font style="font-style:italic;letter-spacing:0.2pt;">Executive Chairman</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gerd Auffarth, M.D., </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(11)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julian Gangolli, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yezan Haddadin, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(13)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kurt J. Hilzinger, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(14)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Andong Huang, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(15)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:121pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owner </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:40.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:12.71pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:378.88pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Lawrence A. Kenyon, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">Chief Financial Officer, Treasurer and Corporate Secretary</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(16)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:40.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:12.71pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Faisal G. Sukhtian, </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(17)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:40.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:12.71pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julia A. Haller </font><font style="font-style:italic;letter-spacing:0.2pt;">Director</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(18)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:40.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:12.71pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">All executive officers and directors as a group (11 persons)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:40.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:12.71pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents beneficial ownership of less than one&#160;percent (1%) of the outstanding common stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on a Schedule&#160;13D/A filed with the SEC on March&#160;20, 2024 reporting beneficial ownership as of March&#160;18, 2024. Includes 3,458,571 shares of common stock issuable upon exercise of outstanding warrants. GMS Ventures &amp; Investments, a Cayman Islands exempted company, is a private investment vehicle and wholly owned subsidiary of GMS Holdings. Ghiath M. Sukhtian, or Sukhtian, a natural person, is the holder of a controlling interest in GMS Holdings. The principal office address of Sukhtian is Zahran Street, 7th Circle Zahran Plaza Building, 4th Floor P.O. Box 142904, Amman, Jordan 11844. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on a Schedule&#160;13D/A filed with the SEC on April&#160;17, 2024 reporting beneficial ownership as of April&#160;15, 2024. Includes 1,071,429 shares of common stock issuable upon exercise of outstanding warrants. All shares are held directly by Syntone Ventures LLC, a Delaware limited liability company, or Syntone. Syntone LLC, a Delaware limited liability company, or the Manager, is the manager of Syntone, and is wholly-owned by Syntone Technologies Group Co. Ltd., a company organized in the People&#8217;s Republic of China, or Syntone Technologies. The principal business address for each of Syntone and the Manager is 1517 Champlain Crest Way, Cary, NC 27513. The principal business address for Syntone Technologies is Beihuan Road East, Renqiu City, Heibei Province, People&#8217;s Republic of China. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on Schedule&#160;13G filed with the SEC on April&#160;8, 2024 reporting beneficial ownership as of April&#160;1, 2024. The reporting persons hold an aggregate of 2,220,000 shares of common stock issuable upon exercise of outstanding warrants; however, the provisions of such warrants restrict the exercise of such warrants to the extent that, after giving effect to such exercise, the holder of the warrants and its affiliates, together with any other person or entities with which such holder would constitute a group, would beneficially own in excess of 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. As a result, an aggregate of 751,324 shares underlying such warrants were reported as being beneficially owned by the reporting persons in the Schedule&#160;13G. Consists of (i)&#160;816,960 shares of common stock held by Biomedical Value Fund, L.P., or BVF, and 414,731 shares of&#160;common stock underlying warrants held by BVF (of the total warrants to purchase 1,225,440 shares of common stock held by BVF), (ii)&#160;562,400 shares of common stock held by Biomedical Offshore Value Fund, Ltd., or BOVF, and 285,503 shares of common stock underlying warrants held by BOVF (of the total warrants to purchase 843,600 shares of common stock held by BOVF) and (iii)&#160;100,640 shares of common stock held by Cheyne Global Equity Fund (an Open-Ended Fund of Cheyne Select Master Fund&#160;ICAV), or CGEF and together with BVF and BMOVF, the GPP Entities, and 51,090 shares of common stock underlying warrants held by CGEF (of the total warrants to purchase 150,960 shares of common stock held by CGEF). Great Point Partners LLC, or GPP LLC, is the investment manager of BVF and BOVF and the sub-advisor to CGEF, and by virtue of such status may be deemed to be the beneficial owner of the securities held by the GPP Entities. Each of Dr.&#160;Jeffrey R. Jay, M.D., as Senior Managing Member of GPP LLC, and Mr.&#160;Ortav Yehudai, as Managing Director of GPP LLC, has voting and investment power with respect to securities held by the GPP Entities, and therefore may be deemed to be the beneficial owner of the securities held by the GPP Entities. Notwithstanding the above, GPP LLC, Dr.&#160;Jay and Mr.&#160;Yehudai disclaim beneficial ownership of the securities held by the GPP&#160;Entities except to the extent of their respective pecuniary interests. The principal business address for the GPP Entities is 165 Mason Street, 3rd Floor, Greenwich, CT 06830. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on Schedule&#160;13G filed with the SEC on March&#160;28, 2024 reporting beneficial ownership as of March&#160;18, 2024. The reporting person holds an aggregate of 1,151,933 shares of common stock issuable upon exercise of outstanding warrants; however, the provisions of such warrants restrict the exercise of </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">such warrants to the extent that, after giving effect to such exercise, the holder of the warrants and its affiliates, together with any other person or entities with which such holder would constitute a group, would beneficially own in excess of 9.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise. As a result, an aggregate of 596,439 shares underlying such warrants were reported as being beneficially owned by the reporting person in the Schedule&#160;13G. All shares are held directly by Tang Capital Partners, LP. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Kevin Tang has a pecuniary interest in the shares beneficially held by Tang Capital Partners, LP. The principal business address of the reporting person is 4747 Executive Drive, Suite 210 San Diego, CA 92121. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:4.2pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This information was obtained from the stockholder in connection with our filing of the Registration Statement on Form S-3 (Registration No. 333- 278209) on March&#160;25, 2024, and reflects beneficial ownership as of March&#160;18, 2024. Includes 1,071,427 shares of common stock issuable upon exercise of outstanding warrants. These securities are held directly by Armistice Capital Master Fund&#160;Ltd. a Cayman Islands exempted company, or the Master Fund, and may be deemed to be beneficially owned by: (i)&#160;Armistice Capital, LLC, or Armistice Capital, as the investment manager of the Master Fund; and (ii)&#160;Steven Boyd, as the Managing Member of Armistice Capital. The shares of common stock issuable upon exercise of the warrants held by the Master Fund are subject to a beneficial ownership limitation of 4.99%, which is not reflected in the beneficial ownership table above. The principal business address of the reporting person is 510 Madison Avenue, 7th Floor, New York, NY 10022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.2pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">This information was obtained from the stockholder in connection with our filing of the Registration Statement on Form S-3 (Registration No. 333- 278209) on March&#160;25, 2024, and reflects beneficial ownership as of March&#160;18, 2024. Consists of (i)&#160;509,412 shares of common stock held by Sphera Biotech Master Fund&#160;LP, or Sphera Biotech, and 728,571 shares of common stock underlying warrants held by Sphera Biotech and (ii)&#160;91,638 shares of common stock held by Sphera Global Healthcare Master Fund, or Sphera Global and together with Sphera Biotech, the Sphera Funds, and 128,571 shares of common stock underlying warrants held by Sphera Global. Sphera Biotech GP LP, or Sphera General Partner, is the general partner of Sphera Biotech. Sphera Global Healthcare Management LP is the general partner of the Sphera General Partner, and acts as the Investment Manager for the Sphera Funds, and holds voting and investment power over the shares held by each of them. Accordingly, Sphera Global Healthcare Management LP may be deemed to have beneficial ownership of the shares held by the Sphera Funds. Sphera Global Healthcare Management LP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. The shares of common stock issuable upon exercise of the warrants held by each of the Sphera Funds are subject to a beneficial ownership limitation of 9.99%. The principal business address of the reporting persons is 4 Yitzhak Sadeh, Entrance A, 29th Floor, Tel Aviv 6777520, Israel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.2pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Based on Schedule&#160;13G filed with the SEC on March&#160;28, 2024 reporting beneficial ownership as of March&#160;18, 2024. Includes 750,000 shares of common stock issuable upon exercise of outstanding warrants. All shares are held directly by Velan Capital Master Fund, LP, or Velan Capital. Velan Capital Holdings LLC, or Velan GP, as the general partner of Velan Capital, may be deemed to beneficially own the shares beneficially owned by Velan Capital. Velan Capital Investment Management LP, or Velan&#160;IM&#160;GP, as the investment manager of Velan Capital, may be deemed to beneficially own the shares held by Velan Capital. Velan Capital Management LLC, or Velan IM GP, as the general partner of Velan Capital, may be deemed to beneficially own the shares held by Velan Capital. Balaji Venkataraman, as a Managing Member of each of Velan GP and Velan IM GP, may be deemed to beneficially own the shares held by Velan Capital. Adam Morgan, as a Managing Member of each of Velan GP and Velan IM GP, may be deemed to beneficially own the shares held by Velan Capital. The shares of common stock issuable upon exercise of the warrants held by Velan Capital are subject to a beneficial ownership limitation of 19.99%. The principal business address of the reporting person is 100 North Main Street, Suite 301, Alpharetta, Georgia 30009. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held directly by Mr.&#160;Trenary III exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held directly by Mr.&#160;Evanson exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:380pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held by Mr.&#160;Thurman exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents shares of common stock issuable under outstanding options held by Prof.&#160;Dr.&#160;Auffarth exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents shares of common stock issuable under outstanding options held by Mr.&#160;Gangolli exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held directly by Mr.&#160;Haddadin exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held by Mr.&#160;Hilzinger exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(15)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents shares of common stock issuable under outstanding options held by Mr.&#160;Huang exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(16)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held by Mr.&#160;Kenyon exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(17)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Includes &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; shares of common stock issuable under outstanding options held directly by Mr.&#160;Sukhtian exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(18)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Represents shares of common stock issuable under outstanding options held by Dr.&#160;Haller exercisable within 60&#160;days of June&#160;17, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEXCO">&#8203;</a><a name="tSCT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXECUTIVE COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the year ended September&#160;30, 2023, our named executive officers are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">C. Russell Trenary III, our President and Chief Executive Officer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.99pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Jeff Evanson, our Chief Commercial Officer; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.98pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.98pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Terry Dagnon, our former Chief Operations Officer. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We refer to these executive officers herein as our named executive officers. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the information as to compensation awarded to, paid to or earned by our named executive officers. We did not pay any non-equity incentive plan compensation or have any non-qualified deferred compensation earnings and have omitted those columns from the table. All equity-related information presented in the footnotes below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:456pt;height:116.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:191.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:5.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All Other</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:191.43pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">C. Russell Trenary III</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">President and Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,147,963<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">10,899</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,758,862</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">600,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">195,462</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">513,650</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">24,068</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,333,179</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:191.43pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Jeff Evanson</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Commercial Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">450,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">267,025<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,170</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">718,195</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">353,077</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">966,730</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">89,154</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,408,961</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:191.43pt;text-align:left;" rowspan="2">
              <div style="margin-left:10pt; text-indent:-10pt; text-align:justify; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Terry Dagnon</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(5)</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Former Chief Operations Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:15pt; text-align:right; white-space:nowrap;">2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">450,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">267,025<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">11,358</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:30.75pt; text-align:right; white-space:nowrap;">728,383</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">353,077</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">966,730</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt; width:5.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">114,148</td>
            <td style="padding:0pt;padding-left:7.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,433,955</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the stock option awards granted computed in accordance with ASC 718, for stock-based compensation transactions. These amounts do not reflect the actual economic value that would be realized by the named executive officer upon the exercise of the stock options. For a discussion of the assumptions used in determining the fair value of stock option awards in the above table and other additional information on the stock options granted, refer to Note 12 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on December&#160;22, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:5.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Amounts in this column consist of the payment of term life insurance premiums, along with 401(k) matching contributions, where applicable. These benefits are provided to the named executive officers on the same terms as provided to all of our regular full time employees. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:5.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On November&#160;18, 2022, Mr.&#160;Trenary received a performance-based option to purchase 50,000 shares of our common stock with a grant date fair value of $912,760, which was subsequently forfeited in accordance with its terms due to non-satisfaction of the applicable performance criteria. See &#8220;Agreements with our Named Executive Officers&#8221; below for additional information. On April&#160;17, 2023, Mr.&#160;Trenary received an option to purchase 12,857 shares of our common stock with a grant date fair value of $235,203. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:5.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On November&#160;18, 2022, Mr.&#160;Evanson and Mr.&#160;Dagnon each received a performance-based option to purchase 5,000 shares of our common stock with a grant date fair value of $91,276, which were subsequently forfeited in accordance with their terms due to non-satisfaction of the applicable performance criteria. See &#8220;Agreements with our Named Executive Officers&#8221; below for additional information. On April&#160;17, 2023, Mr.&#160;Evanson and Mr.&#160;Dagnon each received options to purchase 9,657 shares of our common stock with a grant date fair value of $175,749. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:5.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">On December&#160;6, 2023, Mr.&#160;Dagnon ceased to serve as our Chief Operations Officer and an executive officer. Mr.&#160;Dagnon was appointed as Senior Advisor and served in such role until April&#160;11, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tNTSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Narrative to Summary Compensation Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Retirement Benefits</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our named executive officers are eligible to participate in a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees may defer eligible compensation on a pre-tax, after-tax, or Roth basis, up to the statutorily prescribed annual limits on contributions under the Internal Revenue Code of 1986, as amended, or the Code. We may make matching contributions for the plan year ending December&#160;31, based on employee deferrals for the plan year, in an amount equal to up to 3% of compensation deferred. For the 2023 plan year, we made company matching contributions to the 401(k) plan. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code, with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan (except for Roth contributions) and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Agreements with our Named Executive Officers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Below are written descriptions of our compensation arrangements with our named executive officers. All equity-related information presented in this narrative gives retroactive effect to Reverse Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mr</font><font style="letter-spacing:0.2pt;">. </font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Trenary.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In July&#160;2021, in connection with Mr.&#160;Trenary&#8217;s appointment as President and Chief Executive Officer of the Company, we entered into an employment agreement with Mr.&#160;Trenary providing for, among other things, an initial base salary of $600,000 and a discretionary annual cash bonus with a target amount equal to 70% of Mr.&#160;Trenary&#8217;s base salary. Mr.&#160;Trenary received an initial option to purchase 200,000 shares of common stock, one quarter of which vested on the first anniversary of the date of grant and the remainder of which is vesting in monthly installments over the next three&#160;years, subject to Mr.&#160;Trenary&#8217;s continued service through each vesting date. On December&#160;21, 2021, Mr.&#160;Trenary received an option to purchase 75,000 shares of common stock, vesting based upon the Company&#8217;s achievement of certain performance milestones. 50,000 of the shares underlying this performance option were forfeited in accordance with their terms due to non-satisfaction of the applicable performance criteria. The remaining 25,000 shares underlying this performance option vested for Mr.&#160;Trenary on March&#160;31, 2022 in accordance with their terms based on the Company&#8217;s submission of the ONS-5010 BLA on or prior to the last day of the first calendar quarter of 2022. On November&#160;18, 2022, Mr.&#160;Trenary received an option to purchase 50,000 shares of our common stock, which was set to vest based upon the Company&#8217;s achievement of certain performance milestones and was forfeited in accordance with its terms due to non-satisfaction of the applicable performance criteria. On April&#160;17, 2023, Mr.&#160;Trenary received an option to purchase 12,857 shares of our common stock, one quarter of which will vest on the first anniversary of the date of grant and the remainder of which will vest in equal monthly installments over the next three&#160;years, subject to Mr.&#160;Trenary&#8217;s continued service through each vesting date. Mr.&#160;Trenary is entitled to certain severance and change in control benefits pursuant to his employment agreement, the terms of which are described below under &#8220;&#8212; Potential Payments upon Termination or Change of Control.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mr.&#160;Evanson and Mr.&#160;Dagnon.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;On December&#160;21, 2021, we entered into employment agreements with each of Mr.&#160;Evanson and Mr.&#160;Dagnon. Pursuant to their employment agreements, each of Mr.&#160;Evanson and Mr.&#160;Dagnon receives a base salary of $450,000 and a discretionary annual cash bonus with a target amount equal to 50% of his respective base salary In connection with their entry into the employment agreements, each of Mr.&#160;Evanson and Mr.&#160;Dagnon received an option to purchase 40,000 shares of common stock, one quarter of which vested on the first anniversary of the date of grant and the remainder of which is vesting in monthly installments over the succeeding three&#160;years, subject to their continued service through each vesting date. In addition, each of Mr.&#160;Evanson and Mr.&#160;Dagnon received a performance-vesting option to purchase 10,000 shares of common stock, 5,000 of which were forfeited by each of Mr.&#160;Evanson and Mr.&#160;Dagnon in accordance with their terms due to non-satisfaction of the applicable performance criteria. The remaining 5,000 shares underlying these performance options vested for each of Mr.&#160;Evanson and Mr.&#160;Dagnon on March&#160;31, 2022 in accordance with their terms based on the Company&#8217;s submission of the ONS-5010 BLA on or prior to the last day of the first calendar quarter of 2022. On November&#160;18, 2022, Mr.&#160;Evanson and Mr.&#160;Dagnon each received options to purchase 5,000 shares of our common stock, which were set to vest </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">based upon the Company&#8217;s achievement of certain performance milestones and were forfeited in accordance with their terms due to non-satisfaction of the applicable performance criteria. On April&#160;17, 2023, each of Mr.&#160;Evanson and Mr.&#160;Dagnon received options to purchase 9,607 shares of our common stock, one quarter of which will vest on the first anniversary of the date of grant and the remainder of which is vesting in equal monthly installments over the next three&#160;years, subject to the recipient&#8217;s continued service through each vesting date. Under their employment agreements, Mr.&#160;Evanson and Mr.&#160;Dagnon are entitled to certain severance and change in control benefits, the terms of which are described below under &#8220;&#8212; Potential Payments upon Termination or Change of Control.&#8221; On December&#160;6, 2023, Mr.&#160;Dagnon ceased to serve as our Chief Operations Officer and an executive officer. Mr.&#160;Dagnon was appointed as Senior Advisor and served in such role until April&#160;11, 2024, during which time he received the same compensation as provided for under his employment agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Payments Upon Termination or Change of Control</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Regardless of the manner in which one of our named executive officer&#8217;s service terminates, each is generally entitled to receive amounts earned during his term of service, including salary and unused vacation pay. The terms of each named executive officer&#8217;s potential payments upon termination or change of control are summarized below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mr.&#160;Trenary</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Pursuant to Mr.&#160;Trenary&#8217;s current executive employment agreement, if he is terminated without cause or if he resigns for good reason, subject to his execution of a separation agreement with an effective release of claims in favor of us and continued compliance with certain restrictive covenants set forth in such employment agreement and the Company&#8217;s proprietary information, inventions, non-competition and non-solicitation agreement, or PIIA, he is entitled to continued payment of his base salary for 12&#160;months following the termination, 100% of his target bonus for the calendar year of termination paid in a lump sum, employee benefit coverage for up to 12&#160;months, full vesting of 50% of his then unvested equity awards, and reimbursement of expenses owed to him through the date of his termination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If Mr.&#160;Trenary&#8217;s employment is terminated by us or any successor entity (provided such successor entity either assumes Mr.&#160;Trenary&#8217;s equity awards or substitutes similar equity awards) without cause or if he resigns for good reason within two&#160;months prior to or within 12&#160;months following a change in control (as defined in the Company&#8217;s 2015 Equity Incentive Plan, as amended, or the 2015 Plan), subject to his execution of a separation agreement with an effective release of claims in favor of us and continued compliance with certain restrictive covenants set forth in such employment agreement and the PIIA, he is entitled to continued payment of his base salary for 18&#160;months, 150% of his annual target bonus for the calendar year of termination paid in a lump sum, employee benefit coverage for up to 18&#160;months, and reimbursement of expenses owed to him through the date of his termination. Additionally, 100% of his then unvested equity awards shall become fully vested. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of Mr.&#160;Trenary&#8217;s employment agreement: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Cause&#8221; for termination means that the Company has determined in its sole discretion that Mr.&#160;Trenary has engaged in any of the following: (i)&#160;a material breach of any covenant or condition under his employment agreement or any other agreement between Mr.&#160;Trenary and the Company; (ii)&#160;any act constituting dishonesty, fraud, immoral or disreputable conduct; (iii)&#160;any conduct which constitutes a felony under applicable law; (iv)&#160;material violation of any Company policy or any act of misconduct; (v)&#160;refusal to follow or implement a clear and reasonable directive of the Company; (vi)&#160;negligence or incompetence in the performance of his duties or failure to perform such duties in a manner satisfactory to the Company after the expiration of 10&#160;days without cure after written notice of such failure; or (vii)&#160;breach of fiduciary duty. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Good reason&#8221; means the occurrence of any of the following events without Mr.&#160;Trenary&#8217;s consent: (i)&#160;a material reduction in his base salary of at least 25%; (ii)&#160;a material breach of the employment agreement by us; (iii)&#160;a material reduction in Mr.&#160;Trenary&#8217;s duties, authority and responsibilities relative to his duties, authority, and responsibilities in effect immediately prior to such reduction; or (iv)&#160;the relocation of Mr.&#160;Trenary&#8217;s principal place of employment, without his consent, in a manner that lengthens his one-way commute distance by 50 or more miles from his then-current principal place of employment immediately prior to such relocation; provided, however, that none of the events described </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOEAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; text-align:justify; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in this sentence will constitute good reason unless and until (x)&#160;Mr.&#160;Trenary first notifies us in writing describing in reasonable detail the condition(s) that constitutes good reason within 30&#160;days of its occurrence, (y)&#160;we fail to cure the condition(s) within 30&#160;days after our receipt of written notice, and (z)&#160;Mr.&#160;Trenary voluntarily terminates his employment within 30&#160;days after the end of 30-day cure period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mr.&#160;Evanson.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Pursuant to Mr.&#160;Evanson&#8217;s current executive employment agreement, if he is terminated without cause or if Mr.&#160;Evanson terminates his employment for good reason, he would be entitled to receive an amount equal to 12&#160;months of his base salary plus a bonus equal to 150% of his full target amount, employee benefit coverage for up to 12&#160;months, as well as the acceleration of 50% of his unvested equity awards subject to time-based vesting requirements. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of Mr.&#160;Evanson&#8217;s employment agreement: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Cause&#8221; is generally as defined above with respect to Mr.&#160;Trenary&#8217;s employment agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Good reason&#8221; generally means the occurrence of any of the following events without Mr.&#160;Evanson&#8217;s consent: (i)&#160;a material reduction in Mr.&#160;Evanson&#8217;s base salary of at least 25%; (ii)&#160;a material breach of the employment agreement by the Company; (iii)&#160;a material reduction in Mr.&#160;Evanson&#8217;s duties, authority and responsibilities relative to Mr.&#160;Evanson&#8217;s duties, authority, and responsibilities in effect immediately prior to such reduction; or (iv)&#160;the relocation of Mr.&#160;Evanson&#8217;s principal place of employment, without his consent, in a manner that lengthens his one-way commute distance by 50 or more miles from his then-current principal place of employment immediately prior to such relocation, not to include Mr.&#160;Evanson&#8217;s initial relocation to a new headquarters to be established at the direction of the board of directors; provided, however, that none of the events described in this sentence will constitute good reason unless and until (x)&#160;Mr.&#160;Evanson first notifies us in writing describing in reasonable detail the condition(s) that constitutes good reason within 30&#160;days of its occurrence, (y)&#160;we fail to cure the condition(s) within 30&#160;days after our receipt of written notice, and (z)&#160;Mr.&#160;Evanson voluntarily terminates his employment within 30&#160;days after the end of 30-day cure period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Mr.&#160;Dagnon.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Pursuant to Mr.&#160;Dagnon&#8217;s executive employment agreement, if he were terminated without cause or if Mr.&#160;Dagnon terminated his employment for good reason, he would be entitled to receive an amount equal to 12&#160;months of his base salary plus a bonus equal to his full target amount, employee benefit coverage for up to 12&#160;months, as well as the acceleration of 50% of his unvested equity awards subject to time-based vesting requirements. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of Mr.&#160;Dagnon&#8217;s employment agreement: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Cause&#8221; is generally as defined above with respect to Mr.&#160;Trenary&#8217;s employment agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8220;Good reason&#8221; is generally as defined above with respect to Mr.&#160;Evanson&#8217;s employment agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Outstanding Equity Awards at Fiscal Year End</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth certain information regarding equity awards granted to our named executive officers that remain outstanding as of September&#160;30, 2023. All equity-related information presented in the table below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:456pt;height:130pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:131.73pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="34">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:131.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Grant date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity incentive</font>
                <br >
                <font style="letter-spacing:-0.16pt;">plan awards:</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unearned</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:131.73pt;text-align:left;" rowspan="3">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">C. Russell Trenary III&#8201; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/06/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:24.75pt; text-align:right; white-space:nowrap;">108,332</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">91,668<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.40</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/06/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,000</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28.80</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">04/17/2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">12,857<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.60</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">04/17/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tM2OA">&#8203;</a><a name="tCLPO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:175pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:131.73pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="34">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:131.73pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Grant date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity incentive</font>
                <br >
                <font style="letter-spacing:-0.16pt;">plan awards:</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.16pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unearned</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options (#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:131.73pt;text-align:left;" rowspan="3">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Jeff Evanson&#8201; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">5,000</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28.80</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,500</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,500<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28.80</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">04/17/2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">9,607<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.60</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/17/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:131.73pt;text-align:left;" rowspan="3">
              <div style="white-space:nowrap; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Terry Dagnon&#8201; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">5,000</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28.80</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; line-height:12pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:15pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2021</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,500</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,500<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">28.80</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">12/21/2031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:19pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">04/17/2023</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">9,607<font style="position:absolute;"><font style=" position:relative; bottom:3.25pt;font-size:6.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:8.235pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:21.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21.60</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">07/17/2033</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The outstanding equity awards as of September&#160;30, 2023 are stock options that were granted under and subject to the terms of the 2015 Plan. Except as otherwise indicated, each stock option is subject to vesting, subject to the executive&#8217;s continuous service with us through the vesting dates (or satisfaction of the vesting conditions) and the potential vesting acceleration of the time-based vesting conditions upon a change in control and certain terminations of employment. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Twenty-five&#160;percent of the shares subject to the option vested on July&#160;6, 2022, with the remaining shares vesting in equal monthly installments over the following three&#160;years thereafter, subject to Mr.&#160;Trenary&#8217;s continuous service with the Company on each such date. The option is also subject to acceleration under certain circumstances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Twenty-five&#160;percent of the shares subject to the option will vest on April&#160;17, 2024, with the remaining shares vesting in equal monthly installments over the following three&#160;years thereafter, subject to continuous service with the Company on each such date. The option is also subject to acceleration under certain circumstances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Twenty-five&#160;percent of the shares subject to the option vested on December&#160;21, 2022, with the remaining shares vesting in equal monthly installments over the following three&#160;years thereafter, subject to continuous service with the Company on each such date. The option is also subject to acceleration under certain circumstances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">March&#160;2024 Option Awards</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;20, 2024, the Board awarded options to purchase common stock pursuant to the 2015 Plan to each of: Mr.&#160;Trenary (910,000 options), Mr.&#160;Evanson (50,000 options) and Mr.&#160;Dagnon (5,000 options). Half of each individual&#8217;s award comprised time-based options, which vest as follows: 25% of the shares subject to the option vest on March&#160;20, 2025, with the remaining shares vesting in equal monthly installments over the following three&#160;years thereafter, subject to the individual&#8217;s continued employment with the Company at each vesting date. The remaining half of each individual&#8217;s award comprised performance-based options, which will vest 25% upon the Company&#8217;s achievement of a specified milestone and the remainder in equal monthly installments over the three&#160;years following achievement of the milestone, subject to the individual&#8217;s continued employment with the Company at each applicable vesting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clawback Policy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC adopted final rules implementing the incentive-based compensation recovery provisions of the Dodd-Frank Act, and Nasdaq has adopted listing standards consistent with the SEC rules. In compliance with those standards, we have adopted an incentive compensation recoupment policy, or &#8220;clawback&#8221; policy, which applies to our executive officers, within the meaning of Section&#160;10D of the Exchange Act and Rule&#160;10D-1 promulgated thereunder, who were employed by the Company or a subsidiary of the Company during the applicable recovery period. Under the policy, in the event that the financial results upon which a cash or equity-based incentive award was predicated become the subject of a financial restatement that is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tHETR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:488pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">required because of material non-compliance with financial reporting requirements, the Compensation Committee will conduct a review of awards covered by the policy and recoup any erroneously awarded incentive-based compensation to ensure that the ultimate payout gives retroactive effect to the financial results as restated. The policy covers any cash or equity-based incentive compensation award that was paid, earned or granted to a covered officer during the last completed three fiscal&#160;years immediately preceding the date on which the Company is required to prepare the accounting restatement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Hedging Transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Insider Trading Policy prohibits officers, directors, employees or our consultants from engaging in short sales, transactions in put or call options, hedging transactions, margin accounts, pledges, or other inherently speculative transactions with respect to our securities at any time.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDICO">&#8203;</a><a name="tNDCP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DIRECTOR COMPENSATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information concerning the compensation earned for service on the Board during the year ended September&#160;30, 2023. Mr.&#160;Trenary&#8217;s compensation as an executive officer is set forth under &#8220;&#8212; Summary Compensation Table.&#8221; Mr.&#160;Trenary and Mr.&#160;Kenyon did not receive any additional compensation for service as a director. None of our directors earned any compensation other than cash fees or stock option awards under the 2015 Plan during the fiscal year ended September&#160;30, 2023. Accordingly, we have omitted all other columns from the table below. All equity-related information presented in the footnotes below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:456pt;height:146.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fees Earned or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid in Cash</font><font style=" position:relative; bottom:3.25pt;line-height:6pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font><font style=" position:relative; bottom:3.25pt;line-height:6pt;font-size:5pt;letter-spacing:-0.12pt;">(2)(3)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Randy Thurman </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">207,500</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">242,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gerd Auffarth </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">79,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julian Gangolli </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">77,500</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">112,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kurt Hilzinger </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">60,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">95,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yezan Haddadin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">110,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Andong Huang </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">40,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">75,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Faisal G. Sukhtian </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">78,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:294.29pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julia A. Haller </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">44,000</td>
            <td style="padding:0pt;padding-left:5.985pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:5.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">79,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.9pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.41pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">All non-employee directors, except Randy Thurman, elected to receive annual cash fees pursuant to our non-employee director compensation policy, as in effect during fiscal 2023, in the form of stock options. See discussion below under &#8220;&#8212; Non-Employee Director Compensation Policy&#8221; for cash retainers, as well as discussion of stock options in lieu of fees below under &#8220;&#8212; Non-Employee Director Compensation Policy&#8201;&#8212;&#8201;Option Awards in Lieu of Cash Fees.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Reflects the aggregate grant date fair value of the stock option awards granted computed in accordance with ASC 718, for stock-based compensation transactions. These amounts do not reflect the actual economic value that would be realized by the director upon exercise of the stock options. For a discussion of the assumptions used in determining the fair value of awards of stock options in the above table and other additional information on stock options granted, refer to Note 11 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K filed with the SEC on December&#160;22, 2023. Amounts exclude stock options granted in lieu of cash fees in addition to annual grants. See discussion of stock options in lieu of cash fees below under &#8220;&#8212; Non-Employee Director Compensation Policy&#8201;&#8212;&#8201;Option Awards in Lieu of Cash Fees.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.41pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.41pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">As of September&#160;30, 2023, the following non-employee directors held options to purchase the following number of shares of our common stock: Randy Thurman (63,992), Gerd Auffarth (20,334), Julian Gangollli (26,918), Kurt Hilzinger (42,008), Yezan Haddadin (45,252), Andong Huang (19,213), Faisal Sukhtian (45,160), Julia Haller (5,414). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-Employee Director Compensation Policy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have adopted a non-employee director compensation policy, pursuant to which our non-employee directors are eligible to receive compensation for service on the Board and committees of the Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the year ended September&#160;30, 2023, each non-employee director received the compensation described below. All equity-related information presented in the narrative below gives retroactive effect to Reverse Split. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Equity Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial Grant</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each new non-employee director who joins the Board is granted a non-statutory stock option to purchase 1,250 shares of common stock under the 2015 Plan, which options vest annually over the three&#160;years from the grant date, subject to continued service as a director through the applicable vesting date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:26.61pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Annual Grant</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">On the date of each annual meeting of our stockholders, each non-employee director also receives an annual non-statutory stock option grant under the 2015 Plan with respect to a number of shares of our common stock having an aggregate &#8220;fair value&#8221; of $35,000 as of the annual meeting date, determined using a Black-Scholes or binominal valuation model regularly used by us on the grant date. These options vest on the earlier of the first anniversary of the grant date or the date of the next annual meeting of our stockholders, subject to continued service as a director through the applicable vesting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cash Compensation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Each non-employee director receives an annual cash retainer of $40,000 for serving on the Board. The chairperson of the Board also receives an additional annual cash retainer of $30,000. In the event that the chairperson is an employee and the Board appoints a Lead Independent Director, that person will receive the additional annual cash retainer otherwise payable to the chairperson. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, as Executive Chairman, Mr.&#160;Thurman is entitled to an additional annual retainer of $120,000 payable in equal monthly installments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The chairperson and members of the four standing committees of the Board are generally entitled to the following annual cash retainers: </font>
        </div>
        <table style="width:416pt;height:77.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:318.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Board Committee </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Chairperson</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fee </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Member</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fee </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:318.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Audit Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">15,000</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">7,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:318.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Compensation Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,000</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">5,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:318.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nominating and Corporate Governance Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:318.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Executive Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">30,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">All annual cash compensation amounts are payable in equal quarterly installments in arrears, on the last day of each fiscal quarter for which the service occurred, pro-rated based on the days served in the applicable fiscal quarter. As discussed below under &#8220;&#8212; Option Awards in Lieu of Cash Fees,&#8221; with respect to the 2023 fiscal year, Messrs. Hilzinger, Haddadin, Sukhtian, Gangolli and Huang, Prof.&#160;Dr.&#160;Auffarth and Dr.&#160;Haller elected to receive a one-time equity grant in lieu of cash fees. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option Awards in Lieu of Cash Fees</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under the non-employee director compensation policy, for the 2023 fiscal year, each non-employee director had the option to elect to receive all annual cash compensation in the form of stock options granted pursuant to the 2015 Plan. Effective October&#160;1, 2023, for the 2024 fiscal year, each non-employee director may elect to receive either 50% or all of the annual cash compensation in the form of stock options granted pursuant to the 2015 Plan. This election must be made prior to the beginning for the applicable fiscal year, and each non-employee director must submit a new election for each fiscal year. If a non-employee director elects to receive compensation in the form of stock options, such stock options are automatically be granted on the third business day in October of such fiscal year and vest as follows: (i)&#160;25% will vest on the last day of the first fiscal quarter during such fiscal year, and (ii)&#160;25% will vest on the last day of each subsequent fiscal quarter during such fiscal year, provided the non-employee director is in service as a director on the first day of the fiscal quarter of the applicable scheduled vesting date. Non-employee directors who join the Board mid-fiscal year must make their elections within 30&#160;days following commencement of service, and options are automatically granted on the first day of the fiscal quarter following such election. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:413pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In accordance with such election in the fiscal year 2023, our non-employee directors were granted the following option awards. All equity-related information presented in the table below gives retroactive effect to Reverse Split. </font>
        </div>
        <table style="width:456pt;height:154pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:217.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Grant date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">options</font>
                <br >
                <font style="letter-spacing:-0.16pt;">granted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Grant date</font>
                <br >
                <font style="letter-spacing:-0.16pt;">fair value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">exercise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">expiration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kurt Hilzinger </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,879</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yezan Haddadin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,599</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Faisal Sukhtian </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,743</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julian Gangolli </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,719</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Gerd Auffarth </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,111</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Andong Huang </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,919</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:217.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Julia A. Haller </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,111</td>
            <td style="padding:0pt;padding-left:6.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">20.80</td>
            <td style="padding:0pt;padding-left:6.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">25.00</td>
            <td style="padding:0pt;padding-left:1.65pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">10/5/2032</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPVP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">PAY VERSUS PERFORMANCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">As required by Section&#160;953(a) of the Dodd-Frank Act, and Item&#160;402(v) of Regulation&#160;S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial performance of the Company. For information on our executive compensation program and the Compensation Committee&#8217;s approach, refer to the above Narrative Disclosure to Summary Compensation Table and Outstanding Equity Awards Table. </font>
        </div>
        <table style="width:456pt;height:92.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:87.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Summary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">for PEO</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually Paid</font>
                <br >
                <font style="letter-spacing:-0.16pt;">to PEO</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Summary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">for Non-PEO</font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEOs</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually Paid</font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Non-PEO</font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEOs</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Initial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fixed $100</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Investment</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Based On Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shareholder</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Return</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Net Income</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Loss)</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:87.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,758,862</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(952,353<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">723,289</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,711</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.515pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:18.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(58,982,668<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:87.49pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,333,179</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,834,604<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,421,458</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,422,428</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.515pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">56</td>
            <td style="padding:0pt;padding-left:18.515pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">(66,052,264<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.29pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">For each of the two&#160;years presented in the above table, C. Russell Trenary III was our Principal Executive Officer, or PEO, and our non-PEO named executive officers, or the Non-PEO NEOs, were Jeff Evanson and Terry Dagnon. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported in this column are the amounts of total compensation reported for our PEO for each corresponding year in the &#8220;Total&#8221; column of the Summary Compensation Table. Refer to &#8220;Executive Compensation&#8201;&#8212;&#8201;Summary Compensation Table.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported this column represent the amount of &#8220;compensation actually paid&#8221; to the PEO, as computed in accordance with Item&#160;402(v) of Regulation&#160;S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to the PEO during the applicable year. In accordance with the requirements of Item&#160;402(v) of Regulation&#160;S-K, the following adjustments were made to the PEO&#8217;s total compensation for each year to determine the compensation actually paid: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:74.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:170.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Reported</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Summary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Total for PEO </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Reported</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value of Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(a)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(b)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid to PEO </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:170.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.475pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,758,862</td>
            <td style="padding:0pt;padding-left:1.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,147,963<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,563,252<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(952,353<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:170.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.475pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,333,179</td>
            <td style="padding:0pt;padding-left:1.475pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.695pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(513,650<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,135,033<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(3,834,604<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13.3pt; width:436pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:8.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The grant date fair value of equity awards represents the total of the amounts reported in the &#8220;Option Awards&#8221; columns in the Summary Compensation Table for the applicable year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i)&#160;the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii)&#160;the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior&#160;years that are outstanding and unvested as of the end of the applicable year; (iii)&#160;for awards that are granted and vest in the same applicable year, the fair value as of the vesting date; (iv)&#160;for awards granted in prior&#160;years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v)&#160;for awards granted in prior&#160;years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi)&#160;the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:416pt;height:155.5pt;margin-left:20pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Current Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards at</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Year End </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Years&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unvested at</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Year End </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value as of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Vesting Date of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Current Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Change in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Years&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">that Vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in the Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">at the End</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of the Prior</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Year of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">that Failed to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Meet Vesting</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Conditions</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in the Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dollar</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Dividends or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">other Earnings</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid during</font>
                <br >
                <font style="letter-spacing:-0.16pt;">the Year on</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">not Otherwise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Reflected in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:36.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">43,611</td>
            <td style="padding:0pt;padding-left:5.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,482,449<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(124,414<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:14.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,563,252<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">841,300</td>
            <td style="padding:0pt;padding-left:2.895pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.155pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.155pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(2,558,219<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,177,664<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,759,550</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.535pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(1,135,033<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:1.99pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:1.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported in this column represent the average of the amounts reported for the Company&#8217;s Non-PEO NEOs as a group in the &#8220;Total&#8221; column of the Summary Compensation Table in each applicable year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported in this column represent the average amount of &#8220;compensation actually paid&#8221; to our Non-PEO NEOs as a group, as computed in accordance with Item&#160;402(v) of Regulation&#160;S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the Non-PEO NEOs as a group during the applicable year. In accordance with the requirements of Item&#160;402(v) of Regulation&#160;S-K, the following adjustments were made to average total compensation for the Non-PEO NEOs as a group for each year to determine the compensation actually paid, using the same methodology described above in Note 3: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:92.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:160.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Reported</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Summary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Table Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">for Non-PEO</font>
                <br >
                <font style="letter-spacing:-0.16pt;">NEOs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Reported</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value of Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(a)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Actually Paid to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Non-PEO NEOs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:160.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">723,289</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(267,025<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(449,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,711</td>
            <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:160.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,421,458</td>
            <td style="padding:0pt;padding-left:0.960000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(966,730<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">967,700</td>
            <td style="padding:0pt;padding-left:4.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,422,428</td>
            <td style="padding:0pt;padding-left:5.92pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:12.1pt; width:436pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:20pt; margin-top:7.6pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts deducted or added in calculating the total average equity award adjustments are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:146.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:38.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of Current</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Year Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Awards at</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Year End </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Change in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Years&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">Unvested at</font><br ><font style="letter-spacing:-0.16pt;">Year End </font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">as of Vesting</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Date of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Current Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Change in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Years&#8217;</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">that Vested</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in the Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">at the End</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of the</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Prior Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of Prior Year</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Equity Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">that Failed to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Meet Vesting</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Conditions</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in the Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Dollar Value of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Dividends or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">other Earnings</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Paid during</font>
                <br >
                <font style="letter-spacing:-0.16pt;">the Year on</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock or</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option Awards</font>
                <br >
                <font style="letter-spacing:-0.16pt;">not Otherwise</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Reflected in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">or Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Total Equity</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Award</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Adjustments </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:38.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">32,587</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(379,707<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(102,433<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.25pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:14.25pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:15.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.330000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(449,553<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.330000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:38.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.025pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">168,260</td>
            <td style="padding:0pt;padding-left:1.025pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">799,440</td>
            <td style="padding:0pt;padding-left:6.52pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.73pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.25pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.25pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.330000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">967,700</td>
            <td style="padding:0pt;padding-left:0.330000000000002pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:2.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Total Shareholder Return is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#8217;s share price at the end and the beginning of the measurement period by the Company&#8217;s share price at the beginning of the measurement period. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.61pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.61pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The dollar amounts reported represent the amount of net income (loss) reflected in the Company&#8217;s audited financial statements for the applicable year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-weight:normal;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAOTI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Analysis of the Information Presented in the Pay versus Performance Table</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In accordance with Item&#160;402(v) of Regulation&#160;S-K, we are providing the following descriptions of the relationships between information presented in the Pay Versus Performance table above. </font>
        </div>
        <div style="margin-top:10.13pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Actually Paid and Cumulative TSR</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following graph sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#8217;s cumulative TSR over the two most recently completed fiscal&#160;years. </font>
        </div>
        <div style="position:relative;margin-top:7.22pt; text-align:center; width:456pt;">
          <img src="bc_companytsr-4c.jpg" alt="[MISSING IMAGE: bc_companytsr-4c.jpg]" height="317" width="579" >
        </div>
        <div style="margin-top:12.62pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation Actually Paid and Net Income (Loss)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following graph sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company&#8217;s net income (loss) over the two most recently completed fiscal&#160;years. </font>
        </div>
        <div style="position:relative;margin-top:7.11pt; text-align:center; width:456pt;">
          <img src="bc_netincome-4c.jpg" alt="[MISSING IMAGE: bc_netincome-4c.jpg]" height="318" width="564" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:580pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">All information provided above under the &#8220;Pay Versus Performance&#8221; heading will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tHOPM">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:420pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">HOUSEHOLDING OF PROXY MATERIALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for stockholder meeting materials with respect to two or more stockholders sharing the same address by delivering a single set of stockholder meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This year, a number of brokers with account holders who are stockholders will be &#8220;householding&#8221; our Proxy Materials. A single set of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice&#160;from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Proxy Materials, please notify your broker or us. Direct your written request to Outlook Therapeutics, Inc., Corporate Secretary, 111&#160;S. Wood Avenue, Unit #100, Iselin, New Jersey 08830. Stockholders who currently receive multiple copies of the Proxy Materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:502pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">OTHER MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The Board knows of no other matters that will be presented for consideration at the Special Meeting. If any other matters are properly brought before the Special Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </font>
        </div>
        <div style="margin-left:240pt; margin-top:8pt; width:216pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">By Order of the Board </font>
        </div>
        <div style="margin-left:240pt; margin-top:12pt; width:216pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">/s/ Lawrence A. Kenyon</font>
        </div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Lawrence A. Kenyon</font>
          <br >
          <font style="letter-spacing:0.2pt;">Corporate Secretary</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAATI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">APPENDIX A</font>
          <br >
          <font style="letter-spacing:-0.2pt;">OUTLOOK THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">1.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">G<font style="font-size:7pt;">eneral</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Eligible Award Recipients.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to Section&#160;4, Employees, Directors and Consultants are eligible to receive Awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Available Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Plan provides for the grant of the following types of Awards: (i)&#160;Incentive Stock Options; (ii)&#160;Nonstatutory Stock Options; (iii)&#160;Stock Appreciation Rights; (iv)&#160;Restricted Stock Awards; (v)&#160;Restricted Stock Unit Awards; (vi)&#160;Performance Stock Awards; and (vii)&#160;Other Stock Awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Plan&#160;Purpose.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp; The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">A<font style="font-size:7pt;">dministration</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Administration by Board.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section&#160;2(c). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Powers of Board.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To determine from time to time: (A)&#160;who will be granted Awards; (B)&#160;when and how each Award will be granted; (C)&#160;what type of Award will be granted; (D)&#160;the provisions of each Award (which need not be identical), including when a Participant will be permitted to exercise or otherwise receive cash or Common Stock under the Award; (E)&#160;the number of shares of Common Stock subject to, or the cash value of, an Award; and (F)&#160;the Fair Market Value applicable to an Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; text-align:justify; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To settle all controversies regarding the Plan and Awards granted under it. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or at which cash or shares of Common Stock may be issued in settlement thereof). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(v)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan (including Section&#160;2(b)(viii)) or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under an outstanding Award without his or her written consent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(vi)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section&#160;409A of the Code and/or to make the Plan or Awards granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section&#160;409A of the Code, subject to the limitations, if any, of applicable law. However, if required by applicable law or listing requirements, and except as provided in Section&#160;9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A)&#160;materially increases the number of shares of Common Stock available for issuance under the Plan, (B)&#160;materially expands the class of individuals eligible to receive Awards under the Plan, (C)&#160;materially increases the benefits accruing to Participants under the Plan, (D)&#160;materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, or (E)&#160;materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan (including Section&#160;2(b)(viii)) or an Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Award without his or her written consent. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(vii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of (A)&#160;Section&#160;422 of the Code regarding incentive stock options or (B)&#160;Rule&#160;16b-3. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(viii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more outstanding Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that except as otherwise provided in the Plan (including this Section&#160;2(b)(viii)) or an Award Agreement, no amendment of an outstanding Award will materially impair a Participant&#8217;s rights under such Award without his or her written consent. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing or anything in the Plan to the contrary, unless prohibited by applicable law, the Board may amend the terms of any outstanding Award or the Plan, or may suspend or terminate the Plan, without the affected Participant&#8217;s consent, (A)&#160;to maintain the qualified status of the Award as an Incentive Stock Option under Section&#160;422 of the Code, (B)&#160;to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section&#160;422 of the Code, (C)&#160;to clarify the manner of exemption from, or to bring the Award or the Plan into compliance with, Section&#160;409A of the Code, or (D)&#160;to comply with other applicable laws or listing requirements. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ix)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(x)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction). </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Delegation to Committee.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;General.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Committee may, at any time, abolish the subcommittee and/or revest in the Committee any powers delegated to the subcommittee. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Rule&#160;16b-3 Compliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Committee may consist solely of two or more Non-Employee Directors in accordance with Rule&#160;16b-3. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Delegation to Other Person or Body.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board or any Committee may delegate to one (1)&#160;or more persons or bodies the authority to do one or more of the following to the extent permitted by applicable law: (1)&#160;designate recipients, other than Officers, of Awards, provided that no person or body may be delegated authority to grant an Award to themself; (2)&#160;determine the number of shares of Common Stock subject to such Awards; and (3)&#160;determine the terms of such Awards; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that the Board or Committee action regarding such delegation will fix the terms of such delegation in accordance with applicable law, including without limitation Sections&#160;152 and 157 of the Delaware General Corporation Law. Unless provided otherwise in the Board or Committee action regarding such delegation, each Award granted pursuant to this section will be granted on the applicable form of Award Agreement most recently approved for use by the Board or the Committee, with any modifications </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">necessary to incorporate or reflect the terms of such Award. Notwithstanding anything to the contrary in this Section&#160;2(c), neither the Board nor any Committee may delegate to any person or body (who is not a Director or that is not comprised solely of Directors, respectively) the authority to determine the Fair Market Value of the Common Stock pursuant to Section&#160;13(v)(ii) below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;Effect of Board&#8217;s Decision.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)&nbsp;&nbsp;&nbsp;Cancellation and Re-Grant of Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Neither the Board nor any Committee will have the authority to (i)&#160;reduce the exercise or strike price of any outstanding Option or SAR or (ii)&#160;cancel any outstanding Option or SAR that has an exercise or strike price (per share) greater than the then-current Fair Market Value of the Common Stock in exchange for cash or other Awards under the Plan, unless the stockholders of the Company have approved such an action within 12&#160;months prior to such an event. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(f)&nbsp;&nbsp;&nbsp;Minimum Vesting Requirements.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Award granted on or after August&#160;12, 2024 may vest (or, if applicable, be exercisable) until at least 12&#160;months following the date of grant of the Award (excluding, for this purpose, (i)&#160;any Award granted as an Acquisition Award (as defined in Section&#160;3(a)(ii)), and (ii)&#160;any Award granted to a Non-Employee Director that vests (or, if applicable, becomes exercisable) on the earlier of the first anniversary of the date of grant or the Company&#8217;s next annual meeting of stockholders); </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that shares of Common Stock up to 5% of the Share Reserve (as defined in Section&#160;3(a)(i)) may be issued pursuant to Awards granted on or after August&#160;12, 2024 that do not meet such vesting (and, if applicable, exercisability) requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(g)&nbsp;&nbsp;&nbsp;Dividends and Dividend Equivalents.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to an Award, as determined by the Board and contained in the applicable Award Agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (i)&#160;no dividends or dividend equivalents may be paid with respect to any such shares subject to Options or Stock Appreciation Rights, (ii)&#160;no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Award Agreement, (iii)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Award Agreement (including, but not limited to, any vesting conditions), and (iv)&#160;any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Award Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">S<font style="font-size:7pt;">hares</font> S<font style="font-size:7pt;">ubject</font> <font style="font-size:7pt;">to</font> <font style="font-size:7pt;">the</font> P<font style="font-size:7pt;">lan</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Share Reserve.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to Section&#160;3(a)(iii) and Section&#160;9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards from and after the Effective Date (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Share Reserve</font><font style="letter-spacing:0.2pt;">&#8221;) will not exceed the sum of (A)&#160;4,800,000 shares and (B)&#160;the number of Returning Shares, if any, as such shares become available for issuance under this Plan from time to time. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;For clarity, the Share Reserve is a limit on the number of shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section&#160;3(a) does not limit the granting of Awards except as provided in Section&#160;7(a). Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule&#160;5635(c) or, if applicable, NYSE Listed Company Manual Section&#160;303A.08, AMEX Company Guide Section&#160;711 or other applicable rule (any such Award, an &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acquisition Award</font><font style="letter-spacing:0.2pt;">&#8221;), and such issuance will not reduce the number of shares available for issuance under the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Operation of Share Reserve.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;No Reduction to Share Reserve.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Share Reserve will not be reduced by any of the following shares of Common Stock and such shares will remain available for issuance under the Plan: (A)&#160;any shares subject to an Award that are not issued because such Award or any portion thereof expires or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">otherwise terminates without all of the shares covered by such Award having been issued; and (B)&#160;any shares subject to an Award that are not issued because such Award or any portion thereof is settled in cash. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Shares Available for Subsequent Issuance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any shares of Common Stock issued pursuant to an Award that are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Returning Shares</font><font style="letter-spacing:0.2pt;">&#8221;) will revert to the Share Reserve and become available again for issuance under the Plan. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Shares Not Available for Subsequent Issuance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The following shares of Common Stock will not revert to the Share Reserve or become available again for issuance under the Plan: (A)&#160;any shares that are reacquired or withheld (or not issued) by the Company to satisfy the exercise, strike or purchase price of an Award (including any shares subject to such award that are not delivered because such award is exercised through a reduction of shares subject to such award (</font><font style="font-style:italic;letter-spacing:0.2pt;">i.e</font><font style="letter-spacing:0.2pt;">., &#8220;net exercised&#8221;)); (B)&#160;any shares that are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with an Award; (C)&#160;any shares repurchased by the Company on the open market with the proceeds of the exercise, strike or purchase price of an Award; and (D)&#160;in the event that a Stock Appreciation Right granted under the Plan is settled in shares of Common Stock, the gross number of shares of Common Stock subject to such award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Incentive Stock Option Limit.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the Share Reserve and Section&#160;9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 14,400,000 shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;Non-Employee Director Compensation Limit.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The aggregate value of all compensation paid or granted, as applicable, by the Company to any individual for service as a Non-Employee Director with respect to any fiscal year of the Company, including Awards granted and cash fees paid by the Company to such Non-Employee Director, will not exceed $1,000,000 in total value, or in the event such Non-Employee Director is first appointed or elected to the Board during such fiscal year, $1,500,000 in total value, in each case calculating the value of any equity-based awards based on the grant date fair value of such awards for financial reporting purposes. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)&nbsp;&nbsp;&nbsp;Source of Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">E<font style="font-size:7pt;">ligibility</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Eligibility for Specific Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections&#160;424(e) and 424(f) of the Code). Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule&#160;405, unless (i)&#160;the stock underlying such Awards is treated as &#8220;service recipient stock&#8221; under Section&#160;409A of the Code (for example, because the Awards are granted pursuant to a corporate transaction such as a spin off transaction) or (ii)&#160;the Company, in consultation with its legal counsel, has determined that such Awards are otherwise exempt from or alternatively comply with Section&#160;409A of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Ten Percent Stockholders.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price (per share) of such Option is at least 110% of the Fair Market Value of the Common Stock on the date of grant of such Option and the Option is not exercisable after the expiration of five&#160;years from the date of grant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">P<font style="font-size:7pt;">rovisions</font> R<font style="font-size:7pt;">elating</font> <font style="font-size:7pt;">to</font> O<font style="font-size:7pt;">ptions</font> <font style="font-size:7pt;">and</font> S<font style="font-size:7pt;">tock</font> A<font style="font-size:7pt;">ppreciation</font> R<font style="font-size:7pt;">ights</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Option or SAR Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The terms and conditions of separate Option or SAR Agreements need not be identical; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that each Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Term.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the provisions of Section&#160;4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of 10&#160;years from the date of its grant or such shorter period specified in the Award Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Exercise or Strike Price.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the provisions of Section&#160;4(b) regarding Ten Percent Stockholders, the exercise or strike price (per share) of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price (per share) less than 100% of the Fair Market Value of the Common Stock on the date the Award is granted if such Award is granted pursuant to an assumption of, or substitution for, another option or stock appreciation right pursuant to a Transaction and in a manner consistent with the provisions of Section&#160;409A of the Code and, if applicable, Section&#160;424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Payment of Exercise Price for Options.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The exercise price of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by one or more of the methods of payment set forth below that are specified in the Option Agreement. The Board has the authority to grant Options that do not permit all of the following methods of payment (or that otherwise restrict the ability to utilize certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;By cash (including electronic funds transfers), check, bank draft or money order payable to the Company; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Pursuant to a program developed under Regulation&#160;T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;By delivery to the Company (either by actual delivery or attestation) of shares of Common Stock; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A)&#160;shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; &#8203;(B)&#160;shares are delivered to the Participant as a result of such exercise, and (C)&#160;shares are withheld to satisfy tax withholding obligations; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(v)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In any other form of legal consideration that may be acceptable to the Board and specified in the applicable Option Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;Exercise and Payment of a SAR.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Award Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A)&#160;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B)&#160;the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Common Stock, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the applicable SAR Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)&nbsp;&nbsp;&nbsp;Transferability of Options and SARs.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section&#160;5(e) on the transferability of Options and SARs will apply. Notwithstanding the foregoing or anything in the Plan or an Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior stockholder approval. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Restrictions on Transfer.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;An Option or SAR will not be transferable, except by will or by the laws of descent and distribution (and pursuant to Sections&#160;5(e)(ii) and 5(e)(iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. Subject to the foregoing paragraph, the Board may, in its sole discretion, permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Domestic Relations Orders.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations&#160;Section&#160;1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Beneficiary Designation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(f)&nbsp;&nbsp;&nbsp;Vesting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section&#160;5(f) are subject to Section&#160;2(f) and any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(g)&nbsp;&nbsp;&nbsp;Termination of Continuous Service.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&#160;the date that is three&#160;months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&#160;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after such termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time period, the Option or SAR (as applicable) will terminate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(h)&nbsp;&nbsp;&nbsp;Extension of Termination Date.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if the exercise of an Option or SAR following the termination of a Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i)&#160;the expiration of a total period of time (that need </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements or (ii)&#160;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of a Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i)&#160;the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#8217;s insider trading policy or (ii)&#160;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Disability of Participant.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&#160;the date that is 12&#160;months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&#160;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after such termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time period, the Option or SAR (as applicable) will terminate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(j)&nbsp;&nbsp;&nbsp;Death of Participant.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if (i)&#160;a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii)&#160;a Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service (for a reason other than death), then the Participant&#8217;s Option or SAR may be exercised (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance, or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within such period of time ending on the earlier of (i)&#160;the date that is 18&#160;months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii)&#160;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after the Participant&#8217;s death, the Option or SAR (as applicable) is not exercised within the applicable time period, the Option or SAR (as applicable) will terminate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(k)&nbsp;&nbsp;&nbsp;Termination for Cause.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as explicitly provided otherwise in the applicable Award Agreement or other individual written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Option or SAR will terminate immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(l)&nbsp;&nbsp;&nbsp;Non-Exempt Employees.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six&#160;months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i)&#160;if such non-exempt employee dies or suffers a Disability, (ii)&#160;upon a Transaction, or (iii)&#160;upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Award Agreement, in another written agreement between the Participant and the Company or an Affiliate, or, if no such definition, in accordance with the Company&#8217;s or Affiliate&#8217;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six&#160;months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vesting or issuance of any shares under any other Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section&#160;5(l) will apply to all Awards and are hereby incorporated by reference into such Award Agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">P<font style="font-size:7pt;">rovisions</font> <font style="font-size:7pt;">of</font> A<font style="font-size:7pt;">wards</font> O<font style="font-size:7pt;">ther</font> <font style="font-size:7pt;">than</font> O<font style="font-size:7pt;">ptions</font> <font style="font-size:7pt;">and</font> SAR<font style="font-size:7pt;">s</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Restricted Stock Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock underlying a Restricted Stock Award may be (i)&#160;held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii)&#160;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of separate Restricted Stock Award Agreements need not be identical; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Consideration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A Restricted Stock Award may be awarded in consideration for (A)&#160;cash (including electronic funds transfers), check, bank draft or money order payable to the Company, (B)&#160;past services to the Company or an Affiliate or (C)&#160;any other form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Vesting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to Section&#160;2(f), shares of Common Stock awarded under a Restricted Stock Award Agreement may be subject to forfeiture to or repurchase by the Company in accordance with a vesting schedule to be determined by the Board. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Termination of Continuous Service.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested as of the date of such termination under the terms of the Participant&#8217;s Restricted Stock Award Agreement. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Transferability.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Rights to acquire shares of Common Stock under a Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to the contrary, no Restricted Stock Award may be transferred to any financial institution without prior stockholder approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Restricted Stock Unit Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. The terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Consideration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Vesting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Subject to Section&#160;2(f), at the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Payment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Additional Restrictions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to the Restricted Stock Unit Award to a time after the vesting of the Restricted Stock Unit Award. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(v)&nbsp;&nbsp;&nbsp;Termination of Continuous Service.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates, any portion of the Participant&#8217;s Restricted Stock Unit Award that has not vested as of the date of such termination will be forfeited upon such termination. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Performance Stock Awards.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;General.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;A Performance Stock Award is an Award that is payable (including that may be granted, vest or be exercised) contingent upon the attainment during a Performance Period of specified Performance Goals. A Performance Stock Award may, but need not, require the Participant&#8217;s completion of a specified period of Continuous Service. Subject to Section&#160;2(f), the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Board, in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Board Discretion.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;With respect to any Performance Stock Award, the Board retains the discretion to (A)&#160;reduce or eliminate the compensation or economic benefit due upon the attainment of any Performance Goals on the basis of any considerations as the Board, in its sole discretion, may determine and (B)&#160;define the manner of calculating the Performance Criteria it selects to use for a Performance Period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;Other Stock Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof may be granted either alone or in addition to Awards granted under Section&#160;5 and this Section&#160;6. Subject to the provisions of the Plan (including, but not limited to, Sections&#160;2(f) and 2(g)), the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards, and all other terms and conditions of such Other Stock Awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">C<font style="font-size:7pt;">ovenants</font> <font style="font-size:7pt;">of</font> <font style="font-size:7pt;">the</font> C<font style="font-size:7pt;">ompany</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Availability of Shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Securities Law Compliance.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan the authority required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;No Obligation to Notify or Minimize Taxes.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising an Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">M<font style="font-size:7pt;">iscellaneous</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Use of Proceeds from Sales of Common Stock.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Proceeds from the sale of shares of Common Stock issued pursuant to Awards will constitute general funds of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Corporate Action Constituting Grant of Awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (</font><font style="font-style:italic;letter-spacing:0.2pt;">e.g</font><font style="letter-spacing:0.2pt;">., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (</font><font style="font-style:italic;letter-spacing:0.2pt;">e.g</font><font style="letter-spacing:0.2pt;">., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Stockholder Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i)&#160;such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii)&#160;the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;No Employment or Other Service Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i)&#160;the employment of an Employee with or without notice and with or without cause, (ii)&#160;the service of a Director pursuant to the bylaws of the Company or an Affiliate, or (iii)&#160;the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)&nbsp;&nbsp;&nbsp;Change in Time Commitment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee and has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (i)&#160;make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (ii)&#160;in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(f)&nbsp;&nbsp;&nbsp;Incentive Stock Option $100,000 Limitation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To the extent that the aggregate Fair Market Value (determined at the time of grant) of the shares of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Participant during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(g)&nbsp;&nbsp;&nbsp;Investment Assurances.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award, (i)&#160;to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award and (ii)&#160;to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A)&#160;the issuance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently effective registration statement under the Securities Act or (B)&#160;as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(h)&nbsp;&nbsp;&nbsp;Withholding Obligations.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state, local or foreign tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i)&#160;causing the Participant to tender a cash payment; (ii)&#160;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii)&#160;withholding cash from an Award settled in cash; (iv)&#160;withholding payment from any amounts otherwise payable to the Participant; or (v)&#160;by such other method as may be set forth in the Award Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Electronic Delivery.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(j)&nbsp;&nbsp;&nbsp;Deferrals.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section&#160;409A of the Code. Consistent with Section&#160;409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company or an Affiliate. The Board is authorized to make deferrals of Awards and determine when, and in what annual&#160;percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(k)&nbsp;&nbsp;&nbsp;Section&#160;409A.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&#160;409A of the Code, and, to the extent not so exempt, in compliance with Section&#160;409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&#160;409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section&#160;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance with Section&#160;409A of the Code, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section&#160;409A of the Code is a &#8220;specified employee&#8221; for purposes of Section&#160;409A of the Code, no distribution or payment of any amount under such Award that is due because of a &#8220;separation from service&#8221; &#8203;(as defined in Section&#160;409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six&#160;months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment may be made in a manner that complies with Section&#160;409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six-month period elapses, with the balance paid thereafter on the original schedule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(l)&nbsp;&nbsp;&nbsp;Clawback/Recovery.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;All Awards granted under the Plan will be subject to recoupment in accordance with the following, as applicable: (i)&#160;the Outlook Therapeutics, Inc. Incentive Compensation Recoupment Policy; (ii)&#160;any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law; and (iii)&#160;any other clawback policy that the Company adopts and maintains from time to time. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Board determines necessary or appropriate, including, but not limited to, a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause. No clawback, recovery or recoupment of compensation pursuant to any such policy or Award Agreement will be deemed an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; &#8203;(or similar term) under any agreement with the Company or an Affiliate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">A<font style="font-size:7pt;">djustments</font> <font style="font-size:7pt;">upon</font> C<font style="font-size:7pt;">hanges</font> <font style="font-size:7pt;">in</font> C<font style="font-size:7pt;">ommon</font> S<font style="font-size:7pt;">tock</font>; O<font style="font-size:7pt;">ther</font> C<font style="font-size:7pt;">orporate</font> E<font style="font-size:7pt;">vents</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Capitalization Adjustments.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i)&#160;the class(es) and maximum number of securities subject to the Plan pursuant to Section&#160;3(a); (ii)&#160;the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section&#160;3(c); and (iii)&#160;the class(es) and number of securities and price per share of stock subject to outstanding Awards. The Board will make such adjustments and its determination will be final, binding and conclusive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;Dissolution or Liquidation.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, in the event of a dissolution or liquidation of the Company (except for a liquidation into a parent corporation), all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to a forfeiture condition or the Company&#8217;s right of repurchase may be reacquired or repurchased by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)&nbsp;&nbsp;&nbsp;Transactions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The provisions of this Section&#160;9(c) will apply to each outstanding Award in the event of a Transaction unless otherwise provided in the instrument evidencing the Award, in any other written agreement between a Participant and the Company or an Affiliate, or in any director compensation policy of the Company. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)&nbsp;&nbsp;&nbsp;Awards May Be Assumed.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of a Transaction, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may assume or continue any or all outstanding Awards or may substitute similar stock awards for any or all outstanding Awards (including, but not limited to, awards to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction), and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to any outstanding Awards may be assigned by the Company to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company). For clarity, in the event of a Transaction, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) may choose to assume or continue only a portion of an outstanding Award, to substitute a similar stock award for only a portion of an outstanding Award, or to assume or continue, or substitute similar stock awards for, the outstanding Awards held by some, but not all, Participants. The terms of any such assumption, continuation or substitution will be set by the Board. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Awards Held by Current Participants.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of a Transaction in which the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) does not assume or continue outstanding Awards, or substitute similar stock awards for outstanding Awards, then with respect to any such Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Transaction (referred to as the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Current Participants</font><font style="letter-spacing:0.2pt;">&#8221;), the vesting (and exercisability, if applicable) of such Awards will be accelerated in full (and with respect to any such Awards that are subject to performance-based vesting conditions or requirements, vesting will be deemed to be satisfied at the greater of (x)&#160;the target level of performance or (y)&#160;the actual level of performance measured in accordance with the applicable performance goals as of the date of the Transaction) to a date prior to the effective time of the Transaction (contingent upon the closing or completion of the Transaction) as the Board will determine (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Transaction), and such Awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Board, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the closing or completion of the Transaction). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Awards Held by Participants other than Current Participants.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of a Transaction in which the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) does not assume or continue outstanding Awards, or substitute similar stock awards for outstanding Awards, then with respect to any such Awards that have not been assumed, continued or substituted and that are held by Participants other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Board; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Transaction. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Payment for Awards in Lieu of Exercise.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, in the event any outstanding Award held by a Participant will terminate if not exercised prior to the effective time of a Transaction, the Board may provide that the Participant may not exercise such Award but instead will receive a payment, in such form as may be determined by the Board, equal in value to the excess, if any, of (A)&#160;the value of the property the Participant would have received upon the exercise of such Award immediately prior to the effective time of the Transaction, over (B)&#160;any exercise price payable by the Participant in connection with such exercise. For clarity, such payment may be zero if the value of such property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Common Stock in connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)&nbsp;&nbsp;&nbsp;Change in Control.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless otherwise provided in the instrument evidencing the Award, in any other written agreement between a Participant and the Company or an Affiliate, or in any director compensation policy of the Company, an Award will not be subject to additional acceleration of vesting and exercisability upon or after a Change in Control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)&nbsp;&nbsp;&nbsp;Parachute Payments.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if any payment or benefit the Participant would receive pursuant to a Change in Control from the Company or otherwise (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Payment</font><font style="letter-spacing:0.2pt;">&#8221;) would (i)&#160;constitute a &#8220;parachute payment&#8221; within the meaning of Section&#160;280G of the Code, and (ii)&#160;but for this sentence, be subject to the excise tax imposed by Section&#160;4999 of the Code (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Excise Tax</font><font style="letter-spacing:0.2pt;">&#8221;), then such Payment will be equal to the Reduced Amount. The &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Reduced Amount</font><font style="letter-spacing:0.2pt;">&#8221; will be either (x)&#160;the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y)&#160;the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Participant&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, the reduction will be accomplished in accordance with Section&#160;409A of the Code and the following: first by reducing, on a pro&#160;rata basis, cash Payments that are exempt from Section&#160;409A of the Code; second by reducing, on a pro&#160;rata basis, other cash Payments; and third by forfeiting any equity-based awards that vest and become payable, starting with the most recent equity-based awards that vest, to the extent necessary to accomplish such reduction. The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control will perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Company will appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company will bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. The accounting firm engaged to make the determinations hereunder will provide its calculations, together with detailed supporting documentation, to the Participant and the Company within 15 calendar days after the date on which the Participant&#8217;s right to a Payment is triggered (if requested at that time by the Participant or the Company) or such other time as reasonably requested by the Participant or the Company. Any good faith determinations of the accounting firm made hereunder will be final, binding and conclusive upon the Participant and the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">T<font style="font-size:7pt;">ermination</font> <font style="font-size:7pt;">or</font> S<font style="font-size:7pt;">uspension</font> <font style="font-size:7pt;">of</font> <font style="font-size:7pt;">the</font> P<font style="font-size:7pt;">lan</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)&nbsp;&nbsp;&nbsp;Termination or Suspension.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Board may suspend or terminate the Plan at any time. No Incentive Stock Option may be granted after the tenth anniversary of the earlier of (i)&#160;the date the Plan, as amended and restated hereby, was first approved by the Board or Committee, or (ii)&#160;the Effective Date. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)&nbsp;&nbsp;&nbsp;No Impairment of Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Suspension or termination of the Plan will not materially impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan (including Section&#160;2(b)(viii)) or an Award Agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">E<font style="font-size:7pt;">ffective</font> D<font style="font-size:7pt;">ate</font> <font style="font-size:7pt;">of</font> P<font style="font-size:7pt;">lan</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This Plan was originally effective as of December&#160;4, 2015 and was amended as of September&#160;21, 2018, September&#160;12, 2019, and September&#160;17, 2020. The Plan, as amended and restated hereby, will be effective as of August&#160;12, 2024, which is the date of the Special Meeting of Stockholders of the Company held in August&#160;2024, provided that this Plan is approved by the Company&#8217;s stockholders at such meeting (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.&nbsp;&nbsp;&nbsp;</font><font style="text-transform:uppercase;letter-spacing:-0.2pt;">C<font style="font-size:7pt;">hoice</font> <font style="font-size:7pt;">of</font> L<font style="font-size:7pt;">aw</font>.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The laws of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#8217;s conflict of laws rules. </font>
        </div>
        <div style="margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">13.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;text-transform:uppercase;letter-spacing:-0.2pt;">D<font style="font-size:7pt;">efinitions</font>.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As used in the Plan, the following definitions will apply to the capitalized terms indicated below: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(a)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule&#160;405. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(b)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award</font><font style="letter-spacing:0.2pt;">&#8221; means an Incentive Stock Option, a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Stock Award or any Other Stock Award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(c)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(d)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Board</font><font style="letter-spacing:0.2pt;">&#8221; means the Board of Directors of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(e)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Capitalization Adjustment</font><font style="letter-spacing:0.2pt;">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(f)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cause</font><font style="letter-spacing:0.2pt;">&#8221; will have the meaning ascribed to such term in any written agreement between a Participant and the Company or an Affiliate defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i)&#160;such Participant&#8217;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii)&#160;such Participant&#8217;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (iii)&#160;such Participant&#8217;s intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iv)&#160;such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s confidential information or trade secrets; (v)&#160;such Participant&#8217;s violation of a Company policy; or (vi)&#160;such Participant&#8217;s gross misconduct. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(g)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Change in Control</font><font style="letter-spacing:0.2pt;">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A)&#160;on account of the acquisition of securities of the Company directly from the Company, (B)&#160;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&#160;solely because the level of Ownership held by any Exchange Act Person (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subject Person</font><font style="letter-spacing:0.2pt;">&#8221;) exceeds the designated&#160;percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the&#160;percentage of the then outstanding voting securities Owned by the Subject Person over the designated&#160;percentage threshold, then a Change in Control will be deemed to occur; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A)&#160;outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&#160;more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;individuals who, on the Effective Date, are members of the Board (the &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Incumbent Directors</font><font style="letter-spacing:0.2pt;">&#8221;) cease for any reason to constitute at least a majority of the members of the Board; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the Incumbent Directors then still in office, such new member will, for purposes of this Plan, be considered as an Incumbent Director; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that, for this purpose, no individual initially elected or nominated as a member of the Board as a result of an actual or threatened election contest with respect to Board membership or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board will be deemed to be an Incumbent Director. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the foregoing or any other provision of this Plan, (A)&#160;the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&#160;the definition of Change in Control (or any analogous term) in an individual written agreement between a Participant and the Company or an Affiliate will supersede the foregoing definition with respect to Awards subject to such agreement; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that (1)&#160;if no definition of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Change in Control (or any analogous term) is set forth in such an individual written agreement, the foregoing definition will apply; and (2)&#160;no Change in Control (or any analogous term) will be deemed to occur with respect to Awards subject to such an individual written agreement without a requirement that the Change in Control (or any analogous term) actually occur. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If required for compliance with Section&#160;409A of the Code, in no event will an event be deemed a Change in Control if such event is not also a &#8220;change in the ownership of&#8221; the Company, a &#8220;change in the effective control of&#8221; the Company or a &#8220;change in the ownership of a substantial portion of the assets of&#8221; the Company, each as determined under Treasury Regulations&#160;Section&#160;1.409A-3(i)(5) (without regard to any alternative definition thereunder). The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;Change in Control&#8221; to conform to the definition of a &#8220;change in control event&#8221; under Section&#160;409A of the Code and the regulations thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(h)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Code</font><font style="letter-spacing:0.2pt;">&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Committee</font><font style="letter-spacing:0.2pt;">&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section&#160;2(c). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(j)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the common stock of the Company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(k)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221; means Outlook Therapeutics, Inc., a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(l)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Consultant</font><font style="letter-spacing:0.2pt;">&#8221; means any person, including an advisor, who is (i)&#160;engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&#160;serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(m)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Continuous Service</font><font style="letter-spacing:0.2pt;">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant, or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; </font><font style="font-style:italic;letter-spacing:0.2pt;">provided, however</font><font style="letter-spacing:0.2pt;">, that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&#160;any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&#160;transfers between the Company, an Affiliate or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s or Affiliate&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(n)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Corporate Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </font>
        </div>
        <div style="text-indent:40pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;a sale or other disposition of at least 50% of the outstanding securities of the Company; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;the consummation of a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iv)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;the consummation of a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If required for compliance with Section&#160;409A of the Code, in no event will an event be deemed a Corporate Transaction if such event is not also a &#8220;change in the ownership of&#8221; the Company, a &#8220;change in the effective control of&#8221; the Company or a &#8220;change in the ownership of a substantial portion of the assets of&#8221; the Company, each as determined under Treasury Regulations&#160;Section&#160;1.409A-3(i)(5) (without regard to any alternative definition thereunder). The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;Corporate Transaction&#8221; to conform to the definition of a &#8220;change in control event&#8221; under Section&#160;409A of the Code and the regulations thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(o)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Director</font><font style="letter-spacing:0.2pt;">&#8221; means a member of the Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">(p)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Disability</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12&#160;months, as provided in Sections&#160;22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(q)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Effective Date</font><font style="letter-spacing:0.2pt;">&#8221; has the meaning set forth in Section&#160;11 of the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(r)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Employee</font><font style="letter-spacing:0.2pt;">&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(s)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Entity</font><font style="letter-spacing:0.2pt;">&#8221; means a corporation, partnership, limited liability company or other entity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(t)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(u)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Exchange Act Person</font><font style="letter-spacing:0.2pt;">&#8221; means any natural person, Entity or &#8220;group&#8221; &#8203;(within the meaning of Section&#160;13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i)&#160;the Company or any Subsidiary of the Company, (ii)&#160;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&#160;an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv)&#160;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company, or (v)&#160;any natural person, Entity or &#8220;group&#8221; &#8203;(within the meaning of Section&#160;13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(v)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Fair Market Value</font><font style="letter-spacing:0.2pt;">&#8221; means, as of any date, the value of the Common Stock determined as follows: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless otherwise provided by the Board, if the Common Stock is listed on any established stock exchange or traded on any established market, then the Fair Market Value of a share of Common Stock will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value of a share of Common Stock will be the closing sales price for such stock on the last preceding date for which such quotation exists. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(iii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the absence of such markets for the Common Stock, the Fair Market Value of a share of Common Stock will be determined by the Board in good faith and in a manner that complies with Sections&#160;409A and 422 of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(w)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Incentive Stock Option</font><font style="letter-spacing:0.2pt;">&#8221; means an option granted pursuant to Section&#160;5 that is intended to be, and that qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section&#160;422 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(x)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Non-Employee Director</font><font style="letter-spacing:0.2pt;">&#8221; means a Director who either (i)&#160;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item&#160;404(a) of Regulation&#160;S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Regulation&#160;S-K</font><font style="letter-spacing:0.2pt;">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item&#160;404(a) of Regulation&#160;S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation&#160;S-K, or (ii)&#160;is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule&#160;16b-3. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(y)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Nonstatutory Stock Option</font><font style="letter-spacing:0.2pt;">&#8221; means an option granted pursuant to Section&#160;5 that does not qualify as an Incentive Stock Option. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(z)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Officer</font><font style="letter-spacing:0.2pt;">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(aa)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Option</font><font style="letter-spacing:0.2pt;">&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(bb)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Option Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a holder of an Option evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(cc)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Stock Award</font><font style="letter-spacing:0.2pt;">&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&#160;6(d). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(dd)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Stock Award Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ee)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Own,</font><font style="letter-spacing:0.2pt;">&#8221; &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Owned,</font><font style="letter-spacing:0.2pt;">&#8221; &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Owner,</font><font style="letter-spacing:0.2pt;">&#8221; &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Ownership</font><font style="letter-spacing:0.2pt;">&#8221; A person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ff)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Participant</font><font style="letter-spacing:0.2pt;">&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(gg)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Performance Criteria</font><font style="letter-spacing:0.2pt;">&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following, as determined by the Board: (i)&#160;earnings (including earnings per share and net earnings); (ii)&#160;earnings before interest, taxes and depreciation; (iii)&#160;earnings before interest, taxes, depreciation and amortization; (iv)&#160;earnings before interest, taxes, depreciation, amortization and legal settlements; (v)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation, other non-cash expenses and changes in deferred revenue; (ix)&#160;total stockholder return; (x)&#160;return on equity or average stockholder&#8217;s equity; (xi)&#160;return on assets, investment, or capital employed; (xii)&#160;stock price; (xiii)&#160;margin (including gross margin); (xiv)&#160;income (before or after taxes); (xv)&#160;operating income; (xvi)&#160;operating income after taxes; (xvii)&#160;pre-tax profit; (xviii) operating cash flow; (xix)&#160;sales or revenue targets; (xx)&#160;increases in revenue or product revenue; (xxi)&#160;expenses and cost reduction goals; (xxii)&#160;improvement in or attainment of working capital levels; (xxiii) economic value added (or an equivalent metric); (xxiv)&#160;market share; (xxv)&#160;cash flow; (xxvi)&#160;cash flow per share; (xxvii) cash balance; (xxviii) cash burn; (xxix)&#160;cash collections; (xxx)&#160;share price performance; (xxxi)&#160;debt reduction; (xxxii) implementation or completion of projects or processes (including, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">without limitation, clinical trial initiation, clinical trial enrollment and dates, clinical trial results, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals, new and supplemental indications for existing products, and product supply); (xxxiii) stockholders&#8217; equity; (xxxiv) capital expenditures; (xxxv)&#160;debt levels; (xxxvi) operating profit or net operating profit; (xxxvii)&#160;workforce diversity; (xxxviii) growth of net income or operating income; (xxxix) billings; (xl) bookings; (xli)&#160;employee retention; (xlii) initiation of phases of clinical trials and/or studies by specific dates; (xliii)&#160;acquisition of new customers, including institutional accounts; (xliv) customer retention and/or repeat order rate; (xlv)&#160;number of institutional customer accounts (xlvi) budget management; (xlvii) improvements in sample and test processing times; (xlviii) regulatory milestones; (xlix) progress of internal research or clinical programs; (l)&#160;progress of partnered programs; (li) partner satisfaction; (lii) milestones related to samples received and/or tests run; (liii) expansion of sales in additional geographies or markets; (liv) research progress, including the development of programs; (lv) submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration) of an applicable filing or a product; (lvi) timely completion of clinical trials; (lvii) milestones related to samples received and/or tests or panels run; (lviii)&#160;expansion of sales in additional geographies or markets; (lix) research progress, including the development of programs; (lx) patient samples processed and billed; (lxi) sample processing operating metrics (including, without limitation, failure rate maximums and reduction of repeat rates); (lxii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; and (lxiii) other measures of performance selected by the Board. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the applicable Award Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(hh)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Performance Goals</font><font style="letter-spacing:0.2pt;">&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business&#160;units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The Board is authorized to make appropriate adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (i)&#160;to exclude restructuring and/or other nonrecurring charges; (ii)&#160;to exclude exchange rate effects, as applicable, for non-U.S. dollar denominated Performance Goals; (iii)&#160;to exclude the effects of changes to generally accepted accounting principles; (iv)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (v)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; and (vi)&#160;to make other appropriate adjustments determined by the Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ii)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Performance Period</font><font style="letter-spacing:0.2pt;">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Performance Stock Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(jj)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Performance Stock Award</font><font style="letter-spacing:0.2pt;">&#8221; means an Award granted under the terms and conditions of Section&#160;6(c). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(kk)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan</font><font style="letter-spacing:0.2pt;">&#8221; means this Outlook Therapeutics, Inc. 2024 Equity Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ll)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Award</font><font style="letter-spacing:0.2pt;">&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section&#160;6(a). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(mm)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Award Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(nn)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Unit Award</font><font style="letter-spacing:0.2pt;">&#8221; means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section&#160;6(b). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(oo)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Restricted Stock Unit Award Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:308pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(pp)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rule&#160;16b-3</font><font style="letter-spacing:0.2pt;">&#8221; means Rule&#160;16b-3 promulgated under the Exchange Act or any successor to Rule&#160;16b-3, as in effect from time to time. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(qq)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rule&#160;405</font><font style="letter-spacing:0.2pt;">&#8221; means Rule&#160;405 promulgated under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(rr)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ss)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stock Appreciation Right</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SAR</font><font style="letter-spacing:0.2pt;">&#8221; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&#160;5. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(tt)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Stock Appreciation Right Agreement</font><font style="letter-spacing:0.2pt;">&#8221; or &#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">SAR Agreement</font><font style="letter-spacing:0.2pt;">&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(uu)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Subsidiary</font><font style="letter-spacing:0.2pt;">&#8221; means, with respect to the Company, (i)&#160;any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&#160;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(vv)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Ten Percent Stockholder</font><font style="letter-spacing:0.2pt;">&#8221; means a person who Owns (or is deemed to Own pursuant to Section&#160;424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">(ww)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&#8220;</font><font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transaction</font><font style="letter-spacing:0.2pt;">&#8221; means a Corporate Transaction or a Change in Control.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="min-height:759.71pt;page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;text-align:center; width:595.31pt;">
          <img src="px_24outlookproxy1pg01-bw.jpg" alt="[MISSING IMAGE: px_24outlookproxy1pg01-bw.jpg]" height="1014" width="783" >
        </div>
        <div style="margin-top:11.81pt; text-align:justify; width:595.31pt; line-height:2.5pt;">
          <font style="letter-spacing:0.02pt;">OUTLOOKSPECIALMEETINGTHERAPEUTICS,OFSTOCKHOLDERSOF INC.August 12, 2024PROXY VOTING INSTRUCTIONSINTERNET - Access &#8220;www.voteproxy.com&#8221; and follow the on-screeninstructions or scan the QR code with your smartphone. Have your proxy card available when you access the web page.TELEPHONE - Call toll-free 1-800-PROXIES (1-800-776-9437) in the United States or 1-201-299-4446 from foreign countries from any touch-tone telephone and follow the instructions. Have your proxy card available when you call.Vote online/phone until 11:59 PM EST the day before the meeting. MAIL - Sign, date and mail your proxy card in the envelope provided as soon as possible.IN PERSON - You may vote your shares in person by attending the Special Meeting.GO GREEN - e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy material, statements and other eligible documents online, while reducing costs, clutter and paper waste. Enroll today via https://equiniti.com/us/ast-access to enjoy online access. COMPANY NUMBER ACCOUNT NUMBER Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be held August 12, 2024The Proxy Statement is available at http://www.astproxyportal.com/ast/27823 Please detach along perforated line and mail in the envelope provided IF you are not voting via telephone or the Internet. 00030000000000000000 4081224THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; PROPOSAL 1.xPLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HEREProposal 1. To approve the Outlook Therapeutics, Inc. 2024 Equity Incentive FOR AGAINST ABSTAIN Plan. To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.Signature of StockholderDate:Signature of StockholderDate:Note: Please signexactly as your name or names appear on this Proxy. Whensharesare held jointly, eachholder should sign. Whensigning as executor, administrator, attorney, trustee orguardian,please give fulltitle as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="min-height:759.71pt; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#FFFFFF;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_24outlookproxy1pg02-bw.jpg" alt="[MISSING IMAGE: px_24outlookproxy1pg02-bw.jpg]" height="1014" width="783" >
        </div>
        <div style="margin-top:11.81pt; text-align:justify; width:595.31pt; line-height:2.5pt;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">OUTLOOK THERAPEUTICS, INC.PROXY FOR SPECIAL MEETING OF STOCKHOLDERS TO BE HELD AUGUST 12, 2024 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORSTHIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATEDThe undersigned hereby constitutes and appoints C. Russell Trenary III and Lawrence A. Kenyon, and each of them as proxies, each with full power of substitution, and authorizes each of them to represent and to vote all of the shares of common stock that the undersigned is entitled to vote at the Special Meeting of Stockholders (the &#8220;Special Meeting&#8221;) of Outlook Therapeutics, Inc. (the &#8220;Company&#8221;) in such manner as they, or either of them, may determine on any matters that may properly come before the Special Meeting or any postponements or adjournments thereof and to vote on the matter set forth on the reverse side as directed by the undersigned. The Special Meeting will be held on August 12, 2024, 9:00 a.m. Central Time at Cooley LLP, 110 North Wacker Drive, Suite 4200, Chicago, Illinois 60606. The undersigned hereby revokes any proxies previously given.THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS GIVEN, WILL BE VOTED &#8220;FOR&#8221; PROPOSAL 1. THE PROXIES ARE AUTHORIZED TO VOTE IN THEIR DISCRETION UPON SUCH OTHER BUSINESS NOT KNOWN AS MAY PROPERLY COME BEFORE THE SPECIAL MEETING OR ANY POSTPONEMENTS OR ADJOURNMENTS THEREOF.(Continued and to be signed on the reverse side)1.114475</font>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>bc_companytsr-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_companytsr-4c.jpg
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M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (( [<# 1$  A$! Q$!_\0
MR  !  $% 0$!              0#!08'" (!"0$! 0 # 0$! 0
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M" @(" @(" @(" @(" @(" @(" @A9/\ <P_Q-?\ %% P_P#*ZGW8H)J @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @((63_<P_P 37_%% P_\KJ?=B@FH" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @A9/\ <P_Q-?\ %% P_P#*ZGW8H)J
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MFQ]>Q4JUY:ER!\ILM&43E*8R;)$VT.C:MRL@W$HH@(" @(" @(" @(" @("
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M^]2L<0X:MC7D[(XL@)#9CKO(S'R2B_)ISFJ,_P"#.-?+K)X[AK#X6]3FOO6
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M" @(" @(" @(" @(" @(" @(" @(""%D_P!S#_$U_P 44##_ ,KJ?=B@FH"
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MN/IQ'/:LROLQQQ1BY$1._,S,VJ#ZUVFXQ'WB/9G%CA=R9ML2YG'5^75![>Q
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M_P!*@F(""G/!!9C[*S$$T6HEL2"QCM 3$+Z/JVK.S.WZ4%1 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 00LG^YA_B:_XHH&'_E=3[L4$U 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&L/.?#^5V9Q->GYB7Z^(M3M*
M.'RDA-'8CD!F<M@G;VA;4=H'Y'_MT=?BOAE6=B8IIF9C;&QN.&>);O!;D5TU
MQ335KIJGV:OW\TZVG_+[SOL>7>5;@[B[,0<3\( XACN(Z!O8*O&_(#'^LX,S
M<H%[0>C:;1:FJC-<.F*,Q1,4SJGU>K7'V]W=R?#?$MJK,\+JIB_3\RUC&W;T
M8[*NK5T3BWH_G3Y5"^A<68\7^1Y=/_-ET]K(W[M$5T43535JF'R+,9NSE[E5
MJ[5%%=$X54U:)B>F)?/^]7E1_P!78[WW_HO3Z9FOTZO,Q_J>4_4I_-!_WJ\J
M/^KL=[[_ -$^F9K].KS'U/*?J4_F@_[U>5'_ %=CO??^B?3,U^G5YCZGE/U*
M?S0?]ZO*C_J['>^_]$^F9K].KS'U/*?J4_F@_P"]7E1_U=CO??\ HGTS-?IU
M>8^IY3]2G\T'_>KRH_ZNQWOO_1/IF:_3J\Q]3RGZE/YH/^]7E1_U=CO??^B?
M3,U^G5YCZGE/U*?S0?\ >KRH_P"KL=[[_P!$^F9K].KS'U/*?J4_FA*QOFQY
M;YB_6Q>+XFHVLC;-HJU:*7:.20N81;3G7XKX?F**9JJHF(AZ6\_E[E44TUTS
M,[(EF2P&<(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M,OT!7S1]'$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MXI\(9S@-W_9_LR]4^Q>C5..JFOX:_P"FKW9V*BWSBQ 0$! 09?Y4?XH<'_\
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M%[P>$I8"@U"DYF)223SSSEVDTT\Q.<DLA\FI$[\OS-R**N2 @(" @(" @("
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MFFJ,*J9YIB=,2^JH("#+_*C_ !0X/_\ V<7_ ,26%G_^:Y^%EY'_ *K7XO\
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M.:/ZNOW'!OW]_P#"B76>'M=SR4_:Y7Q!JM_BG^US,NL<P(" @(" @(" @OW
MV$H<2<:X'A_)B3X_*W JVNS+8/8(2T<7T?0F=N1]/T<RT_&<I:S.4KIN1CNQ
MC3.VF>>.6$NA\-\7S7#.(47<M7N35.[5'NUTX3.%4;>C;&R6^*68X[_ISR46
M(XC:7B'RJFD[.ED8V<IJC&^K"VK^R[>F(GV2YP=N5E\;IKNY*K=J]JB>6CFG
MH_B_I*[ELCXFMS<L86<Y$>U3LJ]?XM<>]&IT1@L_A^)L7!FL#<CO8RRVL5B)
M]6Y.<7;G8F?D<7Y66_M7:;E.]3.,/E&;R=[*W9M7J9HKIV3RU=*Y+U8@@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:,F >06YA$6YF9E%3\A5*[2GJB3"4HN+$[:LVJ#VU2KI^XCZ ^I [I5^PCZ
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M_81] ?4@=TJ_81] ?4@=TJ_81] ?4@=TJ_81] ?4@=TJ_81] ?4@=TJ_81]
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M;VA]&K<BUF;R--WVJ=%7V^7UNS\/^*+W#?\ 77':6*NM1.S'7NX^F-4^EBG
M7G-F>'\R/EUYR0[LST.D5/.2:#7LMKH#R']'VO1*/LO^MH_/BY?/56ZNSO:)
MY_7Z_P"+=\7\,6<S9[[PR=^W.FJW'6IY\(UZ/AUQLQAOIG8F8A?47Y6=N5G9
MUO7S&8P?4! 0$! 0$! 0$! 0$! 0$! 0<0_U]_S+@7[G(_\ RKK><,U5?L8]
M[4XW6Z8H@(" @(" @(+O:X;R=2B60-HSACV>W".1C.+M'9AVV;FU=V^=8U.9
MHJJW=+VFU,0V9Y#X:WP_YP<'YC)E&%2G<([HQEVLL#/6E)NTC!G+5VYM&?\
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MLA#P]?.K)2N\0B+9NQ9"+8E>5Q?5X19A:+:9M.71)&U5%$! 0$! 0$! 0$!
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M]C'O:G&ZW3%$! 0$! 0$! 0;3_IL_P =>"/XXOP)5B9SY-3WLZWZIKE&6("
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M5?L8][4XW6Z8H@(" @(" @("#:?]-G^.O!'\<7X$JQ,Y\FI[V=;]4URC+$!
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MG93 7_AO.CQ#C2N%7*G;@GGIW:9D,CPV:LCQR!MCR$VK:B3<[.SJ*NZ @("
M@(" @(" @("#\NOZJ?\ 'WC#_P!]/_@H5U.2^33RVL.[K:>6:\1 0$! 0$!
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MK#NZVGEFO$0$! 0$! 0$!!UW_0/_ ,T\9_P%/\:1:?B?5I9=G4[K6A>X@("
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M^)K_ (HH&'_E=3[L4$U!8.,\]/PWP]9R]9H.TB.&/MKAO'5A::48GEF<?:V
MVMHF'E=!'X3S&2RIVQR&5PN2:)@>-L(9D0;6UKVNU+)SZ>SS>E49.H" @("
M@(" @(" @(" @(" @(" @(/RZ_JH_P ?>,/O*?\ P4*ZG)?)IY;6'=UM/+->
M(@(" @(" @("#KO^@?\ YIXS_@*?XTBT_$^K2R[.IW6M"]Q 0$! 0$! 0$!
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MNK;.$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML"*,R%FVQV7Y&+E;F=THV*HH@(" @(" @(" @(" @(" @(" @("#\NOZJ/\
M'WC#[RG_ ,%"NIR7R:>6UAW=;3RS7B(" @(" @(" @Z[_H'_ .:>,_X"G^-(
MM/Q/JTLNSJ=UK0O<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0:M\U/);%<?[&:Q4VY>-:FAU,M!J':$'*(S;&A/I^K(WM#^EN1:O-Y&F[[5.
MBK[?+ZW:>'_%%WAW^JY':V*M=$Z<.?=Q],:I]+%^ ?.C*X3,#Y=><4+XOB.!
MVBJYJ30:]H== >0OHLY?JRC[!>G1^?&R^>JHGL[VB8V^OU_Q;GC'A>U?L]]X
M9/:6ITS1'6IY\(UZ-M.N-F,-],[.VK<K/S.MZ^9" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @("#7W"/%'$/$5O,2E8H160C,(>&YNUCNT+$1N
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M!W+)?$S]S%U4#N62^)G[F+JH'<LE\3/W,750.Y9+XF?N8NJ@=RR7Q,_<Q=5
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MEH<O:/)1GW5X,M8"".Q/)V;O,S]BP_L@)_V8DVHZNVKL@RM14+)_N8?XFO\
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M1_C[QA]Y3_X*%=3DODT\MK#NZVGEFO$0$! 0$! 0$!!UW_0/_P T\9_P%/\
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M:5N(J]F R%C%CC-F=MH28A?F=E%79 0$$+)_N8?XFO\ BB@8?^5U/NQ034!
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MO1DZR!IF_KU>C)UD#3-_7J]&3K(&F;^O5Z,G60-,W]>KT9.L@:9OZ]7HR=9
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MSR.([K<NP4+.,@:QVPR1Y$WC%I2CC=P<'9W-A$^3Z.K\B8&*I8\PLC'6"2#
MG)8"I>OVPEG[N P8V48S*-Y(F(VD8MJ)]@=?UME,#%-_OR#V\A$]>*M!5J#=
MJ'=L/6*S$8 ?:#M1N'9,Y[!$)D0DVCCRMJP%I@\P<QE+>(@P^.KF4]Z]CK\<
MLY@)'4K=N)0R%$Q;+L[/J<3/Z-/2F!B^4?,*Z.&"]'CI+\5"A%D\W/-/%'-'
M#.<C,T8A&(R&PQD7ZC:,S:[3I@+O0XVGN9T,8>+>&A->MXNO>[<2(IZ4;RN3
MQ,+.P$(EH^UKKZ-'U3 6[B3C>7%<84<;#>KPXVH56/+U)&;MIBRDCPQ.!/\
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MJ/+R$Z##<3QSQ*<M.CDIXGGOYC6C.T3 TN,[W-6E@9N;M('C':)N5Q(7^57
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M[OL WLM\BN(FGP]A9*DU Z8%3L6>_P \+N3B=EYFG<R;7E_:,Q:<R@I93A;
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M'=XV, ,0/9VG^D+H*%3@OAFCD1RM6@,=H)))X1VY"ABFGU[22*%R>,"+5]2
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4.U$3M/ 3LQ,_LC*+N_\ H9$?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>bc_netincome-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bc_netincome-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#^FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXR+6,P,# @-SDN9&5E,V$W-S S+" R,#(R+S X+S$X+3$V.C4P
M.C,P(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N
M=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F.D1E<V-R
M:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.GAM
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z9&,](FAT
M=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240](G5U:60Z,3="1$9#1D,M,CA!1BTT,$%!+4%$,$,M-C,R
M0S$P0D,X1#4X(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.D8W0C-!1#=%
M,C X1#$Q149!13DW0D%"-49",$4S,3 Y(B!X;7!-33I);G-T86YC94E$/2)X
M;7 N:6ED.D8W0C-!1#=$,C X1#$Q149!13DW0D%"-49",$4S,3 Y(B!X;7 Z
M0W)E871O<E1O;VP](D%D;V)E($EL;'5S=')A=&]R(#(V+C4@*$UA8VEN=&]S
M:"DB/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB>&UP
M+FEI9#HY,C!E9F8P8RTR93-D+30X,#$M86$P9"TV,S8P-S(P-V4Y-3@B('-T
M4F5F.F1O8W5M96YT240](GAM<"YD:60Z8V(R8C=F,68M,61E8BTT964W+6$Q
M-C@M,V9F-F$P-S,R,F4R(B\^(#QD8SIC<F5A=&]R/B \<F1F.E-E<3X@/')D
M9CIL:3Y+979I;B!'=7)L97D\+W)D9CIL:3X@/"]R9&8Z4V5Q/B \+V1C.F-R
M96%T;W(^(#PO<F1F.D1E<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M
M971A/B \/WAP86-K970@96YD/2)R(C\^_^T 2%!H;W1O<VAO<" S+C  .$))
M300$       /' %:  ,;)4<< @   @ " #A"24T$)0      $/SA'XG(M\EX
M+S1B- =8=^O_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$!@0#! 8'
M!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04
M%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (+ YT# 1$  A$! Q$!_\0
MRP !  $$ P$               0#!08' 0()" $! 0 " P$
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M19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19
M\-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H
M=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VC
MZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+(
M'AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM#NT?19 \-H=VCZ+('AM
M#NT?19 \-H=VCZ+((Y4*7;HX^SAP/#(3CPMIJQ S/_XJBOB_LZM\F*@EH" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @BE]HQ?(2?G@@XQ?V=6^3%!+0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!%+[1B^0D_/!!QB_LZM\F*"6@(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(""*7VC%\A)^>"#C%_9U;Y,4$M 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$$4OM&+Y"3\\$'&+^SJWR8H): @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(->Y/=6[,]NG([2V$%*N&#")\WG,FTDT06+#<<=:"&
M(@<S8/.,B)F'5F\JJ+[B,GG\7BK]KVA'C:8X\G+Q2I*4=26LPL_6&,_+$3.[
MBXN1-[SJ*J;=WWM#=LTU;;N8KW[-<6DE@C)QE:,GT8^ V$G%W_G,VB"+>]IF
MP<9,,%_<-*"8K$E/@.1M1G@DZJ03_%X3\W4M&U]U7 2H]][.FW!_=6+-53W#
MRZ4!D9Y'<1XG%G\CDS<KCKQ:>XH.N9W[LW;QV8LSF:U.>F<<=B&0GZP3G#K
M;@9G)]1\[S6?D07&+<&"GPH[DBR-<L 4/:6R32CV;J6Y7/K-=&9O=00MO;VV
MINR2>';V5@O3UA$YH0=QD$#^"? ;"7"_N$S:((,OM0]GL$U6";<=$);DA0P,
M\K?I E>%V)_('](+BW'IJ_D5P%RW#N_;6U(H)=PY*&BUEW&N,CN4DCBVI<
MQ$[,WE=FT;W5!2R&^-H8K%4\W?S-6+%Y%F?'V.L8VL,3<7]$(ZD?)R^:SH(.
M0]I&U*VT+>\J.2KWL9 ,@0$$G",ML6=@KN^CN!D3,.A#JVOD5P&-W?:W@\O@
M*!;>W+B<1N6X5(Y*^2<YXXNM,'F@?@X'<]'*,7_&]Q,$Q9MN/>.U]I! >X\I
M!C^TNXUXY2=Y)''E+@ 6<G9O==FY%%=H]W;9EP([HBRM:3;Y<.F1"1B@UD-H
MQ9R;71^,F'1_(Z"/B=^;.SV6L8+#YJK=R]9B*6K#(Q'P@_"3C[AL+\CN+OH@
MR)!K#97M+R>XMX6L7D:\$&WLF%NQM"U'Q-+9AQECLMAY-7=M7+20--/-5P1F
M.X]Z[4VB\ [DRU?'26=7@CE+^D-A^$3 +.7"WNEIHRBL>S_M>VE@LQ@\?)?K
M2T,M%):L9(9VZJM5ZHI()O-$F,9B'@%V=7!,66UL_AKMZ/&5;L4M^6F&2CKB
M^IE3E+@"9F_%=^1G452;=.W.JRM@LI6"#!R/!F)3D$ JRB R.,I%HPOPF+\O
MOH(NW]];0W59FI[?R\%ZY7%I):X.XRM&3Z,; ;"[B[_SF;1!K27?6ZQ]G61S
M8Y#3*P;K+%Q6.JBY*398:_5\/#I^C?AXM-?=\JJ-N8[.8C+6,A4QMR*S:Q4_
M9,E#&6IP6. 9. V]Q^$F+[SJ*YQ.:Q6>JE>PUN.[3"66L4\+\0==7-XY!U]\
M2%Q?[J#74>Z?:=FLMNL-M#A.Q;;OG1AIW8[33V."".;EF"3@!RX^%GX'T]Y5
M%^Q7M1VO9V?A=WYJU'A8<S'K#4LFQ2O,#N,D8"#.4G"3/RB/DY4P57S&[J.1
MV)E-S;1SV.ACA@E*#,V^*:C7EB^$\X@XEH/\X>1T$[*[QV]M?%4+VZ<O5J-;
M$!BE=W89Y>!B)X@;B)V_G<C/HWE4%EV+NJSN7<F\0"_%?P-*Q1;#20=64;0V
M*82EPF'PM3=_*[Z>15&6!FL5)F)=OA;C?-0UPN2T=?Z5JTAN R:?BN3.VOOJ
M*AVMX;7HMEBN9:M".">,<NYR,S5CG!CC$_\ F(79Q'ROJ@J[?W-@=TU#O;?O
M1WJT1O#*4>K$$C,S\)B3,0OH[/RL@NR#5VP/:=E-P[FR.W]Q5(*@RSWFVW9K
M\;#9BQ=AZ]F,^,B_I(W<"Y/*+ZZ<BN",DVANFUFBW265ZBO7P68M8Z&4-0'L
MU:.,V.1S)VU\Y^)^1D5)P6_]F;FN'C\%FJUVZ /+U,9.Q'$+Z.<?$S<8L_\
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M" #J1/IRZ"SJ"KA,]AMR8\,I@KL5_'R.0#/ 7$+&#Z$+^Z),_E%^5D%Q0$!
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M=$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^T8OD)/SP0<8O[.K?)B@EH" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\JW1['HWV_\ LJ/\O]I;C6OM@$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 012^T8OD)/SP0<8O[.K?)B@EH" @("
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M+'7A*8V#BDE-@%FU=O(Y:D_N-ROR(*LN8Q,%R#'3WZ\>0M#QUJIR@,TH\O*
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M<&BE$>'AK2!/QNSLPZ$[_"Y:-W+BJ%9GM=JCJU>K8B I"*1B?D%V;1F9V]]
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M(79Q?E9VY6=E!R@(*?:(.O:KUH=J<'E:#B;K'C9V%RX?+IJ^FJ"H@(" @("
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M-G4HVS']57NC"E:?)Y%GF@Q#E%77:W^*<#^\J7]8!==SLSN=MKMP]?5I[-"
M@(" @A08G&ULA<RT%6,,ED BCNV6;SY0KL31L3^\+$6GWT%8:=,*Y5 KQC5/
M5C@8!:-^+RZCIH^ONH(K8'#MD_&.QQOD>RMCAF=M>&HQ<?5"+^:(N7*^C<NC
M:^1D$HJ=,Z[4SKQE49F9H' 7C9A?5FX=-.1!V.K6E-I)(8S-M-"(6=VT\G*[
M((6,V_AL/0BQF/IQQ4H93L1QNW'_ $\AE*4CD?$[FYDY.3OKJZ"<\$+S-8>,
M7L"+@,O"W&P.^KBQ>737W$"*O! \CP1!&\I/)*X"P\1OY2+3RN_OH*B @("
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M[JH_U<%I]SM3O9N%_76H@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(-=>T7VT;-]G,95[L_B&>=OZ+#TR$IM7\CR/Y(V_*Y?>9UCLSGK=G@VU<G3
MR-LT7[7SFISC3'4M]^K9S=[FX.66K(=J^U[V[3C=WG8DVEL(]#AQ$+.,TP::
MB_5EHY:Z_#FY/=$%C(M7\W.-?X:?+9'OGF;I5J&D_;]/5RL1F,QQUSLCGXMU
M//4WGLS8.U=@X]L=MF@%82_3V2\^S,_OR2OYS_>\C>XS+-V,M;LQA3'/QO-]
M3UC-:C<Z]^OK<D?EC='E/*R5?2PX@(" @(" @(" @(" @(" @(" @(" @("
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M<FG,HHW(CDL"Q&S-YK&[MIP\/#H.J2C-U%$$4OM&+Y"3\\$'&+^SJWR8H):
M@UK/[+9L006=F9$*YQ7&R34LG$UD); N3\)6AX;+ _$_(1GI[C:*XI@V- \S
MP1O981L. ]<,;N0,>GG,+NS.[:^35E%5$! 0$! 0$! 0$! 0$! 0$! 0$!!\
MZ?QK?Z-Q?OJC^;,LCI_S>9TWNQ+SX6QL,(" @(" @("#I-^BD_)?^1'.CM1O
M>NVQO\$[;_=5'^K@M/N=J=[-POZZU$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[7-=<S55.V9X9E(7)U" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @("#&=[9Z?;V.KVZ]ZK0*2=HGENU;-P"9Q)^%@JNQ,_)Y7Y%8$+9
M.>S.Y'DOOE<7DL-"1UY.PU+=:8;(<+\+O8D+R,_*W"DHS-11!%+[1B^0D_/!
M!QB_LZM\F*"6@(-4[Q@GCW99+*XV7+T;L,$>%B\;CQ;"8LXRQQP//"Y.1.+\
M?*_+IY&95&SZ0/'3K@\3P.,0#U)%UA!H+-PN>K\3MY-=>515= 0$! 0$! 0$
M! 0$! 0$! 0$! 0?.G\:W^C<7[ZH_FS+(Z?\WF=-[L2\^%L;#" @(" @(" @
MZ3?HI/R7_D1SH[4;WKML;_!.V_W51_JX+3[G:G>S<+^NM1 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$&N/:+[:]F^SL2JVYO$L^[?T>'IDQ3,[\C=:7*T;
M?E>=[PNL=F<_;L\':JY.F>)MNB_:V<U.>M3'4M]^K9S=[V>=J^':/M<]NLPW
MM\VI-I[$)VD@PT#.$TH>47ZLN5WY?AS??$%C8LW\W.-<]6GRV1[YYFYU:EI/
MV_'4RE,9C,<=<[(Y_=3SU-Y[.V'M78>/;';9QX50=OZ>P_GV)G]^21_.+[WD
M;W&99JQEK=F,*8Y^-YMJ>KYK4+G7OUS5R1^6-T>4LD7TL0(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @Q;>^4MXZM0AQMJW#D[
MEGJJU?'UH+=B?A C,6&P01B(LW$1D3::?=512V$020926>>]+G#N?M<,G%#7
MGCF&&,8Q:*OK$P=4P.) 1<7E=]4D9<HH@BE]HQ?(2?G@@XQ?V=6^3%!+0<.[
M,SN_D;E=!IG=MO 2Y?*78Y]NY2/.T*Y1GF9) FJ1/&0 0,,,KE$3?TC"+QEQ
M:\ONMR1MG"P-6PV.K-9>XT-6&-K9?"FX(Q;K'UUY2TXEQ5.0$! 0$! 0$! 0
M$! 0$! 0$! 0$'SI_&M_HW%^^J/YLRR.G_-YG3>[$O/A;&PP@(" @(" @(.D
MWZ*3\E_Y$<Z.U&]Z[;&_P3MO]U4?ZN"T^YVIWLW"_KK40$! 0$! 0$! 0$!
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M:>3.#:UTJ1Y#$O$,AR%CPCC%@GXF<!D&&-I?-)WT?1VXG3$P9XHKH<44NG6
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M5RJ:JYFJJ=LSPRK+DZQ 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$! 0$! 0$! 0$! 0$! 0$!!\Z?QK?Z-Q?OJC^;,LCI_S>9TWNQ+SX6QL,("
M@(" @("#I-^BD_)?^1'.CM1O>NVQO\$[;_=5'^K@M/N=J=[-POZZU$! 0$!
M0$! 0$! 0$%*S9KTX)+5N8*]:(7.6:4F",!;RN1$[,S??7&JJ*8QF<(<Z**J
MZHIIB9F>*-K1.[?X@[&3R);3]CV,DW'N"34?$6!RJQZ:LY /)Q\/XYN(?E,L
M)>U&:IZEF,9Y>B/?+TO3OLVFU;\1J5<6;<?EQ_%._DW1C5N==J?P^W,QD W9
M[9,I)N#/'H38SK'*K&S:.PF3:<3-^(#"'Y3)9TZ:IZ]Z<9Y.F?='I74?O&BQ
M;\/IE$6;?>P_%.[DWSC5N;XK5:U*O'4IPQUZL(L$4$(M'& MY&$19F9OO+-T
MTQ3&$1A#S.Y<JN5355,U3.V9X955R<! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 012^T8OD)/SP
M0<8O[.K?)B@EH#MJSM[_ +R#6L.*W[B< >QZ&&QMRAU,M.MFY;3Q0]1+Q,QV
M*G5$12:%J8B>AE[K:JHS[$T&Q6*HXL9"F:E7BK-,?(1M"#!Q/]U]-5%3$! 0
M$! 0$! 0$! 0$! 0$! 0$!!\Z?QK?Z-Q?OJC^;,LCI_S>9TWNQ+SX6QL,("
M@(" @("#I-^BD_)?^1'.CM1O>NVQO\$[;_=5'^K@M/N=J=[-POZZU$! 0$!
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M/,V:LDTX0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M=DP'; [VQ6X+@4J]>W5.S7>]CY+D+PQVZ@FP/+"^KZLW$#Z%PEH0OIHZ#)5
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M,]1U3,Y^Y\2_7-4\7)&Z-D+\OH8P0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!%+[1
MB^0D_/!!QB_LZM\F*"6@(" @(" @(" @(" @(" @(" @(" @("#YT_C6_P!&
MXOWU1_-F61T_YO,Z;W8EY\+8V&$! 0$! 0$!!TF_12?DO_(CG1VHWO7;8W^"
M=M_NJC_5P6GW.U.]FX7]=:B @(" @Q_=N]]K[&QSY+<V1CI0NS]3$[\4\Q,V
MO#'&VI$_WFT;W=%\][,468QJGI973M*S.?N=2Q1-4\?)&^=D-$6=\>UGVY2G
MCO9Y3/;&RG)X[.=G)XY9 ^"3=8.O+_R0ZO\ C%HL)5?OYJ>K1'5I\ML^Z/6]
M+HTK2M B*\[5%^_MBW'#$<WOJYJ6S/9S[$-G^SWAOQQOE=R/RRY>XS$;&_*[
MPARM']]M2]\ED<MD+=KAG\57ELAI^M?=6;U+\$S\.UW*?_*>/V>9LM9)IX@(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @((I?:,7R$GYX(.,7]G5ODQ02T! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0?.G\:W^C<7[ZH_FS+(Z?\WF=-[L2\^%L;#" @
M(" @(" @Z3?HI/R7_D1SH[4;WKML;_!.V_W51_JX+3[G:G>S<+^NM1 0$%&U
M;JT:\ER[/'6J0BYS3S$T<8"WE<B)V9F^^N-544QC,X0[+=NJY5%-$35,[(CA
MEH;=?\0-[-Y MI^QG%R9[.&[B64>-WK1LSNSD EPZLWI)'$/RF6$O:C-<]2S
M&,\O1'3Z'ING_9U%BWXC4ZXM6^YC^*=\^Z,:MRKM+^'R7(9)MV^U_)'N3<,C
M,3T"-RJ1^\)ER<?#^(+"#>\[*V=.FJ>O>G&>3IEUZC]Y1;M^&TVB+%N/S?FG
M=R8\LXU;F]J]>O4@CK58@@K1"P10Q"P (MY&$1T9F^\LU33%,81&$/-:ZZJZ
MIJJF9F>.51<G 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!%+[1B^0D_/!!QB_
MLZM\F*"6@(" @(" @(" @(" @(" @(" @(" @("#YT_C6_T;B_?5'\V99'3_
M )O,Z;W8EY\+8V&$! 0$! 0$!!TF_12?DO\ R(YT=J-[UVV-_@G;?[JH_P!7
M!:?<[4[V;A?UUJ("#5OM&]NNT=A/)C*Y^-[IUZN/$4RXN"5]-&FD9B8/+\'1
MR_Y5C,SJ%%K@C\57EM;IHGVEF]0PN5?]5GOU<G],<>_@CSM>U/9Y[4O;99@S
M/M.NGM_:/$TM;;M9GCE,'?5M8RUX7_YYN(_>%F6/IRU_-3UKD]6GRV1[Y];:
MKFLZ7H5,VLA3%Z]LFY/#&._CW4X1YV]]J[-VULG&MB]LX^*A5Y'E<&UEE)FT
MXI)'U(R^Z3K.6;%%J,*8>::AJ>9S]SXE^N:Y]4>:(V0OJ[V,$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!%+[1B^0D_/!!QB_LZM\F*"6@(" @(" @(" @(
M" @(" @(" @(" @("#YT_C6_T;B_?5'\V99'3_F\SIO=B7GPMC880$! 0$!
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M'?M])J@WRL1#2-A(;#F+1.TCLPOQ:Z<KNVG*@[V;-:G!):MS!7K1-Q2S2DP
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M\)\R!^UO>K_A/F0/VM[U?\)\R!^UO>K_ (3YD#]K>]7_  GS('[6]ZO^$^9
M_:WO5_PGS('[6]ZO^$^9 _:WO5_PGS('[6]ZO^$^9 _:WO5_PGS('[6]ZO\
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MSYN>3+V1?B'M.C5P+_D@'0&_XL[_ '4%[$1$6$69A9M&9N1F9E!R@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(""*7VC%\A)^>"#C%_9U;Y,
M4$M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08I[0-Z!LK;%_.P5FR%FF\(E
M6$M!B:>4(NNG<6,@ACX^.0F%W86?D5&#W?:_?PFWMM1WK."LY_,P6)CS;7R#
M /!1X!.PTT<1G_2D8\,;!YGG<3Z#RL$7>#VJ=MWW'L^L6*@BKG7@N2V[Q!8M
M3V:S6>&A&,1#(P"0^=(0<?+PMYJ8#G?WM0R.T\G>I8G#QY.O@<9'G=P2RSO
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MCU;\Z!XBW=;'JWYT#Q%NZV/5OSH'B+=UL>K?G0/$6[K8]6_.@>(MW6QZM^=
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M56Q?DL $+%%:@@GFACM5C$F>"88S%B#B)C\GN:>1W5"ULC;5N]%?DIN!QC7
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M4$M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M022@$\_$T,1$S&? VI<+/ROHW*^B"IKIROY$!!0MW*E"N=N[,%>K'IQS2DP
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MT\CL_E9!W0$! 0$! 0$! 0$! 0$! 0$!!%+[1B^0D_/!!QB_LZM\F*"6@("
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M /(O8(S-KOT_JAX_.5O1,_\ 57^F3^YFZ/\ *^2_^/G^(GB;7?I_5">&O?\
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M$%&6G5GGKV9H0DL57(JTA,SE&1BX$XN_D=Q=Q^\@K(" @(" @(" @(" @("
M@(" @(" @(*=BO!;@DK6H@GK2BX2PRBQ@8OR.Q"6K.S_ '4$;&XC&8:!Z^+J
M15(2?B,8A8>(O)J3^5WTY.5!-0$!!1*K6.S'=*$'MQ <4<[BW&,<CBY"S^5F
M=Q%W;[C(*R @(" @(" @(""C6IU:8R#4A" 9I#GE:,6'CEE?B,RT\I$_E=!6
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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()[FGO^Z@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_outlooktherapeutics-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_outlooktherapeutics-4clr.jpg
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M_\0 Q0   @(" P$               <&" 0% 0,) @$!  (# 0$
M      4& @,$ 0<0  $#!  $ @8$"@4("04   $" P0 $04&(3$2!T$346$B
M,A0(<8%"<I%28B,SLW05%C:AL8*R)))#T[0U=3<8P5-S-&16%R<XX=*4)781
M  (! @,$!0D%!P0" P$    ! A$#,00%(4%1$F%Q@2(&\*&QP=$R4G(3D4(S
M%#1B@K+2(Q4UX?&2HL(6XF.#)/_:  P# 0 "$0,1 #\ O]0!0!0 3:@-?E<[
MB,'',K+S&H;(%[NJ"2?#@.9^H5NM69W9<L$Y/H.;,9FUEX<]V2A'BW04F^_,
M;@]1QZ\CBM?R6PM-=0>7'2F.TV!R4I3EU=)_&"#;QJ7_ ++?2K*B\[(;+^(<
ME?N.W"6WBTTGU-B$R/ST;:XZM6%U/&QXY/YOXM]^0NWK\LM ULCI<=\F2DLS
M3<:=/SN]UPL%6)P2F[W*/(E"X]%_B:V?VNWQ?EV&O\V_+_<W^*^>K8VW4G/Z
MC"D1@/;^!DNQUW](\T.BM4M*CND;8YJI;#0MUE;IJT#:9.OSL(UD4^;'A2^A
M;Y9(]EWI0;A*^:+BY%C:QJ%NVU"3C6M#L3J2IF0S(3U,K"QXVYCZ1S%:FCT[
M:\ 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
M 4 4 4 4 4 4 4 4 4 4 4 4 4!TR946%'=ES'FX\1A"G7WWE!MMMM NI2E*
M(  ',FO4J[$"N.9^:K7,YLKVEZ+)!6I)2SL#Z;,/O ^TU%0H"YM[JU\#]D'A
M>QY#3(2=;WV>UE8UW/YFQ9KETOVI/;R]/+O[7LX$<DO2)DA4N<\Y+FJ)*I$A
M1<<ORYGE] M5SMPC;CRP2BN"/D-Z<[T^>[)SEQDZ_9N790^ 2#<<^7U5E0PK
M05F^]GH.<+N6U<(@9DW4[!X(BR%?D^#:S_DGU5Q7<O7;$MVFZZ[=(7N]'CO7
MM71]@A7L7DX^2_<[\)]&6\P,B"6U%\NJ-@E* "22>5N=1TN[B7NW2XDX-23W
MHN)\O_RHJA.P]W[IQ4KDHL]C=6= 4EI8LI#DP<05#F&>0^U^+4!F\_7NP^WV
M$K:L<NUXEP@D#PJ#.HZ)$5A\]2ATO#W74'I6/H(KU,"7A?,]VW_]0Y_;S(9#
MR/A'4Q(NQ.%/[OD2^3C16  WT*]@+/L*-^(X7[GDKGTU-+L-?U%S4'<E:5 %
M)!!%P1Q!!K@-A]4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M\T\$<KE=;]ZD.NFWUU'35,/J 4 4 CMNLGO-C"S^D\S'DVY]?MC^[:KODO\
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M^&<QSI6*2C)XO9R],EO[,>@D/S::C"U/M#KT**X77AFTNRGU6"GGG(SH*B/
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M&@<^GWU> L>H=V6R<[SKA'B:YW%%;3SLVS:\]N^P3=HV669F9GKZWG3[*4I
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M_<][1P1VK7E&!K]@H,&2&S\26.K['%'U=-89VO+#F]^FTRMXNF!8^HLW"?\
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MRIA<GXN4TA8LKR7Y3JVU6]"DD*'J-=.?DG>=#795(H=%<!N$/GO_ );ZI_\
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M9H=+;+:0A"0/  57)2<G5[67B,5%*,51([JQ,@H H H H H H H H H H H
MH H H H H H H H H H H H H H H H H H H H H H H H H H H H H H
MH H#B@ ^\/KH"$=T?]@_6K^JNBQ[QA(KJS^D;^\G^NI,\+.Z-_L%K[QJ*N^\
M>Q)*:TF9QX4!S0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0
<!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0!0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>px_24outlookproxy1pg01-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_24outlookproxy1pg01-bw.jpg
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M_\0 P0 !  (" P$!              8'! 4" P@!"0$! 0$!
M      $" Q    8! P(!!0D)"0L(!  ?  $" P0%!A$2!R$3,4$B%!8(43*4
MU!655A=78=%"TB-3TU48<9&2DU1TM-4W@5)BLC,D=;4V=I:AL7)SLS0X"<&"
M0R4U&6.CQ":B@\.$Y*5&QB>'\41%987%9H9W\,+C1TA8$0$! 0 # 0$! 0
M        $0$A,4$2 E%A_]H # ,!  (1 Q$ /P#W\
M
M
M
M
M
M
M
M
M
M
M
M                       -.>68JF;\F*O*\K'=L]#.6P3^[7339OW:Z_<
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M <HU[237DQH=E%D2%ZFAEE]MQ9DDM3T2E1F>A ,\
M
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M3<Y)2MNN$U'M6YR6VY+2XRE.-MEX&3AD6OE$1Z/
M
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M+JSZ'VFW\[YPC<=<;U;%_AB&-]KD.KK1LFUN4\\@S(TJ:+5MM&Y);EGT5H9
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M!$3H
M
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MNC2?I))[)Q]"5KI_DS-'AX ,K*\.Q?.:LJ7+JJ/<51.ID)BRD;T)>;(R2LO
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MP&'!X\PFLRJ7G$"DC1\MGI4B9;(292'$N;=Q*/73KL3Y/( DP
M
M
M
M
M
M        ,2?:5E4T3]I-8A,'T)R2ZAE&O[JS(@&+ R?&K5WL5=S!FOGX-1I3
M+R_WD*,P&U  '#O,^'<3K^Z0#F ^*4E):J,DE[I] 'Q+C:ST0HE'[A&1@/AN
MM)/12TD9>0S(C .\S^<3_"( [S/YQ/\ "( )UI1Z$M)F?@1&0#F      ,2?
M:5E4T3]I-8A,'T)R2ZAE&O[JS(@&+ R?&K5WL5=S!FOGX-1I3+R_WD*,P&U
M  !@6-Y24Y).WLHL E=4^E/ML:_N;U$ XUU_17!FFHM(D\T]5%%D-/F1?=[:
MC ;$ \.I^ #@3K1GH2TF9^!$9 .8#XI24EJHR27NF>@#AWV>A=Q.IF1%YQ>)
M]"(!V  #AWF?SB?X1 '>9_.)_A$ =YG\XG^$0#ZEQM9Z(42C^X9& ^&ZT1Z&
MM)&7B1F0#GX]2\ 'PS)):F>A%XF8#BEUM1Z)6DS]PC(S <E*2DM5&22]TST
M<>\S^<3_  B .\S^<3_"( [S/YQ/\(@'(S(BU,]"+Q,P''O,_G$_PB .\S^<
M3_"(!R(R46I'J1^!D ^@ #XI24EJHR27NF>@#XEQM?1"B4?W#(P'(!\,R(M3
M/0B\3,!Q[S/YQ/\ "( [S)]"<3^^0#F  .'>9_.)_A$ =YG\XG^$0!WF?SB?
MX1 .25)66J3)1>Z1Z@.)NM)/0UI(R\2,R <R,C+4NI'X& ^&9$6IGH1>)F X
MDZTH]$K29GX$1D9@/JG&T'HM1)/[ID0#YWF?SB?X1 '>9_.)_A$ =YG\XG]\
M@'U2T(]^HDZ^&IZ /J5H66J%$HON'J ^@,>;80*U@Y-C*9B1BZ&](<2T@C/_
M  EF1 ,*!D^-6KWH]7<P9S_YJ-*9>7^\A1F VH  ZI,J-#95(EO(CQT=5NNJ
M)"$E]U2C(B :EC,L0E/%'C7]:](,]":;F,+69^&FTEF8#=^/4O       <5+
M0CWZB3KX:GH )6A?O%$K3QT/4 4XV@]%+2D_<,R(!](R46J3(R/P,NI /H#A
MWFM=.XG7PTU(!S  &IGY3C-6\<:SNH$*07BS)E,LK+_U5J(P&=#G0K%@I-?)
M:EQE=$O,+2Z@]/<4DS(!D
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MTK,MK#KAET+Q,&=>3/:!>>1S;GB4N+))7,O0B4?]^8+C]5L._P!D:#_1L/\
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M-:]M+VW<AULC,S)MU/5)'X&2DZGMU,PML
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M8RLNWYQJT0>FGAH!7H>%$9@0X\".1E'BM(8:)1FI6QM))3J9]3/0O$$=X
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M,C26Y5BAMN=)E27'UNI9,S1JDS)LM#4KJE!>("R
M
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MI)F1D [0
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ML2CV:/:0XEXUXGK\5RRU?BW;$J8\ZPW#D/I)#SQK0>]M"DGJ1^Z";BWOVSN
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M0I2?%/D48(DH
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M!]>BE:'U(&KP_0P&0!4O._!L+G*IJ*F;<NTS=5)<E)<983(-PW&]FADI:--
M'5P-P-"X+A7<*%=O7*+EUAY2GF$1^T<=*TZ%M6O7=O\ ^0!&N;O95J^:<P9R
MZ;DLBH=9@M5Y168J'TFEEQUS?N4XD]3[NFFGD!:MWCO#FN/\)I,+9EJGM4L9
M,5$Q:":4X23,]301J(O'W01DYKB%+GN*VN(9 SWJFV84P\1:;D'[Y#B#/71;
M:R2M!^11$ \QX[["%'CV05-^UFDM]RJF1YR&506DDLXSJ7229D\>FNW34%KU
MT"*VY9X,X_YD@MLY7"4W:1DJ1!NH9DU-9(]?-WF1DM&IZ['"4GW-# >8K/\
M\OB;Z6HZ;.6C@F?FIF0%$ZDO<,VWC)7[Q U4ZX\]A? L:G,6F:6K^5OL&2TP
M#:*' -9'J7<02W%N$6G@:R2?E(P2O5+++4=IMAAM+3#220TT@B2A*$EH24D7
M0B(O @1Y^YN]E6KYIS!G+IN2R*AUF"U7E%9BH?2:67'7-^Y3B3U/NZ::>0%J
MV.,\':XWP6FPAB:NQ9IVELHFN-DTIPENK=U-"341:;]/$$2P
M
M
M                                                          85
MO6,753.IY2G$1K".[%>6PXIEU*'T&A1H<09*2HB/HI)ZD8"N^'.!\,X8ARCI
M.]8Y!8]+.^G&2I3R=V[8G:1$A&O7:74SZJ,]"T"T0
M
M
M
M
M
M
M
M
M
M                  !"^0>6>/\ BQJ ]G=RBJ39J<1!2;3SZW39))N&26$.
M&1)WIU,RTZD E-5:5]W60KFID)EU=@PW+A2F_>.L/H);:TZZ=%),C 98
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M>3* LFPZ8J=3*><C$^MEV.?=9TW%L>2A734O( DX
M
M
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M2TEJG7W_ /U2@$K]A_\ L-9_TK._YVQ#>WH\$
M
M
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M?$0UZ[!
M
M
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M;*IMG(NLDRB0VN7.DI;:)F'%)28L1EMHB2E#25F6[WRS/<H]0$S,B,M#+4@
M  <$,LMJ6MMM*%.'JXI)$1J/W3,O$!ST+Q\I^(   !$1="Z$
M
M
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MG_VK9-^_'_%"%/DK/_M6R;]^/^*$*?)6?_:MDW[\?\4(4^2L_P#M6R;]^/\
MBA"GR5G_ -JV3?OQ_P 4(4^2L_\ M6R;]^/^*$*?)6?_ &K9-^_'_%"%/DK/
M_M6R;]^/^*$*?)6?_:MDW[\?\4(4^2L_^U;)OWX_XH0I\E9_]JV3?OQ_Q0A3
MY*S_ .U;)OWX_P"*$*?)6?\ VK9-^_'_ !0A3Y*S_P"U;)OWX_XH0I\E9_\
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M\4(4^2L_^U;)OWX_XH0I\E9_]JV3?OQ_Q0A3Y*S_ .U;)OWX_P"*$*?)6?\
MVK9-^_'_ !0A3Y*S_P"U;)OWX_XH0I\E9_\ :MDW[\?\4(4^2L_^U;)OWX_X
MH0I\E9_]JV3?OQ_Q0A3Y*S_[5LF_?C_BA"GR5G_VK9-^_'_%"%3/V?;O,$\J
MY=B-]E5CDE7!J($R*=F;9J0\^L]QEL(M.AZ":KTR(
M
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M>HA
M
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M[?<Y_P! 5?\ CC&M9T]1"
M
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M##5[#3(      ,O@C^WW.?\ 0%7_ (XQK6=/40@
M
M                                               JOVD_["LZ_P!&
M+_QT N*8I/\ X!5'\PB?]@@;89PH     ,*YJ8=]43:.Q)9U]@T;$DFU;%F@
MS)7FJT/0]2$'3CF/5F*4L;'Z9+B:V)W#82\ON.%W5FXK56A:]5'H S9D5F?#
MDP)&OHTMIR.]L/:KMNI-"M#\AZ'T,4:G$\0I,)JUTU EY$%QY4E29#G=7W%I
M2D]#T+0M$ET$-U@RN.L7DY>WG242(N2MK0X<B*]VFW%H3L,UHVF1[T^:O^^(
M(5RS#CK$,[)M>0P-\UE/;9GQUFS)2@M=$&HM24DM3T2HCT\@0S8TF-\(<>8S
M.;LV(;UA-842XZK!PG6VU%U)1-I2E)F1]2W:A%NMYE_'^.9V_#?R;TJ0B#KZ
M/&:?-IC59[EJ4DB,S4K0B,]? @B9K;W='59#32<>M8R7*B4VEE<=&B"0EO3M
MFWT\TT:%M,O !BXKBM7AM5\B4JY!UJ7%/--2G>^;2EZ;B;/0M$F9;MONZGY0
M*QV<&QYC,7L\;0^61R$&TZLW=6-IM$ST;TZ>:1>7QZA"I$*/I&9=2Z& A\7C
M'#867JSJ-%=1D"GG)6O=_P W2^\DTJ631%X^<9EU\>HD*EYDE25(6DEH61H6
MA1$I*DJ+0R,CZ&1D>AD*BL+3V?\ C:SEJF-QI5<:U&I<>&^1,:F>OFI<2LTE
M]PC&8U]:F>+8=C6%P5P,:@IB-/&2I#RE&X^\:==.XXKJ9%KT+H1>X+$W7/*<
M6I\RJ%45ZEU5<IU#YI8<[2][6NWSM#Z><8#95,*/2P(-; )11*UIJ/%)P]ZB
M;8(DHW'TU/0NI@-!C> 8WBCUQ(ID/I=OB--B;SO<U)1K,]GFEM_RB@A63B&'
M4>"UKM3CJ7FX;SYRE]]SNK[II2C4E:%H6B2Z ;M84+CC$JW+GLW@1G8]\^IU
M;I(<TC&M])I<,FB+INU,_'QZA"LK+,'Q;-XK47)8!238U]&E-J-J2T2NIDEQ
M/7:9]32>I!#-B'UOL^\:5\A,EZ-+L=ADI#,N1^2U(]?.2TE!J+[AF)%^M69'
MCQXC#42(RB/$823;$=E)(;;0DM"2E)="(AI&BS#":#.X,:NR)#RXL1U4ADH[
MG95W%)V'J>AZEH(9L?+S!L>R*SI+>T0^J=CVSY,-IWMH+M+2M.\M#W=4EJ$*
MRLKQ6CS6J52Y"P;\(W4R$&VKMNMNHU+<A>AZ:D9I/W2 KY!Q2A@XRC#BB^E8
MZAI3'HDL^Z:FU+-SSE=#U)1ZI,M#+R ($KV=>-52N^2;!#&NOHA22V:>YN-!
MJ_Y1(OUJR:>GJ\?K(]-2Q40ZR(DTL1V]3(M3U4I1GJ:E*/JI1GJ8J-4]@V//
MYBSGCB'SR..@FFED[HQM)HV>K>G7S3/R^/4(5F9/C53E],[07:7%5KZVW7$L
M+[2]S)ZIT5H?34P&945L6BK(-/7DHH-<RF-&2Z>]7:1T(E'IYW3QZ (]C/'.
M+X=<2[K'$28;\Y*D28I/F<0TJ5O(B:T+38?O.OFA"M/DO"''V46+MM)BOP9\
MA1N2E0'":;<<5U-1MJ2HB49]3VZ:F$6ZW>&\=XG@;;WJ]#4F7(22)$Z0ONR%
MH(R/:2M")*=2(S))=?*$3=KMR_ \5SJ.TQDD+O.QM2BS&5&U):)7BDEEXIUZ
M[5$9!#-C18OPK@&)V#5M#BO3K%A1+C.SW"=2TLNI*2VE*4[B/J1JUT"+NZL!
M1;TK2KJ2R4E1^711&1_\XK*/8?A&/X)"E0,=0\B--=0^^4AWO*WH2:2T/0M"
MT,2+NUQL\&QZWRFNS*:A\[VJ2VB&M#NUDB94I:=R-#UZK/7J$*[,LPC%\WBM
MQ<E@E)-C7T:2VHVI#6[J9(<3UVF?4TGJ00S42IN ^-J>8F:N)(LUMF2FV9[Q
M+8(R_OD(2C<7W%= B_6IKE&,U.8TSE!>)<56N.-/*3'63*]S&NPB,B/0BU\-
M 1DMT]<BC3CBV>_3IB%7*8>/>:XQ([>U1GXGH7C[O4!JL-P;'L"C2XF.(>0Q
M-6AV0F2YWM5-I-)::I+IHH]2\H0W:BEOP!QO;3%S6XTJM4X9J<CP7B2QJ?\
M>H6E6TON)/02+]:F&)X5C.$0G8.-PO1DR#2J4^XHW9#QHUV[UGY"U/1):$6H
MJ;K?"@      ,O@C^WW.?] 5?^.,:UG3U$(
M
M                                           *K]I/^PK.O]&+_P =
M +BF*3_X!5'\PB?]@@;89PH
M                                         #+X(_M]SG_0%7_CC&M9
MT]1"
M
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M_+6891:8K=8Y5S*>!%C'=PW(BENQW-%$DU%M/W="/P$UIZE$0
M
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MB(R/0!P;RS%7G$,LWE>XZXHD-MHEL*4I2CT(B(EZF9F W
M
M
M
M  #S;F;31^VAQPX:$FX6-3M%F1;BT3/(NO\ ZQ_OF I+V<,NN>,>1W9-J9%Q
MUR%=SZ%+R3,T1KF&]JP:RTT0:B>)'W4JU_ %59WL_<;8?R1QYFN-9Q5E8U43
M/K2:W%[KL?9*:8:9)6YA;:NB5J3IKH BW 7!'%.5YMRI#O: I<7%LD7"HFU2
M922CQFWGR2@]CJ=^A-IZN:F!NH=8KX8;YWY9^M[';*_;.S;^2$U:)"^RK5SO
MFYZ.\S[[\GINU\# 37D*'Q6GV4,TLN)Z*;14LJT@-RX]DF0A]<EB7%+>12'7
M3V[5D1:*T\?*!G:LLEB^SAD&!PJCAVHM9?-;B8'H)5[=DM?IB%-G(4HGE&C;
MIO,C0716AEH0'*?>TK4\@2,WXG*G=W\D5&.NVBUI/5QV=4H3*?)&FN]1FTX9
M)_"\/*!B4*SR!RAS/[/.=UZ";;M(5RF4P1ZFS,8C.(?9/R^8O7:9^*=%>4!4
MU:O@QKD[E8N6\8M+Z6>33CK%U;<I:6FSDO\ <)?H[[)$:E:&6[4!Z5P+B3V?
M>2^-HC%+B4J/AR;.3.8K[!V;%D)G;$1G7#_S@UZ*0T@B+?MZ>&H)54^RQPKQ
MGE*LLN[RD]*L\:RIZ/2OG)DH[#43MN,IVH=2E6U7759'KY07=>UQ$ 'F3/<Z
MR]O/+WDJDLIC?'G%L^MI+FJC*4N)8IEZ_+#JVDGYSD-,AC;J7FFA1]!1<F<<
MDQ,2735E762<ERG)#<*AI*Y3*%R&XZ"<=>6\\M#3;*$J3JXM7E+3401U?.U?
M!IYB[W&[6MS*)8QJ1.(FAI^7)L9Z#=C(C/MK-AU"T)4LW"<T223W:=-:.:.<
M(E1%N_K"QNRQ&VI(K-@JO=[-B4N/*>*.R45^&MQIQU;QDUVMQ*W&7DU,@RZ#
MEB?)R&NQO-<.LL.EWR7EX\_-=BS&)2HS9O.,K7$<<[+Q-D:R;<\2)6AZEH(-
M90<XS,@547$;!;@N/[^6F%4Y4VN+))1NN&TV\_#9<6^RPI9&7<6GS>FXBU%'
MV9S?,],NY%#@UO?XAC5@]3WE] <BFXW+AJ)$GL05.E)>2R9D2E)1UZFG4BU$
M$]S"/>W&%W,;$)*8F0SJ]]%/+>-;26Y+S1DTM1D1J1H9D>I%J7[H"L'\SN^(
M+F(G/HOI5/F=W6TM)-A277VZXE066B:?*09:()Y+JDJ1JI9;EK/<*-O6\_XA
M8<DY=QN;+\>7B$%VQFV+AH]'=;BI;5(2V1'NU;[G77QT,0:WCSVC:C.[VGI9
M./3J!&054F[I9LYQA34B-#>4TX6C:C-*OR:U]?P2U\I"C6U/M7X/;\:9-R8S
M736X.-36J]=<LVO29*I*FTLK;\[0B7O,]%=2VJ$&S9]HRE9Q?/+Z^H9M-8\?
M.1V;FED.,+D*5-T*/L4VLT?E%'M+4Q1DL>T)C\Z!QM*JZJ5-E<EOK9K83:VB
M<BHCJ),EQXS5IM9,_.V^X>@"199RI78;GN(X1;UT@F<Q4['KKM)H]%1+9+HP
MX1GN)2S-!)T\35]P](-/)YZQ6%EF;8_,COM5& 06IV19%JA41MY\DFW&0A)F
MM3JMQDDB+JI)I\?$(W2>U%2S;"B+),2O,6QK*7BCXYDEHRA,*2XXHB:)S8HS
M:)PCU29ZEIU][JH41WC[G3+KCG+.Z+)ZFRA8C4-(0@GD,MQ:6/$8>D.2)JD]
M3](V?DU:GTT+PZ@)'4>U#26$BIL)^)7E3@5_-*LI<RF--E!>?6LVVS6E*C6V
MA:DGM4?]WRZ!D6WM(QXN89/@=#A-YD>2XRXV3T>M0VXVXPI&];QK-7F$G5*2
M29;E&HMI>.@=5C[56!PL!QWD-J!82ZB\L_D63$:0CTR#+0@UN(=;-7G&DBU(
MD'YQ&6GB(,BQ]HV/2TE8_=X5>P<QOYSL#'\+6T@[66E@FS.0:=VC;6J]NJNN
MI'H1EU%&7CO/\7(XV35S6*6L/D+%8_IL["9A--6#T;H?<C*W&APMJB,O S,T
MD7ODF8:RA]J3$,QEX?4855S+W(<I)Q<JK96RVY4M1U;'5S5*5HA):*4G37<D
MM2]\DC@W-'[06-6N"YIFLVOE5:L$DRX-U42#;.5Z1$(MJ4[5;?RJS[:-3+SB
M,!*J[D>J<XS8Y1R".]0TJZ[Y8?CRM''VHRD[T:DWKJI:=II27751%X@*_P 7
M]I6!?7./0K3#+^AI,O<[.,7TQA#D:4M2DDWO)I2E-DX2B-*CU+KKKMU45'"_
M]IRI@6U_$QG$+S+*3$W%,Y-?5339Q(KC9GW4H-:B-SMDDS5IH737WOG ,S(/
M:8PZH5A+E36V.1P\\CR'Z1=4VAQY3L?1'8-I:D'W#</M*ZZ(/7<>A&(-)']J
MEB4B[K8_'^0NYECBG%WF/(0T:HL-E!+5(<?W;-.NB4%JI7D(RZBC9R3L.>,;
MIL^X^MIE3465%;P28.8[#64Z6I,=LUH9)1$N,ZVXOND:CZ:)(]VI!;,B<QB.
M*KL+F0[)8I8/<G26VUNO.E&:\]26T;E*4K;J22U,S/005U!YNLV[#'"RS K;
M&,>RV6Q74=Q-?A.F<N8DU1FI,9EU3L=3I%IHLNBNA^4!AS?: ED63R*+ ;JZ
MJ\+L)]=DUA'=A--,E7'JM;!.O)4^HV_RAMMIW)(RW:&8#>7',D8WZ.LP.@F9
MG?7U4UD4:!#<CPD,U$C3M2'WYBVT([AGM0CWRC(_#0!I_9_RJTRU[D>?9+L$
M(9RN5'AUUJ9^D06DQ8QG&V&M:4$VLU%M0K;Y2\11$;S([:;[0=D>60K>OPO!
MZIBV0^S;-1JV.RVY)=78R8[#A+?2Z326TM&2E%M/<G0P$VKN<W''Z:?D.%V^
M/85DDAF)19--7$<:<=F?]V])CLNK>C)>Z$A3J=-3+73405A!RO*E7##2[V>M
MM7-=A3FA4ES3Y+1%6I,/37_(),M2;]Z*+,F\\J([>WHL+M[S <>D/Q+G*XJX
MJ&4JA&:9+D:,ZZEZ2TR9&2EMIT\U6W700;B/S5C#[&9S.VX5?A];$O?3"4DV
MK"LL(:ID=^,?34EDA3>A_A%IY0'"KYII;JAP"ZK:^2^]R!-]!@UZ5-D]&[+;
MSDMQ[4]#3&)A9.;>NOD :GG?-<SQ&7Q^QB==*FMVV21HM@45^(P<E!,O+*"9
MR3+;WS3OWEHDB;,C46XM0BU'RCF%'F'*,&%C-UFC53=)D.$Q(CM1JZ <!A?:
M95+>3O<WDX?882?N_A%K1.IW-E9)AXP6#TL[+;W+8/RQ64\0V8JVJY&PER);
MLA:6V$)4LF_.,]R_-3J()%@6?QLW9LX[M=)HLEHI!0KZ@G]LY,1];:76SW-*
M6AQMQ"B6TXA6U1 --DW*LN!D\O#<*Q6=F>05+#,J^:A/Q8;$!N41J80X]+<;
M2;KB2WH:3J>WJ T\OVA*!-3C%E4T5K:2\FG3*9NF9;;;L8EK!0HW(LEIQQ)(
M62T[%*W[4EYYGMZBB1X#R4YE]M=8Q=X_,Q;+Z%,=Z=437&))*C324;+S3\9:
MVW$F:%)5H?FF6@@[<\Y$/$+&BQRJI9.1Y=DAR3J:B,ZQ%)3,!"7)+KC\E:&T
M)0E:>FIJ49]"/KH&G<YIAU^+NW-_C=O59&BT1CS&*/--KFRK9Y)*::BN)7V7
MFUI/>3R7-FTE'Y &NG\\EC=1D$O.,0M,>N<>B1[5^K6Y&EI?KI$E$4WF)4=Q
M3*E-J7Y[9J)7N:BC(<YIL68D-E[!+=O++N4ZSC.+N.1$S9L1AI#RYCJC=[<9
MI"7$I7WEZI6>W0P&5%YMI(U'DEAEM5.QR[Q+T=-WC[Z6Y4K=//;#]%7'4MN0
M4A7Y-LT*]_J1Z:"#MQWE:?+R*NQC-,0L<.L+U#KF/.3GHLMB6<='=<94N(XY
MV7R;\_M.::D1Z'J6@")-^TJ3E YFB<"N_4*!(=B7F0FN'LBK8DG&6MMCO=U]
MM)D1K6VG0NI>*3%%ZH6AQ"7&S)2%D2DJ+P,CZD8@Y
M
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MG5,I2TDD)T)7G&6@#50>/LX;MF)#E&^AI',4_)#49MF7R*]%6VB9T7[PS/\
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M^^ >B(*%MPHS;A;5H:0E23\2,DD1D(,@
M
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M#QCVH^7<TK_E7%.,G[>MW&CTJ*TXMO<DS(RU[Y==2,!NOKT]H7['9_P=?Q@
M^O3VA?L=G_!U_& '3Q9[6DG/[J)2SJ XDB59,5I+92>ULWNAFLU.GH9& ]1"
M
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MQHF3O_DTFUG_ )B3_FFHW-F_;Y^WWOE,05=$Y1LJ+C_,W\1S"??6L>?4UM7
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MTLD^8?7KH*/4E!5.TE-"J7[&5;/1&R:796"DKEOF7X;JD)0DU']Q)"#9
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MU/S4_P!^"1Y(]G#^T"%_O/%_QS U^EX@
M
M    @N0<7560Y-<91(G269=SC#N'OL-=OM(BO/./&\C5)GW2-PRZGMT\@#A,
MXKJIF(X7B"I\E,/"95--@22[9O/KH"03).ZITT7L+?M(ON: (_<<&+G2+V%4
MYI<TV&94_(E9)C+!19#3[DXM)1,2)++CT=#VI[T-KTZGMV@-[]5%9#S.AS#'
MK*53?(U2UCK]3')MR'+J8RE+8863J5*3VU+,R6A1*\@#IB\,XRWQ$WPU,D2I
M>.MQO12EJ4EN61I?]);=2I*=I+;<)*D^;IYI:D P:3AF3%RS'LVR?-+?)\@Q
MKTMJN5-3%9C)C38YQUM]EAE!;CU):G==ZS2G4]"T :^3[/E>\U+QQG*;:+Q=
M825S9F"L^CIAFX\]Z0XRW)[7I+4=;FJELH<(CU/J1& VMUPM76USF=BU=3H5
M9G=4=5?TS2651C=1$*$S*:-2#4VMMHB(DD>T_*0#E<\/D[-K+[$<FL,4RNOK
M&:-VVAMQI2)D"/U0B3&E-N-+4D]30X1$I.IEX=!1Q:X.QMB@K*1$^<Y(AY%%
MS"PMWUH=F6-K%=)TUR%&@DZ+VI29(2G1)$1"#>WO&]+D66>M-FZ\YOHIN,R*
M]*B0R["L7$..F:DZ+)7F;2-*B_? 1>JX/7'FT3>0YE;Y)B^*26)^,T$]$1"(
M\F&1IC+?D,LH>D&R1^9W%^.AGJ L7)<<J,NH+'&+^.4JFM6%Q9C&II-3;A:'
MHHNJ5%XI474CZD KVFX4=9M:27EV9V^7U>+/(E8U4VB8J&H\EE!MM2'UQV6U
MR7FDF?;<=/H9F?B F&$X3!P>/=1X,EZ4F[N)]^^J1MU0_9N]UQ"=I%YB3][K
MU =&=X&UFK-:]'MIM!D%)(.9375<I'>CNK0;:R4VZE;;K:T*-*T.),C(!&HG
M!M++K<GCYQ;3LNN,O9C1;BWF=F*XEF HUQ4QFHJ&VV>RX?=2:4F>_J9GT(!U
M1N#H]C*5*Y$R>RS@V($VHJ6[%$6,B'$LV3C25$41IHW'W&C-M3R]5:&8#4N^
MSQ(L**OQF[Y O;"AH'8;N-0C1!83$.N6A3'>4U'2J2:4HV%WCT+773=H946-
MC^#P,>R'+,BC27G9.728\N8RYM[;*XL5$5)-Z$1Z&E&I[C/J(.7'N%P>.\,J
M,*K9+TN#3M*89D2=O>6E3BG-5;"27BKR$ C-]PW"N<DRN^8O9]?'S:F51Y)5
ML$PMA\BC.Q69"5.-J6AQI#JM-#VF?B0#86_%M5<8SAN,/3I+<7"YU1907T=O
MNON4:22TEW5)EHO3S]I%]S0!IKGAB0[<75EAV:6^'0LG=.3D=96)B.,R)*T$
MVY(85(9<5&?<2DM[C1ZJ,B/Q(!8.-X]68G0U^-TR%-U=8RF/&2XM3KFU'E6M
M9F:E&?51GY0$)R_A^+>Y!)S#&+Z?B&5SXZ(=M,KB8?C6$=HC2VF9$E-N-.J0
MDS2A9D2B3TU,N@#0\9\ -\49*S>8]D3\Z))B*@WD6TC,.N+;0IQUA,%QDFBA
MM)<<U4PA"D*(BZ$9:@)]QU@E?QQB$/#JV2]-@PW)3J7Y6SNJ.;)=E+)6PDIZ
M*=,BZ> #'X]XZK>-HUK54,Q]6.SISMC7U#VPV*XY)FIUF,:2(R:-1[DH/7:>
MONF P\RXS7D%_&S'&L@F8EF<>*=:Y;0&X\E,B :^Z3+\>4VXVLDK,U-JT)23
M,^H#2JX$QUBBKHE/;6-;EE78R;V-F3:VG+1=K8)VRWGM[9M.)?3HAULV]II(
MB\@#*J^$Z,XN2GFME,S&\RZ&FLN[:R[3*O06R5L8C-1D-MQT)4HW"[9:[_.U
MUTT#6P>"9!7&-6V0YW>9"6'S$2L>BS?1$-MM(;4T:'S990I]Q1&6KSA[^G33
M<K6COM>$%NSKE.,YE<8OC.3/NRLBQ^N**IEY^26C[D9Y]EQV*I[Q<-I74^I:
M +*HZ:NQVF@4%2T;-761VHD-I2U.*2RRDD)(UK-2E'H752C,S\H@B;7%&-M<
MIR^6-SJKN;6?)3T)6PXGB@CD;=N[NFVVADSUTV%H T-)[/\ B>/\79!Q562Y
M3=1D2Y+DR<?;.4GTG:DB2>W;HVVA#:=2\" ;N3Q=%7F]1G,"XF09L&K30V<)
M!-+C6-<TI;C;;I+09H4E:U*WMF1^048$CA2CD<00^'5V,LJ6&B(A%@7:]*,H
M4M$Q&OF;.JD$D_-\!!93KG::6[M4O8DU;$%N4>A:Z$7E,_( H[BG&X^0\K9E
MS.BCG4M;9LQJVE8MF%PY+SJ6V_3Y?HKI$;1.&RPT2O%>Q1GXBC=VW"!OS[HL
M:S&WQC&<H?=EY)C]<F*IE^1)+:^Y'>?96[&4]XN&TKJ?4M &9?<,5LA&,OX5
M<3,+M\1B+JZ>=7)9D)^3WDH2MAYF4AQ#J3[:5$:NI*\[Q :QGV>Z)J@R&A>O
MK69ZRVM?>V-A,6R]*.97+9<,]W;2G1U;.JBVZ)UT21$1$ N 055>\,RYUE=O
M8[FUQC5'E#BW\CI8:8DAI]YYLFG7&')3+KD93B2+>;:M/*1$*-YC_%F/XQE<
M')Z9Q]A%;C<?$(58:B7'1!B2#?;7N41K-S4]IF:NI?=$&N>X8I'N/\JX]58R
MRKLLG3[&9++M]]IRRD>D+2WYNW:D^B=Q'T =-IP_*7EECEF*9C:8M+OV8D?)
MF8+4.0F:5>UV&7$'+9=-ATFSV[V_N=-0'11<#8_05U!51+:P>AXWD;V55WI"
MT.NF](0ZDV''#3N6@C>4K<?GF?B8HD5]QVW;9[1<A0+B74W%1'<KI3,=+3C$
MZM=>0^J.\EU"C26]!'N09'_R:04SQ+PC;WW&=96YA>7M5C,^5.DWN /(9CLN
M+39/J0GN+9*2TP\E*'%LH<)*]QGTW"B\JS!:ZJSBXSF.^[Z9<0(58Y"T04=I
MJO-PT&@B(CU/N'KUT$$15P-CWJ\=/'M;")9Q[Z7E-/?1EMMS8-C-<4M7;\PT
M+:T6:%-N),EI\?(949%9PTPE.0V&59%/R;+LCJ7L?D9!+;C1UQJUY*B-F*Q'
M;0TVG<KN*\T]RR(S$&RF\55,W$<,P]<^4F'A,JFF09)=OO/KH"03).^;IHO8
M6_:1?<T :>YX8D.W%U98=FEOAT+)W3DY'65B8CC,B2M!-N2&%2&7%1GW$I+>
MXT>JC(C\2 2:#@$>E1B<+'[:?5T>*H=:^2FG2<9GH=:)"2EJ<)2UFA6KA&2B
M\XSU 2\!%LPP:!F4W&)LV4]'7B]LU>1$L[='7F6W&B0YN(_-,G#UVZ& ^9_@
MT#D&ECTEC*>B,1I\*S2Y'V[S<@/I?0D]Y&6U1IT,!&9_#THLFN+W%\SML9K\
MF>1*R2I@(B+3(D(;)DW&'WV7'8RU(21*4TK7REH>@H[:[A/&JWBB;P^W*E.8
MU(*641]Q2#EQO2I*Y;:D+).AK8=42VU*+75):B#-/B#$G>,H?%<@I"Z*"PRV
MQ,;<[,Y,J.LGDS$.H(MK_=+NFHBTW&?30] &)CG%,Z#D<#*<PS&TS"RI4/-4
M+<U$:''B)D([;BU-0VFB>>-'F]QW7IY->H"7Y9D,3%:"7>3X,RQB1R0EV'61
M5SI2R=63>B6&R-2BU5YWN%U/H K/@/BV+BO&T^!>5!Q'LND2YMC33#[SC%?)
M(V(L%TS\2:BI0A2/P3-1 .43@!I+-;C]OF5U<<<TKS$BKPZ7Z+Z.11%$N.R_
M(0RE]]AHR3L:6O3S4ZZZ -M></N3\OL\MQ[+K?&%9$B.UE$*M]'4B:4-OLMK
M0M]IQ<=PF_,-QDR/0BTT/J ^8UPAC^+L8%%@6$Q<?CU^T?J4.]L^Z5NEY"D/
M&2"U)M+QD@TZ'T+=KU 6>          *@]I[^QG(/^BW_C"X*VR3$;_-?9,P
MREQV.4FP<H:[1M2MG3L->70_< ]>3C]ESF(BU^2&_P"-+[P1KZ>O>?:Z94^S
M#\GST$U+8["74$>XB/1?E!C'1[+<*/8^RX]!E2_08\A=NTY,_,I6I:3<TU3K
MMUW>) NJFN?8RORPUW*<-SU60OJ::?KH7HZHJ)"'%I(_ROI+A)T09J+S3UTT
M!:M/A5RMXWXSE8+R98-U-[,=6LD/.DZLF5)2DE)-:DGIJD^@K*02L?@8O[*-
MU2UEV>106*JX6U;FCMF\3QR7=-N]S39NV>^\@BHQ['L=Z9P7;1(Z=TA]$UII
M)GH1K6I]*2U_=,#7F*T]F'F%^RF/%4-$3CSBBT>(R\Y1GX[>H1?IZW]D/CK*
MN.<+R*ORJ*F+)ESE2&$I7OU;]':1KX%IU28)NUYF]G#^T"%_O/%_QS U^EX@
M
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M%HJEQ?(&)UH3:GVXQH>84\R@]%.,=]#9/(+RK:W)^Z FX
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MHS49Z*(N@IK](QD
M                                               4#E.4XCB'M/0[
M3,ID>MB/82B-76DTR1&CR%6CREDMU7FM&Z@M$K69$>TTZZGH85O=,0[VIR'(
MH$8E<?Y;R?CKM.VXV:8\YM*X\>9*0A1$2FI#J%>?^'IJ*+3S>SJL*]H'&\PS
M5]NOPR1C4NFJ+646V##NES$/N=QTRV,*>CEM2M9IW;32((FQEV%)M^9N0W8Q
M6_%=S'JZ=AEA!K8R"Y2RZP\U#21?E%*-QMA3B"T-7G:F2=11D\$4OJ9<VW&G
M)T CS;):QB9"G27W)K<VC:CICG5I=<+3= \YM;:3\]*NYU+J P.,:^TN,VQO
MB2Y2^]!X1?L)<Y^0E)M2UNF;&/*+3P-$1UQPONH(!:WM$U-Y><+9A68ZR[)M
M'8B%E%C[C>>CLOMNR&D$G4S4ME+B"21:GKH(-+]:7$F46>'Q,-A,Y==Q694V
MICU:$]VEC,PEDM3^A$<;>6V,32R)2E*(MO04>=<US+Y;X,<B-9A20XK[<9QK
MBG&JI!.5R&9C;KB9KZUNOLDQH;CKO;9+N%T4>XM0]'XBQ$D>T9R-.-M#LAJC
MQYN/(T)2DM/>E+425>XHT(,]/'0@%/-Y=AF*>S9F_&F;R66N2HZ+^/:TLA!G
M.EVDI^1(C36VS+>ZV9*9>*0G5*$IU-6B05ZCP#7U$Q?<>I_)$#4_=/T9L1'D
MW(\X=MN/L[@L9/486<I5Y$^JNJJ6Y6029*E/(,Y:W5K<W2-.XZ\U'T0V>XEI
MVGI1,\GN7>-,8XPYQJ8ZI\=K%V<9NV8I&\N0Q-@HD5IEU+S4S4)1KXZ.@%[%
MD<28EQ1C,WY+KKZ9(G2K;D+(6?3(=/;R63E2G/?M)-Z0XZXTRIQQ*=$@(LS;
ME:WW-$M>5%F*U\;R4_+K4)JOBR#93+2LHB6-4O,MFHD]W>L]VJ=QZ -[#G%7
M9#5SODH[ST?@[O'2Z*/TQ*'V#..>B5'^4]X9$1GUZ$8"&Y!F!7>(X&1Y_3V,
M5-QCLIK"<6K&FH5.PB4R1%)D*6\\REC<32-_:-2CTT/J M'&<]XYP?EWF9S-
M+&)32Y,VN6B;/+MHDQ6*IC<PTLR_*+0:C4;*=5'O(R28",\<UMA4VGL^QYT1
MVN;D3<UF5E=(2:78U?+C/OQ6UE^#^26E1)/P(]/N (;CTN/3\26V 9OR/\C6
MC:Y];D> G2Q)=Y*FRWW-?1C=4EV2Y(-:5LOIU(MR?.+;T#V=B<-VNQ6CKWG9
M+ST2OB,./3R2F8M33*$FI\D&I).&9:K))F6[700>0Y6$V&1RLEX28BO-,<61
M\CN\>62C2V<JV6W*H-BBZZM)=D)]PM--.@HR\AL/7W@;D[F.5%=BMYS/HHD&
M*Z>IIJJF;"A$G1.NA+?5*4>GD4 N?D6-#C<Q\(I:80VEF7?L,$V@DDAOY%=(
MD)T(M$]$]"]P0>?\?F-4O&&08)G'(Z:"U1(M(>1X,NEB2[B9*G273W15/&EV
M4J02T*9>(C(M4^<1)Z47'@U0Q"YWJX\E#[\VJXQIXS4FR0DIZ5%/>;<4\234
M27E$DNYM4?74M3(!O> 4-M+Y3:93L:1R!=DE!%HE.YJ*H]I>X9F9]/*(-1SM
M:2N+<FH^;*V(N6VW!FXO>QF4&XX\B4A4BL\TC+HF:@FS/QT=%$7DXVSQ'*X1
MM,V<,L;I$V_K1;OZN1XV27C*'DRI*B(RVJ?4\VVZHM$:EU+4!PRB5$Y'S#E2
M]XY_]]4'U;SJ"PL*XC<B3[YTW7(K32TELD.-,FI)J0:MN\D_<!6)D/(V%Y7C
M?!>/XY;-6=O"R;%GK*+')2U0DQVU,+*5H6C*^XHD)0YHI1^!&1&"/07*,_Y+
MXYRFP.F]84,5DI2Z0R-29:.THE-+))&9H,C/>1%KMU$'EF[RTKAKBU#O(%/D
M4-C*<9DEBN+5;4>LIXZ)"$)-Y_>^ZTEK7LM)<4T:M=-IZ'I18.*YI@?'<GER
MAY0DQX5Y89#:6BZZ=YS]O2V#:2A)C)67^<)-HC8)IO=M41I,BU ?<6R#%\!Y
M1=O<V8;PNDOL0HV,,3;[8[5?%@DZ<JL-Y?F(=0I;:U-;M3Z>4!$\FLZF5><?
M\AXT:N/N-BGY$W$R.17-2(*)\Y;1,6*V'C(FFII)<)EU9)V_X)*U,,QJ-B63
MM<K75O?W'(52[2PJW)+3'*N)$AR"8=4XTJ(XRX:9,F(@S4XKJE+>B=3]Z V&
M'YA(F\C8S2M953\Q54R%9K*WCU[3-_21/136?<D13[:2D&26%)<)I:U&GW#
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MJ3*:#(Y-M#I9J9<FBEJKK9M*5I-B6A)*4V>Y)$9D2BZIU(0;@
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MDFC5KW7"U)/4BZ@)>(
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MEFZ2")Q1$2ED1;C(O C,!TLP(,>0]+CQ66I4C0Y#[;:4N.:>&]1%JK3[H#(
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MQ_=,!W(:;;-1MH2DUGN6:2(C4?NGIXF Y
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MK+C'V4<5P^QILEK<MLI;D25%LTQ5DR3*W&2W$@]J==#UZBL]O38@
M
M
M
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MKFO6'"7##5'85MK&Y.C711Y\.4[ BS6I:3-LMW8/:ZK0U:^&@K#UV,J
M
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M'IK1';/F/FZUH,OYTQR[AP\"Q&[.JBX8[#:<*="9=9:6ZY)/\HE1]Y!^:?\
M?:::%N*GN<<E9YG7(6)<8<67;6*%=4"<JL[YZ(W/>;COD:F&4-N^;KYI;S_P
MBT/H9&1+O9UY,ON1\2M&\M[*LMQBUDT=M(C()MF0N/H:7DI+H6XE;3(M"U29
MD1$>@@BWM#9GR14\@<:X1@&2)QKUN=FQYDQ<2/-22FC8[:C2^A7O=ZNB3+Q!
M6LQ3/>6L'YVHN(\^RF#G-?DD)^4W,BQ&84N$XRTZZDW&V"(B2HF3+SM=25J6
MFFAT0_CK*>=^3XV1W#?,5?BT:HN9=6S FUE:XI3<<D.)<W+2@R3HO;KU]Z8#
M?8A[3^1PN",ISW+8\:XR#'+5=%6SHB>U"LWW-G:<T1M(DIWFM>S35!%IH9@,
MB71>UC68@YR:KD"%)NF(?RK(PA58P43L$WWEQR>(B4;B4ZEH1%JHM-_E!&RR
M7E/D;+N%,>YQXJ>-B17:R<HQ0V6I+4J/&=[<M"5K0;B>TIM2B-!I,VC,_?$0
M!@G,.6\[\I1%\>2WJ?B3'(;$C)'W8S1NS["0DEE#2MYM2D$D_,4;>G1*SU\Y
M @C<?FCDIW >>KQ5R7REAETN%C;WHT;_ #6.F8IK;M[>B_,+35PE&*&,S.9L
MCH*:Z5[15%!E6\2-+.L<KJ@WF')3:5]E6ID9K2:MA^:77R 5L^:.4,TK^4ZG
MBY.<1N-*%52W8/Y=+AHD^G2U+-!MH-W1MM/0_P ).AD>I^](!8O"$SEHW+FM
MSZTK\LQIA2%XSF]:Y%+TYL]=Z'&8RE:&DC+J9>.I:JZ& D/+N6VF,8W$@XVM
M+>7Y381L=QYYQ'<0Q+GF9*DK3UU3':2X_H9:&:2(_$0:+F3,<ZP3")L7!ZI^
MUM8-++G2\JL%M(B0F8#!FMYPS+\M*7IJVRAO::O.5HDC(!8.&S9-EB&/V,UT
MWYDRMAR)#RB(E+==80M2C))$1&9GKT(!7G+&4Y%#S#%<-AY"C",>NVIC\W+%
MM,.K7)BD@VH#*Y:5,-..)-;FKB3-24F2>HHBL7F+,:OC#*+#OQLDO*V^1BV(
M9,;/H\*W<F.LL-25):T0KLK=6EQ3'Y-9MF2?* D,&PY X[Y$Q/&LKRI68X_F
MJ9L7TF5"BP7X-K"CG+2;9Q201L/(2M!-J2I2%$7GF6H"(%FO*]QQM/\ :#JL
MB3&J(WI5I6X&N''.$]1P7EH-$B0:52"D.--J>[B%DE)Z)VZ:@/1=78Q[>LA6
MT34XL]AJ4P:NA]M]!+3K_<,04)RLCE_!X#MQ7<IORK&XL$U^*8NW0U1JD39K
MAE'B]Y9;MC9><XZKJ2$F?B*)?>8MRJW15L]_E=./KJ:LCR26BEKY,=^2R2G7
MY6L@B[:"3TVD1%HG7Q,Q! L?Y%Y2IN)IN<W-PW?6.5V4*JXV;LX4>LT9GO\
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M)W$E;9+,E%U\HK+TH(
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MN+E\V%&2C+:HT1FC+QU+?Y '9[0K5E:X57896MR%%F5Y5X_8/Q$+6IBNE/\
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M/3"D*639&9D1&L]=-3,&J]W0651H4:.I1*4RTALU)\#-"2+4OWA$9
M
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M\/-(R/7PT 8F-\C8%F,Z768KDE=<6$'K*C0I+;SB$D>F[:DS,TZ]-Q=-0$G
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M=':DNV%E;3Y-O<6D@DD])F2U[E*,D$24I0@D--H26B4(20"2@
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M=H NJ(P46*Q&(]Q,MH;)1^)[$D6O_((.X
M
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M)TW:^!"#=\R1;*9Q9ES558_)DE-5-<7()E$C<RW'6IQK:LR(NXDC1N\4ZZD
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M*]'?>?=<6:V#=Z[$,]$Z:F9[M$AZACO%(CM/D6TG4)7M/KIN+700=@
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M]"O(8(]<1WD26&I#?5MY"7$?]%1:E_SB#L
M
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M9(]2;2E!'II[TM/ 178
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M
M                                                          %
M9_*:M^9'*C'Z"BEY?4T+3TNZS*4]Z!'KY#[ADF%"02B6X:DF;SQ;-"(D&H44
MU5,UU[Q;=U#[L"PI)/+T&&M%0A3%4IA]V&3I0FS6LVV%&I9H)*SZ'J1]0%X6
MN,8W3>T'B,"GJ8==!ML7NX=I%B,-QV9,=IV+L;=;;2E*DIW*TU(! ,:CV%I:
MX][,]@EUZ+A.0RK*Y<=+>3^+U)HFU"7=2VJ2^Y)CM;?_ (B?]T/68@\W9$UZ
M'RWRXN@8C-9JK"XLG&-K;29J['LV!=R/J1+4LST)1I^YN%$5R2/QG']F#';?
M#2@)S<V:E>,SH79.Y<R=3K/<)*RU=5(-TW.\D]>F[4M" 69A=]18]R_S4]?6
M,6LVNT,UU4IU+!>CHIFDK=(W#+5!+)1;O= 4YQPBH=PKV=(>4I:+C^1-R54M
MJ7L*N7;$^^NL2^2_--1F;QM)5XK^Z"I7S17\7N8SR'2X@PENP?L,43E[4(S;
MKR6[9LMM);[9DVB0;9F;O;(E::&KJ")=E6-T>*<Y<3EA]5!IY4NMR:$MN(TB
M(V^S$AL.,-/=E)&IMM9[B\=NNI ,?DU/+$[B#D1/)=9C::]JAEO0#I'9<MXI
M*$&>Y29;*$I)*=3)2?.(P&KB-8C-Y9XYAWB*UW!5X<\]BS"R9.L<R,Y+7I1M
MH(NTI\F#U+IK[X_$!!.26J5%%S]5XEV48$3^*I=;A[2KV[J1.9*:4;87;)>W
MM&]L]ZO37J MO*<4Q?$>8^%T8Q51:4ENWE>[Z TB,;L1NH<<0T[VR(W$I6E*
MBWZZ'U\3 4ECM78V_$>4S,LGX5!6N7:^N5I>Q9;V2PK+TEWSEJ:=U[[6B#C)
M:3U(D$DC,SU#V+A13"P['RL)RK2<5;#])LUM.1URG>PC<\IITDK0;A^<:5D2
MBUT/J(*NY@BT9\M\.2KMB'Z(N?<LR'YR&NV9%5/&TA:G2T_RAZH2?X7AU%%5
M4L"VM;/EE^_<PE<AJ]LDY'ZXQY3MDQ5HZ0]%I=1MBE'VFPI!:>.A[@&UQ\K6
M-:<6)J;E626[6!9)\C7*6'HRI>TX_H:B:E$3A'M)!$:R\[37R@(/7T:YG!51
M.E76$TL#6'(/(40;&1E4:^2^A:E&IIQ3RYQ/ZH62$'J6NA=OH M^C@X/+]HW
MD(\V;K)%^BCHCK2L$-:*C^CN^G+;0_J1$1DUO\I)Z>&H"N:JGJ,AI^/:69&1
M8<>O\GW*<5BO%W(KM"RB6N,E)*UW,;TJ)*5=#3T\ $LY!KG\:Y"Y1C\>PTU=
MC*XS1.*/5MDPIR8W,ELD\E#)%J\EHMK:DEN\-.H#&S*OXUK^%<#F\8LUK>8E
M,H/4B17DT5@[.7)8*0DU-_E%FIHWO2$N>77?U 27!,*P[(<PYOL+VDA6<MRZ
M. IV8PV^I,8JUA9H0:R/81J6HU;=->FO@6@554'=6E%[/D62]4KJOD:>JM+*
MD//T[EPP:&V$.):6DC>0QN]&[A].NWS@%Q\+UCE;R3G:?EFA<E.,5YWF.XK$
MEL5T6<1+)$@UO*6R3SK>I.H;5N/:DU%KU,+?RVRB4V*WEO8(?=@0*^7*E-PS
M,I*F6&5K631I,C)9D1[=#\1!XSRE)1^,<+M(57AF+8[+LJ27BE?!<>GY.?<F
M,NDHYJNTE+R4&M4A>US7J1J(S%%TX7AF)Y'S?S3.R"FAVLE#])"1Z<PW)2B.
M]4,J<2E+B5$6\R+=[NA>X(*OP$ZV3CGL^1<P<0_@29F3Q]M@HEP#M8TE]JJ;
M?-WS3-"$.ICDK\(M/'046;QM#PZ#[1W(K&%MPV8OR+4JM&:\D)818FZ]W"VM
M^:2MFPUD7X6NOG:@+YDQH\R.[$ELHD17DFV\PZDEMK0HM#2I*B,C(R\2,0>,
ML>KJ)/&'$Y7T6,S@EAFEHC+5J;0W%?-F?9?)Z)ID1)6P3VU.CNJ/>D?D%%C9
M-%QZNYI0S@+46.;^'W2LW9K"0ACT="6_D];Z6M$=W>:R0I7G[/\ ! 1/"%62
M?J9.EZW)<;W1UQ%H9G*)J)VO'_"T UC/P.+R]DQBU9;A>NB8+3[,]O;\N>N&
M\C,R<+_.?2?23-)]=VSI[P!GYK'GUF67'&-B3K$CFI.-R5(BH)+;3[;B8V0[
M3(M"4<9E+A^[N]T!F\,-R<CSC'L,GDXXUPA%MZ^6MQ)D@["3,<KZWQZ+TKV5
MK2KR&K]X/4H@\8Y$Q10>&_:'CQ&HD2T:RV8T;;2&FI#<%4BN)LM"(E$UJ:MO
MX.O@*+8R[$L6P_E/A=&+U,2E(IMK7F<%I$=2XI5+RB:<-!$:T[DI5Y^O7KX@
M*3QVKL;?B/*9F63\*@K7+M?7*TO8LM[)85EZ2[YRU-.Z]]K1!QDM)ZD2"21F
M9ZA[%PHIA8=CY6$Y5I.*MA^DV:VG(ZY3O81N>4TZ25H-P_.-*R)1:Z'U$%><
M@DV?/?#.[3>3.5;-=-?^XQM= %+UN'8F?LBY7DITT-5^\N\G*M#90<HI,2UD
M-L+0[IO3L2VDD[3+3^Z8HEN1U"[+D"WM\8LL:NLJ715363XKG,5SM>A$RM:'
M8,LTGM0X2U]XD)6C?[_0]- T]1/PN^=]GJX:H8M%COI5_ *%.=3-CMIB0I33
M:$2I.INM*=2:HYJ/KJ6TM= $IXYQ+'9]CS9E#M/&E92SD]M$A62V$.RVD-5S
M)H2RLTFI!F;SFNS0SUZ@(5<Y)C;OLI<<U;=K#<L),C'(S$1#R%.K?C363?1L
M(]=6R0K?J733J GN*P,(L>2N8'.36*Y^Z:EQVFRNR94EO&3@MFR;7I'FI94H
MW3=-&A;O?=0&BQ!/'CG)W%$O'(W:Q61BMHWCSEVWMF.''G1DQMJI1=Q2B(M8
M_77MZ;?-,!%,>*O=B<81,J[7U=/YMEY7B)FGH*[-+\DZM$@E>:9&[NVDOH:M
M-0$LS!JAKN2\]B8*W&9KE<<VCV8QJ]*"A)FH-28*GDM%VRD&WW2T5YQM_<T
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M2TI4:3+0_*"O9<"O@54-FNJXK,&OC))N/$C-I99;07@E"$$24E]PB$1D@
M
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MTEM5M,M2\0'V'3U-=*FSJ^!'BS;)Q+UC(8:0V[(<0G8E;JDD1K,D]"-6H#-
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MI1$E6I:&8#15'%?&E"A3=-B-1!2J0U,/L06$'Z1'5O:<(R1J2FU=4:>]/PT
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M1VD>BN2]W?4SM27;-S>K>:=-VIZ^(#;
M
M                               K#+^4<AJ>06.-<2Q,\@OI50F\3*=G
M(@0V6/25QU^D+-IU:2(TEL-"%FI2M-"(C40:6?[0)5F'RKN9BTKUIJ;V-C%Y
MBK4AM<AF;+4DD&P\:20^A:5I4TK1!+U_!ZBC,?Y9SB.[58LO!$'RE:MR)WJX
MBV:7#B549Q+9S),Y+)DE*EK)"$)949JZ= '%',U\J@RMQ6&/EGF#K87D&)(F
M(<6Y!D)[I2H4A#9I?2IHEK;0:$J4I!H,B5H(.R+S>UE#]NKC:F5E-1241W4J
MU;?]'97.>9[\6L:(VUFJ0XWYSGD:U(E><>@#8R>8:]W%L$R&B@*LY7($N#$J
MJXG4H6T4MLWI#CJB2KS8K:'#=T+Q3ITU 2[,LMI\$Q:UR^_6INIJ(ZI,DVRW
M.*(M"2A!&9$:EJ,D)U,NI@(9CO(V>/WE37YGQ_(H*N^2Z=?8Q9B;3T9QIHWB
M;L6VV6_1U+06B3)2T[_-U\H"/6_.>9X_3EG5]QV]5\;E(;:>FS;!#%XU%>>)
MA$ARL4P1EJI1'VN_OVGJ*-U<\K92CD>?QSB6%*OI56S G6-DY8LP8S4.<:R4
MH^XVHS<2:?,;+7>6X]4[>H07DKE[*\EXSSNWQ#$7Y. -0K2MC98S8ML3%.QT
MN1US&(G;U5&:=2>J^\E>U*E$GIH O# U+7@^,J<6;CBJF :W%*-:E*.,WJ9J
M/4S,_=,05UD?,&>U,.^R:OXY==P?'%R/3+"SL45=A(CP=3D2(L-UA>]HDI4I
MK>ZDW2+S2ZD E&/\GPK[,V\33!7'8L:&)E%!8K7TF0I"B0ZDT;2V.,J4C<G<
MK4E$?0!'XG,UU>T*;C$,+EWJ[*[FTN.$R^2(DB)7*4VNQE2C;-$9@UMK2DC)
M:E:$22,U:%1@RN59L^GY&Q3/<773WN.8[)N)4*MM$R6IM:]'?(SCS&VVELN:
MMJ1YS9*2>BBU :;%KUN/RKCMA&1/31(XG:L6JCO/6#^U$UA:2VZF;\@D'LW[
M=ZS_ '0&\=YGS:F50V^9<?+HL/R&=$KH\I=FT[:15V*R1'5+@FRC9J:B[B$N
MJ4WX&6I ([29?R#7\K<M5V(XL[E7HMC6O.>EV:*Z(PT=6R9,1S=0[J\M6Y6T
MDI07BI1:EJ&8[GL3/<^X)RBB<E1:RW7DR95>\I;*TO1JY3;C,AI)[5*9=;4G
MKKU+5/B(-BYSM?R:F?GM#A+EIQ-6+D&_D2;%EJ<_#@K4W)F18)MGO9;-"S+>
M\A2DI,R3X:A<#%DU8U#5O2FB<Q+C)EUZB5L;?0ZWW&CW&1Z$LC+KH IRS]I.
MCJN/L+SN34/:97/*!*KN[HY7)8<<:G/.J-OSDQE-F2O-3KJ7@*-1[1'(*Y&(
M<C8G5-/L>JL2@F65Q&D*:=3)L;-E:(C:4;5;E,-[C42_PR+3KJ F=-RKE)9G
M1XIG&%KQIK*T2E8Y+18-6*U.PF3DN,RVVFT$PYVBW>:MQ.I&G<>FH@U+_.61
M2*ZSS7&\(<M^+:=R2F3?E8,L3I,>O6MN5)APE-F3C39H7IO>0I9)/1/D.C.M
M^9[1_+X>&\?8L>4R[3'XF55]DJ<W KS@RWW&B4ZXMMQ22T2DT;$+-9JTT21&
MH02GC//OK!I)LV36.4MY36,JCOJEQU,@HUC"-/<0AY!$EU!DM*DK(BU(P'.-
MG:5<F3N-YL!462BJ9O*J?W-[<R,;IQWTDG:6Q;+FW4MQZI41] $(;Y\595T!
MW',;<MKG);BSJL*KT2VVF[&'3JV2+%U]2-&(Z32K\%:M-NA'NZ49:.:9]9"S
M&%F6,G39IB-*_DQTS4U,N-85C*'#)Z-*)I!Z;V^VYO:(T*,O$0;K(.4FZ&AP
M*\54KD%G-K44Z&$O)0<0[EI3A.J4:3WDWMT-)$6[[@"7Y%?5F+4-GDERZ;-3
M4QGILUTB-2DLQT&M6B2ZF>A="+Q,!7%!RMF\Z7C\N_X[E56)Y2ZVQ5V<>8BP
MEQCDMFY'781&F2..AQ)><LG%DV>A+T%&MO\ FO.:.HL\U7QO(1Q]4NNE(F3K
M!N!<.Q8[AMKDM5[S/O.AJ0EQY*EI\XBZD C>>W,F3F/*,B!-?3"/BLYT)*''
M&TH<=.<I+J$D9;5Z$GSB\X!<_&:W'.-\/<=6IUU=)6J6XXHUK4HXC1F:E*,S
M,S\IF>H@E(
M
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M+%];E,:+T&9#C--I9)G0U/=Q6XMZ#T3H()T
M
M
M                  #5^K=&61GE_H+?K*<$JH[+KW?02>-\F?'3;W#W>'B
MV@   .B;#C6,*17S6^[#EM+8D-&9D2FG4FA2=4F1EJ1^0!JL3P_&<%I6L>Q*
MM:JZAE2W$QVMRM7'#U4M:UFI:U'Y5+49@-X
M    C<S </L<OA9Y.J69&6UK!Q8%FX:U+9:,U&>Q!JV$KSU>?MW:'IJ D@
M
M
M
M
M
M
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M#Y1K_P"5,_QB?O@'RC7_ ,J9_C$_? /E&O\ Y4S_ !B?O@'RC7_RIG^,3]\
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M7_RIG^,3]\ ^4:_^5,_QB?O@'RC7_P J9_C$_? /E&O_ )4S_&)^^ ?*-?\
MRIG^,3]\ ^4:_P#E3/\ &)^^ ?*-?_*F?XQ/WP#Y1K_Y4S_&)^^ ?*-?_*F?
MXQ/WP#Y1K_Y4S_&)^^ ?*-?_ "IG^,3]\ ^4:_\ E3/\8G[X!\HU_P#*F?XQ
M/WP#Y1K_ .5,_P 8G[X!\HU_\J9_C$_? /E&O_E3/\8G[X!\HU_\J9_C$_?
M/E&O_E3/\8G[X!\HU_\ *F?XQ/WP':T^P^1J8<0ZDCT,T*)1$?\ < =@
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M77H1FDDF?D 7[!GP;..F76RF9D11J2E^.XEULS09I41*09EJ1D9&(,@
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M^N,@^$Q/B@%/V"N(?UQD'PF)\4 I^P5Q#^N,@^$Q/B@%/V"N(?UQD'PF)\4
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MI1F8@V0        #RG[9_P#WWB?_ 'B+_&8!7JP$
M                            >5;[_P =F+_[N._T>:*OCU4(@
M                            #RK["_\ L;FO^\;O]':!=>J@0
M
M                                                      >4_;/_
M .^\3_[Q%_C, KU8"
M     /*M]_X[,7_W<=_H\T5?'JH1
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M\3*U:>/E ;2'80+#OG E,RBBO+BR>PXEWM2&NBVE[3/:M.OG)/J0#)
M&- L:^TC%,K);,V(I2D)?C.)>;-3:C2HB4@S+5*B,C]PP&2 XH<0Z@G&E$MM
M75*DF1D9?<,@'(      8TBQKX;\:++ELL29JS;ALNN)0X\M*=QI;2HR-1D1
M:F2?( R0    &-.L:^L8*392V8<8UH:)Z0XEI!N.J)"$[EF1;E*,B27E, CV
M$"5(DQ(LIE^5"4E$QAIQ*W&5K22TI<2DS-)FD]Q$KR ,D
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M].L'H$$  !Y5OO\ QV8O_NX[_1YHJ^/50B
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M%*;V;>4.1\XKLW]HK(8EE#J%$J!CE=YS"B2HEDA1$VVVAM2B(W-I*4LBT-1
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M_P!'FBKX]5"(                                    \J^PO_L;FO\
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M>2X395\MZ*:E.;4%HKM;O#IJ E429#L(Z)<"0W*BN:]M]A:7&U:'H>BDF9&
M[P   8T2O@5Y.E BLQ2?<4^^3#:6NXZOWRU;2+51^4SZ@,D      =4>-'B,
MICQ6D,,(UVM-))""W&9GH22(NIGJ [0   8\F! FN,.S(K,AV*LGHJWFTN*:
M<+P6@U$>U7W2 9                             #JD1HTMLFI3*'VB4E
M9(=22T[D'N2>BB/J1EJ0#M           !Y3]L__ +[Q/_O$7^,P"O5@(
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M"+=M2HR\H(OJ/(8ELHDQ74/QW2)33S2B6A23\#2I.I&0@[
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M"4E[@#/
M      !Y3]L__OW$_P#O$7^,P"O5@(
M                  \JWQ'^W9BYZ=#QQTR^#SA5\>JA$
M                     >5?87_V.S7_ 'C>_H[0+KU4"
M
M                                              #R3[<,>7*;XRBP
M)'H<Y^[<:C2^I]EU9,I0YTZ^:9DH%QFGP3[4!GK]=J_XMX5'SZB/:@^VUS^
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M, ^_L8R?M7R3^$?Z8!T^P>UZ/@V8,;S7VL@<1O5XJVQF2U/[IB+KU>"
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MHEH4D_ TJ29D9 .$:="FJ?3#DM2%1G#8DI:6EPVW4^*%[3/:HM>I'U 9
M           ^$9'J1'X=# ?0         !U294:$PN5,>1'C-%N<>=43;:2]
MTU*,B(!V$9*(C(]2/J1EX: /H      Z9<N) CKESGVXT5O0W'WEI;;3J9$6
MJE&1%J9Z .X            !P==:8:6^^M+;+:36XXLR2E*4EJ9F9]"(B\3
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MLB);K:%J)/AJI)&>@@[@       >4_;/_P"^\3_[Q%_C, KU8"
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MPG-8>?L\F\<.US]J_6%27M'<K>8C2HS3QOL.M/L(<4V\VI2DGN;4E23TZ'U
M1V9P;?Y)AF?MY-;Q6N0>07H,R7*@MK570U4QM*@1FR<(EN-H[6CBU)2I6XSV
M^[1DL8/R[E'(&#9QG;]!7Q</>L#544ZY;YO%805QC?[S[:.N\T[6MNB4ZF:U
M'T*"ZP%&,<*Y*SP%2\4*GP57U9+AR7II&\412(UL4]1)U1OU-LMI:I]]]SJ*
M)ADG']M=\E5N81IZ(==$Q^SI'%-FHIB)%@XTIMUKS=OF$V9]5>.@"F'_ &?.
M2I/&\GC2)#PZG)+;:7\IC(E.65NJ.\EY)R#-E"F5.J0DWW.ZZ?BE*=/ )![1
MU;"RVUPK%:*X;B\C6,QVDE5T1QMZ46/745:+1;K6NY+2&FR<)Q2?%/3J8#T%
M @Q*R#&K8#26(,-IN/%806B6VFDDA"2+W"(B(A!!N8,$NLZQB.UB=BW3YI33
MF+7';5[7MLR6MS3A+VI69I6RXZ@RVGU,C\@#3WO#/_W.,1Q/#YK5;?8&_ LL
M=G26U.1ESH"5(7Z2A!I4:)!..=S:>NJMQ>&@!385R!DN>TF><F'504XHQ+;Q
M^EHW9$I"I5BV3#\I]^0TS_[,C0VVE'374U:] $7B\&Y<]@]E@5E-JVF*>]]9
ML#N&DO2%G+].?G;;**ZA+9H(W>T9-K41I,S\A:T2C#\2Y+/*8-WD[&-XU25K
M+J7*C&6?25V,EU.Q+C\F3&:6TVWU4VVSYQF?GJ,N@"UG76F&EOOK2TRTDUN.
M+,DI2E):F9F?0B(O$Q!YUXBQJJN>:<UR^AL46^!44F0>,NL&AZ&W<Y"VQ(M_
M1WD&9+V&T@CVGM+NFDO**)(S@_+6"V631.-'Z*5C63V,BYCJNURFI53.GZ')
M-*&&W$2&C61N-H,VS(SVF9EU 8C_  GD&)T/'"N.YT2;D?';DYPFKLW68MC\
MM-N(G*6M@G%MK-;BG&^BB+P/4!UM<1<B6OUJ6F4652=SR+C[-1$CP"D)BP7V
M8TF.2%+<2:W&R[J5&[IN4>[S$EH0"XL7JWZ/&::EE+0Y)K8,6&\XUKVU.1V4
MMJ-.XB/0S3TU$$>Y&I,YM6JR5A$V I<)UWY4QV[;W5EK%>;V=MYQ#;CC:FS+
M>VI"3+=T41D JMK@+)).%\EPME)CESGS$9B+C]-WDTD'T37\JI7:0:G7=Q]Q
M2&$ET+H?B*+,S/!;3([;CZ?#D,--8E;)LK!+IK)3K10WH^UK:D]5;G"/SM.@
M"LF^%.0:^7E]?6LXO(]:IL^6C/K%E^1?QH]AN(F39-O:XIDE;6E%)0@BZ[/P
M3"4XMQ-D5/-XBES94(RX^I+"GM4,J=4;[DN/&8;6P:FTZE^0-2M^WQZ:B#KR
M;C+*ZW/KK.L'@4%ZUE#45-U39*3C9-2X+78:DQGVV7S(E-DE+C1HZ[=25J*,
MTL(Y6@X/!B0,CJI&8,SW)]E"=@-QJ&9$>)255NQIM3C;*$&DD/:*<U3JK770
M@ZN*^+[G&<POLYN(%+CCMU$CP4XSBY.>@:L.N.JER%K;9)R0LU[=4-)(D^Z9
MF8@DO,>$V?(W&M]A=/(8B65JVPAB1+W]A)M26GCW=LE*ZD@R+0O$ K<*LH?+
M=[GSC["JFTIH%4Q'2:_2$O0WWW5J41IV[3)PM-%:@/O&&%66$0\EC63[$A5U
MD=M?1CCFLR1'LG^ZVA>]*?/27OM.GN&8"%>T F[5?<4IQJ3'B7WK.9P7IJ%N
M1C65?),VW4MF2MCA?DU&D]2W:EU%&; XPRC,+O(<FY7=@L/V^/R,1@TM$X\Z
MQ%K9RC7*=7(?0VI;[JMNAI;22$I(NIZF(-%2\8<MP(=/B1KQ6#4U+D=I[-(D
M/NW4NOBF1$V41^.IEI]Q"=CCINK+Q,DZ^%%B8QA-G2<E9[FDJ0PY6Y6W3(@1
MV]_?:.JC.LN]W4B3YQN$:=IGT\1!5V8\.<G9I$E8ID/JQ<PG9*EU_(,QEQO(
MX,-3W=2E#++*4&^TD^VVXA]"3(B-2===:);881R-B6;7>8<:N55I&RIB$F[J
MK]Z1%4W.KF?1FY3+\=I[4EMDDG6U-EJ9;B5UT :MG@Z]9QZACN6T65DI9S%S
M_*YRD.-1WWD.FM]J*@MYI(D$AMHEGX)U/370!.9F%64CEZJY!0^P53!H)E,[
M&,U^D&_)E,OI41;=NPDMF1^=KKY!!(,OIW\AQ.^H(JD(DVM=+@LK>U)LER6%
MM)-9I(SVD:NNA:@*;B<6<L7.-XUQAFT^D7@5"=:JPM*XY1V5DS4FVXQ&4PZ@
MFVBWM()QTG5&HDZDE)J,BHU?,^/T/('+^&XM2VK;UQ.:=K\^JXJTNK]6H+[%
MF2)>TS-DE/H2TWNTW]Y1%TU >D1!2F:\8Y;+Y-=SZEJ\=RF/,KX]<S"RI3R3
MJG(ZUF;L/8Q(2:7=^KI;4KU+HK0S%&G9X*S57%F=X3/N*U[(LDR'UFKK-EIY
MF'WB>ARB:=8/>;:"<C&V1(4O1!D?CJ0"4R\/Y)D9WAO(R"I"MHE:]1Y96F]*
M]'3%ER67W'8+G9W+<236B4NI21^Z7B BL7B'D?$(<_#\&9Q9[&Y$B2_29)<1
MUN6]4W->6^M!L=AQN4IE;BC84MU)'T)9;2T 3Z'QY;Q.2<<R]RP:F5]-C+^/
M2G'$$S+D2G9##O?[;+:64I432C42=I$9]$Z (W;\(6%]'Y*CRK-F$]EEQ!O<
M=G1TJ=<A2JQF.3*W4+2E)_E6/.2DSU09]2/P#X6%<QY3G>#Y5FSV/P*W#Y4M
MYZOJ');ZI:Y4-R/WR6^VC9H:BVM:="-1FM1Z$ QU\*Y(>.R:@I\'OO\ (1YN
ME>KNPH!V"9?9/\GKWMI:::;=?PO* FF18',N>3<?S-:V%T=53VM7.A+W]]U5
MB;)IV$2=IIT;42M5$ \O91<W$?@>PP3%LWHK3"W".JQY@VY"<RD&Y*)#50[7
MJVDEU*C[:W=-W;+7MEKO!7MF$VMF''9<+1;;2$*(NI$:4D1B([P       >4
M_;/_ .^\3_[Q%_C, KU8"    /-7-OM;U_$.?,80Q0%=DRPP_<2BE=A4<Y![
MB;2CM+W*)K:YU4GWQ$"QZ.@S8ME"C6,%U+\*6TB1&>1U2MIU)+0HON&1D8(\
M\\@>U*Y79K(XWXHQ.3G>705*18G'4I,5AQH]'4?DT+4HVST2XH]J4JZ;C/H"
MQ\XS]J9=_G#7&?)N*R,(S*4KMP4OJ4J.\XHM4-F3B$*0I>A]L_.2L^A'J9$8
MB7<W>T'CO#2:^L7!?O\ ,;CK5T$,]KBDFK8E;BMJS2E2_,1M0I2E:Z%T/0BK
MC]KC-\-LH!<Q<7SL8QZS42&+-M3JE-ZZ&>J'6TDLTEU4@EI7I^"*L7OGW+>%
M\>8(7(5O-*11R&VEU11#2XY.7)1W&41]3(E&M/G:ZZ$G4SZ$(B@&O:PY=GUJ
MLPJ>&ILC!$ZN)G=V0I:XY'U<):8^AITZFI*#27NBK%Y<4<TXIS!B<G)L9[C4
MB!JW9U4G1,B,]LWDE6FI*0HB\Q:>A]? R,BB-#[/'.<CG2EN;=^C11G52FXJ
M6D23E$X3C?<W&9M-::>&F@&NJ_YYD4G/E)PHFB0\Q;L-OG<G)-*V][3SNA,]
MHR/3M:?Y0O$!H,B]JJLQ+G5?$>0TR8E,EZ+%]9?2==CLV,T\VIQDVR)*"6X2
M%*[GFEYW@"Q+?:#YI?X.Q6MR1BF3=JGV":XXRY!Q202F77M^XFW=?\GIIIY0
M,:GDSF7E'#\@8J\0XKGY?5/0F)9VL1Q]+27GMVYG\G&=+5)$7X7E\!45?C?M
MB\F9BF6O%.')5RF LFIIP9C[_9<5KHE>R&>AGM/Q$6/5N,6<^ZQRHM[6O74V
M<^''E3:ITS-R*^\VE:V5&9)/5M1FD]2+P!%(\S^U!%X9Y'I<-M:$YE)81(\Z
M=;MR#2[':?D.LK-#!-*[AH)K?IO+7P!8GW+W*3?&G&,WDBMAMWL>.4-<9A+_
M &6GVIKS;25I=2ASIHYN+1)Z@B#<C>TA)P/A_#.4V\=1.=RST3?5JEFTF/Z7
M$7*Z.DRHU[=FWWA:^(+%RM7BG<31DO8(EKKBL?1MW0C-CO;-VG]S70$4YQA[
M1TKD3BG-.27,=1 =Q-$M:*U$LWBDG$AE*T-TVD;-VNWWIZ>(+&LX ]JI'-66
M3<3G8\BAE,P53XCB99RB>[3B$+1H;+6AD2R47CT(P-QJ^;O; +B7/I>#U^,-
MWBH#$=R7+5..,:'Y".[V]B6'?!"D'KN\H&8D_.?M%V'$"L/9K\83?R<L9=<;
M8]+5'4VXWV"2A))9=WFHWM/)X?=!,0NR]K'D_%XY6^:<)VM1CK:THE6"GWTI
M;WGH1ZN0TH_<W*+4^FH+%M9CS?54O";O-.,1/ENJ-F+(B0W7/15+*3*;C+2M
M1)<VJ;4M6XB(^J=/N@BI:GVIN9KVMC7%+P;93ZJ8@G8LR-(D.LNMGX*2I,(R
M,@58E1S3FI\5Y=R'F& 2<8LL:2XY%I)SKB#EM-M)7O)QQA!I(S4:>B#\!45G
M0^UGRWE-6W=XWPG/M:ATUI:FPY4A]E1M*-*R)2(1D9D9&1B+%F\'^T;3<QV%
MIC<FFD8UF-.@WI=/+7W3-I"R:<4E1H;41MK-*5I6@C+4O'KH(NL$  !Y5OO_
M !V8O_NX[_1YHJ^/50B                                    /*OL+
M_P"QN:_[QN_T=H%UZJ!                   0J;;X6[R"Q@TNJ8D9'-K';
MQ<EV.RIOT9A]N-HIQ7G*<-3A:)(C\TM?<%&#@%MAV>41W;>.PZXCGSZYJ,^S
M'4M:JZ2N,M:=$%J1F@ST+P!$K=Q[%6&U//U5>TTCJIQ<=E*2+[IFG017).-8
MRHB4FG@&DRU(RC,F1D?_ *H"%\A7N+8.5170<19R'+LB?<BX_01&8K+DER.V
M;SRE//$E#;;:"W+6KPZ=!2-)C.81'LL@X-R+QS&PW([EI]^@-+D.U@SRAI)Q
M]#;[+;9I=;0>XT+;+IJ>OAJ(LQ=!B;:VT+JZY*W3-+251V"-1EXDDC3UT$')
MS'<69;4Z]4U[;2"U4M<=E*2+W3,T@/J<;QA:4K140%(41&E11F3(R/P,CV@.
M#>/XHZI:&JNO6MH]KB4QV%&E7N*(D]# :K&(%=<8_%M[[#HV.6+Q.*DU,IN(
M^Y'[;BDEN<9)2#W)22^A]"/KU%';<Q,2JL>LLA;I8$R/71)$TVV6&/RA1FU.
M&E*MID1GMT!'3AS>*YAB5%EC&/PXK%Y7Q;)N,N.PI;:9;*7B0HR01&9$K341
M8BU#R]C9<Q6_"46D55RZ]DI+%BWVT1)3YQV)*VD(0DC)PFG=QZ^1!_< 9O('
M,M3@6;89@SU>]8VF82D1B6PM"$0VG'FV$/.[NIDI2SVD7CL5Y= %CN/L,J0E
MUQ#:G5;&R6HDFI7N)U\3 <U*2A)J49)2DM5*/H1$7E,!ASK6# JI-T\Z2Z^(
MPY*==:T7JVTDU*-.GB>A= $;JLZ>R&EQ+(L=I),^HRCM///=UEI=?$D,F\AY
M])J/=^"DT(,S(S 2U;[#9I)QU"36K8@E*(C4O^]+7Q/[@#ZZZTRVIUY:6VD%
MJI:S)*2+W3,^@#DE:%D1H42B,B41D>NI'X'_ '0'T  8)4U.FU5>)KXQ7:VB
MCKLB9;*4IA)ZDV;NF\T$?7;KH S@       <7&VW6U-.I);2R-*T*(C2I)EH
M9&1^)& Q:RJJZ2$W6TT&/75S.O9B0VD1V4:GJ>U#9)26I^X0#,
M         !T2(4.4XP[*CM/NQ5]V,MU"5J:<T-.Y!J(S2K0S+4@'>
M    #!CTU/$L)5M$KXS%K.))3IS3+:)#Y-D24]UQ*24O:1:%N,] &<
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MBRENQFS6I6U#:CU)LCT1NVEH1:$%[(6AQ)+;42D*+5*DGJ1D?E(R$'(
M
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MV5&2C6DOR#VTBW]%?@D0+NO4H(  #RK??^.S%_\ =QW^CS15\>JA$
M                             >5?87_V-S7_ 'C=_H[0+KU4"
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M-:PW%A1DFI26V&4DE"2-1F9Z$6G4Q!G
M                                           \I^V?_P!]XG_WB+_&
M8!7JP$                                                >5;[_Q
MV8O_ +N._P!'FBKX]5"(                                    \J^P
MO_L;FO\ O&[_ $=H%UZJ!
M
M                      !Y3]L__OO$_P#O$7^,P"O5@(
M                                  \JWW_CLQ?_ '<=_H\T5?'JH1
M                                  'E7V%_]C<U_P!XW?Z.T"Z]5 @
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MTI3(9TWHT6E)ZEN+R -\      ,>;/@UL=4NQE-0XJ="4_(<2TV1GX:J69$
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M2I*5)42DJ+5*B/4C(^O0!Q9>9D-D\PXEUI6NUQ"B4D]#T/0RZ>) .8
M  #RG[9__?>)_P#>(O\ &8!7JP$
M               >5;[_ ,=F+_[N._T>:*OCU4(@
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MM!>TG]ADO^%)_1 '[07M)_89+_A2?T0!^T%[2?V&2_X4G]$ ?M!>TG]ADO\
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M ^4;#^6/_P :O[X!\HV'\L?_ (U?WP#Y1L/Y8_\ QJ_O@'RC8?RQ_P#C5_?
M?#GSCZG*>,_^L7]\ ].G?RI[^,7]\ ].G?RI[^,7]\ ].G?RI[^,7]\ ].G?
MRI[^,7]\ ].G?RI[^,7]\ ].G?RI[^,7]\ ].G?RI[^,7]\ ].G?RI[^,7]\
M!\.;,/QDNG_\\7]\!\]+E_RAW^,5]\4/2Y?\H=_C%?? /2Y?\H=_C%?? /2Y
M?\H=_C%?? /2Y?\ *'?XQ7WP#TN7_*'?XQ7WP#TN7_*'?XQ7WP#TN7_*'?XQ
M7WP Y<LRT.0Z9?\ 35]\!\])D_GG/X:OO@'I,G\\Y_#5]\ ])D_GG/X:OO@'
MI,G\\Y_#5]\ ])D_GG/X:OO@'I,G\\Y_#5]\ ])D_GG/X:OO@'I,G\\Y_#5]
M\!4T1:U^VCAQK4:C]6G"U49F?_=IONC.M>/88@
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M@NLOJ**_QS&IG=.URAZ3'JT-HW(UA1U2GE.*,R))$A!Z>4S ;_4M=/+[@
M       \J^V9_P#!#B7_ 'C+_&8!5CV__P %['^=2/\ M5#3##%
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M"'$O^\9?XS *L>W_ /@O8_SJ1_VJAIAAB@
M                    *I@_^-##O]VW/Z--&=:\>Q1
M                   !Y5]A?_8W-?\ >-W^CM NO50(
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MVJAIAAB@                                              *I@_\
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M5CV__P %['^=2/\ M5#3##%
M          53!_\ &AAW^[;G]&FC.M>/8H@
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MYG78,SF4S'9QRIO)T?D*9C4-KTJRB5)NI2:#9:-6]\D()Q:$'XJ/W# 6AQW
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M#B7_ 'C+_&8!5CV__P %['^=2/\ M5#3##%
M                      53!_\ &AAW^[;G]&FC.M>/8H@
M                       \J^PO_L;FO^\;O]':!=>J@0
M        &HR?)Z##:.5DF3SD5M'"[?I4UTE&AOO.)91KM)1]5K2GP\H#;@
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M_>,O\9@%6/;_ /P7L?YU(_[50TPPQ0
M                %4P?_&AAW^[;G]&FC.M>/8H@
M                \J^PO_L;FO\ O&[_ $=H%UZJ!
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M8#DV Q#78VEG+B%)7(?6^PM"&T$:2[;3:269J/4BT(!&H/*/(N0,TW&/RLS
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M5M9YG%CB&?OV9,3L6OZEMK%9493RDE'@2VF==QM[3:>5*-2E>)>(#U:(
M    /*OMF?\ P0XE_P!XR_QF 58]O_\ !>Q_G4C_ +50TPPQ0
M                                   %4P?_ !H8=_NVY_1IHSK7CV*(
M                                    /*OL+_[&YK_O&[_1V@77JH$
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M3]\ ]'=]Q/\ #3]\ ]'=]Q/\-/WP#T=WW$_PT_? /1W?<3_#3]\ ]'=]Q/\
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M1K_Y6S_&)^^ ?*-?_*V?XQ/WP#Y1K_Y6S_&)^^ ?*-?_ "MG^,3]\ ^4:_\
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M4RT[XTV(XEYEQ/AYJD&9=#Z'[A@,\
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M9<,W-3VNK5LZ*4G<D]%>X%XB
M
M
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M.U&FTMI^&A= &8
M
M
M
M
M
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M+2I#B%),E)+J0#9@                   A?+O3C/*/Y@[_ .@!-
M
M
M
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MT>W&K8XG<1&G<*+$$                    $(XI_V8F_[P9+_KV< FX
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M9PQQ/A&9<$\GY1DD YUW72+E%3(<=<TA'$A(DH6P@E$E*E.'JL]/.(B(^@#
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MM11<8KT5\>SB1;6>A"G%]V;*BLDZZ9N*4>JMJ>A=.G0A$6$
M        A'%/^S$W_>#)?]>S@$W                   !"N7?[,\H_F#O_
M * $U                     17D@KYS"K:+C=$C);*8UZ&=,Y,37)?CR3)
MI_\ SA71!DVI2B/]X!YH<X[Y"=PZHP%S@E@\6HIQVM9&+,6R>1,4:S-:G2+<
MHC[BO-%$DN(_->09?1YY;<)Q'LIQM+K=/*1E;#;3:7R,E;VDEM7[X]-0&&NO
MYJB9%DV=0N%(S>6Y- .OMI992PZAQAMI#:";CGHDE$3:/#QT^Z8"H<%X$S[U
M1BUF0\*JLI++[AR9BLD31NS6]_<0B3'2:MZ6S/1"NA^X"KAR.FY8RW$XF"W_
M  #3R,5KTMHKX+>1QF#BDR@VT&PXC12%$D]-2/KY=01J,"P/DKC6V<R#%^"X
MJL@=;-@[6SRUF?(0R9:;&C<(B06A;3-);C+IKIT ;[$XO-6#6N17>,<*1(ME
ME<OY0O7'LK8D(=D[W%[D(66C9;G5]$^[]P@&D/".3OK <Y/1P;':RY]2G)2V
M\N93"?=6T;)K=C:&E6J#,E)]Z9]3+774(\WPADZ&I<17 ;;M9+4MPJQS-B5#
MCNNIVJ=CM:Z(<(NB5GN-)= $L<QKEAZ7A\][A%AR9@326,6=7F#2C8;0E"4D
M[T_*Z$A/O@&P=B\U/YZQR>YPG$/-HT,ZUF:65L$R48]WFFQIM,_/5U :7'L*
MY0Q3.)G(F/\ ![$+)9ZGG)!)R]DX1NRM>\LHYEM(U:F>FNA:]"+IH$CS=WG3
MD?'9&)YCPM#F44I3;CS#&4QXSAK863B#)Q!:EHI) .C)(_-.7X>6 Y'P=7S<
M50TPPW%/*(Z'FTQ-I,J0\1;R6G:7G>7J1ZD9D PGJ'E>5@4;C";P-73,'B(2
MW&KY.4,..M[5&HE)?Z.)61J5HM)D9:Z> #281QKR!Q[=-9'CO!$9R^C)-J%/
ML\N9GN1FC2:-K!.$24>:HTZD6NG37J8#,GX7RC9<A,\I/\'L-9HRXT\J5&RY
MEAAYV,24M+=926BC(DI(RU(E:=2,!FT..\K8S4Y#0U/!$!5/E3[LJ^AS<I8E
MMR'9!;5Z$X7FIT\"+P]T!%\<X<R[%;N'?U7 ;#LVM=[]4S/S%N9%B.[B7O:9
M<+3<2BW)-9JT/KX]05LLTX\Y'SZ\=R>^X-9CY#(;*/-L*G,&J]R2P221L?)L
MC)?FI).IEKIH1]"+0B98C.YUP.BC8SB'!U75T<34V8S>1QEGN4>JE+6O52UG
MY5*,S,!KLH@\T9GD&.Y3D?"<21>XF^<NBD-96PPAIXUMN:K0@M'"W-(/17[G
ME ?.0:[F+E2I9I,\X,K[&!&>*3%-K*(\9]ITB-)FAULMQ$HCT4GP/]TBT#2Y
M;@W*&;_)3^0<)-KMJ.,B%67D;,6X]JEAI)I)+LE);G?$S,UZGJ9F6FIZAG8]
M0\P87B-EAV(<$4T6IM$K*Q189 Q9'+-U.USTDUJ0MW<G5)%O(BUZ$1 *1MN)
M,RR*JEXIBO #V,7UB\RI^_DV+TEEA+*]ZD1U33)#2%>71U1F734^@+5N9/@7
M*.93ZFYO^$VDW]/%;@1[:KS!JMDKC-)-.QQ3):J+0SZ^)$9EKH"/E3QSGU#
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M9109I>\)Q'\DQA2ETLEO*V&6VE*,E'O;26U?4O* EOK_ .TY]D%=_P 11/O
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M]F)O^\&2_P"O9P";@                   A7+O]F>4?S!W_P! ":@
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M3<9F7)4G_.D/=PTN)01$:-21KM5UZ@+3
M                                 0CBG_9B;_O!DO\ KV< FX
M             (5R[_9GE'\P=_\ 0 FH
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M9IB/+..*P+&L\A\>V*50<OBYBA+C)+,C[4MM2'7229&>Y9]/#0NB@1ZCSO\
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M:]D"(
M     A'%/^S$W_>#)?\ 7LX!-P                   0KEW^S/*/Y@[_Z
M$U
M   >;_:4ATN7RX.+W7'V873]8E,^JRS$XS;BHCSQF2FT..'H?5M!K09>1)D9
M'H8HJ.EQ_L9+4Y3FF&\MYW,H5I<J(=[#;7%96V9*0I2>ZM2C(TD>FI$9EYVX
M%;_()DJ[Y2C\M5^ \I8_D"6V(]C%K:]@F)D>,I"B:6I2R4E+A(2EPNI&1>&H
M(U.0U9663W&68I@_+&"V.1[BR"/0PF4QI?<,S6LTJ<2:5J-2E&>XRU,S(BU/
M4K>USF*5G&,OB1G@O/W,7G*-Z9(=@MG/=E:I44I3J5$7=2:$;=$[2)))TV]
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M4:7GC;;<9\Y+:C5L+7_!(!Z<$
M                         $(XI_V8F_[P9+_KV< FX
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M4:>]29@)   -3<Y+1X^_5Q;>8F-)NI:*ZK:42E*?E.)4LD)))'^"E1F9]"T
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MQ3_LQ-_W@R7_ %[. 3<                   $*Y=_LSRC^8._^@!-0
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MIR)ORJM)LP5SDN)1VHYJ6O>3._Q22C >AQ
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MJ[B7DC%L6PB-AN7QXN1XA!=JY4*8S(=H;.,X?F&_'0ZA:'$:)-+B5:ZZEX&
M[:;A.VFQ^0++.;F([E7(=8=+-721#BU\**3#C*3:;=6M;J]7#6I;J]3Z%T+Q
M"NLSQ3D*EF<(8?89-";RNOM)T:EO84-1,IC0ZM*64OQW'//W[-CVU2=4JZ:&
M MO%>.LN?S'ZQ>3;>#99-$@NU5'7TT=V-606)"B4\ZGTAQQU;SNTB4I2M"3T
M+7R0,4X;B5_!['#&3RRL8GH,B!+FQ4FSJ3[SCR'&R6:M%-FI)EKKYR?[@",S
M^(>5\MI8O'N>YE6S>.(ZF$SGJ^"_&O+2+$6E:&9+JWUM-[C0CN+93N/3[IBB
M23^'F,NS>TR/D)R-<X\W7+I<5QY#2DL08LM&V6\LU&>LATB)!+02=B"T+R&0
M:"WK*?CCA.ZP?F3+(L['CBS:VEL)&C-@_7I9,X[)I4K\M+:(M$=HO.VIZ:D9
M@,/C_%K3%/9IO9N4N./99D%-:7^0R)>I/*D2X2C0EW=U)3;"&FU$?@:3 1WC
MWC?DS.>&\1Q&XRZ#]5MI4USTPF83C=^J&IM#IUY/]XV2:+_)$Z3>_86AEXZA
M962<8Y179?Z_<3VL"HNI->Q46U/<1G9-5+C0]?1W#]'<;=;=9(]B329D:>GN
MZAI)' ]S:8=R"S?Y S/Y$Y$:99L[E,=3,",S$(DQX\=@EJ43;:=2U-6Y1]5
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M\&2_Z]G )N                   "%<N_V9Y1_,'?\ T )J
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M)(::;22$)2GH1)26A$1?< =@
M                              A'%/\ LQ-_W@R7_7LX!-P
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MUTS+[-[GX;1_UB >NF9?9O<_#:/^L0#UTS+[-[GX;1_UB >NF9?9O<_#:/\
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MUTS+[-[GX;1_UB >NF9?9O<_#:/^L0#UTS+[-[GX;1_UB >NF9?9O<_#:/\
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MR^S>Y^&T?]8@'KIF7V;W/PVC_K$ ]=,R^S>Y^&T?]8@'KIF7V;W/PVC_ *Q
M/73,OLWN?AM'_6(!ZZ9E]F]S\-H_ZQ /73,OLWN?AM'_ %B >NF8_9O<_#:/
M^L0&3QI6VU9BZV[N NLL)5I<V!P'7&7G&FK"TDRVDK6PMQLU=MU.[:HRU 2\
M                                    !17 I']8'-G^]/\ ] !=7J"
M
M
M                               **]DPC+C"=K](;G^DF"ZO4$
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M& UDKD?&8L^YK-TE^=03*^NM&8T5]]3;]LVV['T[:3U2:'$J6LNB?PM $M
M     !I,;RNDRQNS<I'E/(I[*72SC6VIO;-@+[;R"W$6XB5X*+H?D ;L   $
M3^L;&2EQ(+RI4>3.N9&-Q$OQ'V>[81&W'5[#6@M6C2VHTNEYBO(8#<7M]"QZ
M-'E3T/K:DRF(+916')*B=E+)M!J2TE1I01GYRS\U)=3 ;0  1*)R7AE@]BS5
M?8^EIS0Y98Z\TVX;4CT!E3[Q[C26TB0A1D:M-?( EH        #38GE--FN.
MU^58^\I^FM&^]#>6A32E(W&G4T+(E%U(_$@&Y         :NYOX-$JM3-1(6
M=K-:K8WHS#L@DOOI6I)N]I*NVWH@]SB]$ETU/J Z,NRRDP;'+#*\C>5'I:Q"
M79CR&U.J2A2TH(R0@C4?51>! -V  -+C.54V70Y4ZC=4]&A3959(4M"FS*5!
M=-EY)$HBU(E),B/P,!IK/E+#:@\Q*=+<0>"-1G\DT8=5V436/2&MFB?RFJ#U
M\S73P :NCYKQ;(+.%50:K(FW;!:6V)$JBLHT8MY:DI;SK*4)3_A&>@HL<0
M          :V[OZ?'(K,VZEIB1I$AB"PM9&>^3+<)IEM))(S-2UJ)) -D
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M)^TMKV_M9>UU::];BY"&&4)T)*E*4A"W%:Z&KS2\HJ[CW$(@
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MDABEA.&775P_2)!$?_JL@UKW*#(
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M-"R\0'8?%G'QX@Y@9T$;U4>7WGJ_SRWO[R<[RG=W=-W<1*[IKWZ^4!*(<2/
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MU)DVMC9:M%HDFY<A1L)_=0REI!_=(!/@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0O\ EZ=06)?R1R[AG%:*PLI>DG+N5NMUL&#'<ER7O1TDIU1(;+WJ"4G<?W2
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MAD?0R!$T  $<Q_.<=R>XR*CJ)"G9^+240KA*VU(0AYQON$25*+11::D9EY2
M;R'-AV,9N;7R&I<-XMS,AA:76EEKIJE23,C+]P!W@
M                                      "!\D<P87Q6=8UE#LE4VX4Z
MFN@P(SDR0XF.DE.KV-ET2G<G77W?W="M#AWM&\;YKDT+$JY5E"NK)+IU[=G
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M43TMXO+[IMS9I>B)3V'U1U;^[MV^>@R+7Q 2D
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MAYR 4J)-0CQ:D>DN.FA7N*VN)5_=!-7:"
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MK+C9*0M.I$>AD>O4@9;(
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M=<(]Z2T4>U2=3!=6."
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MWS$*_=\ 7%J0F/18<>-M2CLM(;V-D24%L21:)(B(B+IT!'>
M
MC.?8%CG)6,R,2RIIQ^EE+:=>;9=4RLU,+)Q&BT]?$@%0?L5<"_JN=\X/_?!:
M?L5<"_JN=\X/_? K98[[)'"^+WU9DM1736[6HE,SH2USGEI)^.LG$&I)GH9;
MB+4O*!5Y@@
M
M
M                             #5*R?&DJ-*KF"2B/0R.2R1D9?\ K /G
MK1C/ZZ@?"F?Q@#UHQG]=0/A3/XP!ZT8S^NH'PIG\8 ]:,9_74#X4S^, >M&,
M_KJ!\*9_& /6C&?UU ^%,_C 'K1C/ZZ@?"F?Q@#UHQG]=0/A3/XP!ZT8S^NH
M'PIG\8 ]:,9_74#X4S^, >M&,_KJ!\*9_& /6C&?UU ^%,_C 'K1C/ZZ@?"F
M?Q@#UHQG]=0/A3/XP!ZT8S^NH'PIG\8 ]:,9_74#X4S^, >M&,_KJ!\*9_&
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M?Q@#UHQG]=0/A3/XP!ZT8S^NH'PIG\8 ]:,9_74#X4S^, >M&,_KJ!\*9_&
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M71?-</\ 1 4^J[C+Z%T7S7#_ $0%/JNXR^A=%\UP_P!$!3ZKN,OH71?-</\
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M71?-</\ 1 4^J[C+Z%T7S7#_ $0%/JNXR^A=%\UP_P!$!3ZKN,OH71?-</\
M1 4^J[C+Z%T7S7#_ $0%/JNXR^A=%\UP_P!$!3ZKN,OH71?-</\ 1 4^J[C+
MZ%T7S7#_ $0%/JNXR^A=%\UP_P!$!3ZKN,OH71?-</\ 1 4^J[C+Z%T7S7#_
M $0%/JNXR^A=%\UP_P!$!3ZKN,OH71?-</\ 1 4^J[C+Z%T7S7#_ $0%4SZA
M8+Z]>C^K%3Z/]8GHG9] C=OT;U+[_:V[--G=_*[/#?YVFH*MKAC^R/!O]!5O
M]&;!-3@
M
M
M                                     4=_]G__ -\O_P"T8%3GAC^R
M/!O]!5O]&;!-3@
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M%((W$I-?5Y*MNY)I(C\06+8!
M                         !1W_P!G_P#]\O\ ^T8%3GAC^R/!O]!5O]&;
M!-3@
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MB3\W)D3X4JNR>(TMU611%6+#I...+6LS?9;)6]&[1)>!:DHS"8<:XG@[-_\
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M'EK#YUI7U!IM84RT?]$@'8TUI 9=D&A;A-D])C-MDHTH49$:NN@"<@
M     H[_ .S_ /\ OE__ &C J<\,?V1X-_H*M_HS8)J<
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MGD(P&@B>T;CKM3F$JSQZZI+["X2;.TQVU8:CS7(KA>:XR9.+0I)F9%J:B\2
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MZIW%IJ!&QLO:%7'RVZPZDX_R+(;+'T056RJQJ.ZAA=C&3);0O5TC)1:J0?\
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MRJ+1617D"CBO6Q0Y4QLD)9-3*=#,C/K_ ,FI=0&1R'?SLQL^/>:L5QN\L*?
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MO7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
M/7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\= /7K.?LRM_A]-\=
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M.W^%NZ /0((
M                                                *]S;^T;C'^?V
MW^J)(*L($
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MI=;5L4:5:*29D>AD9']T!D
M
M       *]S;^T;C'^?VW^J)(*L($
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MJ@!;G!W<^JS'G'8;U>X\B2\J#*0II]CO2WG.VXE9),E)W:'TZ^(&K"!
M
M                                       %>YM_:-QC_/[;_5$D%6$"
M&I:Z>7W             'S<G374M"\0'T               'PE)-1I)1&I.
MFXB/J6OAJ ^@     !J1>)^/@ ^:D9Z$?4@'T                  ",C+4
MNI'X& $9&6I=2/P, (R,B,CU(_ P !\,R+Q/0!](R/J74@
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M+0K:LDJ+5)D>BB(P&<
M
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M#:<L9%7S+W$BAQ#SEK)J^BQ]G:\J,]6VZ$RF9CI$HE?DHR)9N[#TWL'IIKH
MCD/G7*;.<J[J82)^/?+3E2UCD:HM7K!RN8FG!<G)L4).*3B5)4\;.W:39&DW
M-X#T*((#F7]H7&W\]M?]5/BB?"  KW,O[3.-?^ON?]7*%%A""O>;_P"S.V_Z
M^N_UC&%PU80@ *]YO_LSM_\ KJ[_ %C&%Q-6$(KHF_\ <Y'_ %2_\4P$0X=,
MSXGPG4]?_<=?_1D )L Z9AF4209=#)M>A_\ JF A_#G]D^$_Z$K_ .CH 38
M
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MI;:4M.*96V:T$25&8":3JBLLZJ116$5N33RF%1),)U.YIR.M&Q3:DGXD:3T
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M^A*_^CH 3<!T3?\ N<C_ *I?^*8"'\.?V3X3_H2O_HZ $W
M
M                                %>YM_:-QC_/[;_5$D%6$"
M      #RY*Y)L#FYY)N.9V,3MJ.ZM8-/C#\:I>3Z)"47HVK#C/I3O<\/,7N5
M^#U%$SP[E3*WIU[/RBOF2%1,<Q.R3BU9$[DQFTO$RDR&FT'M<ZK0C=WE[6B+
M51I(E& WDCG.IIZW)I.54-G3VF*'7*LZ<O1ITA;5R_Z-$6P<1YQ#FY>J31N)
M1&7AX:A(L0Y 1DUS:XU8TD['<BJFF)CE=8]A2G8,Q3B69#:XSKJ#(U-+2I.[
M<E1:&()D
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M8
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M-J5$>I )XG=M+=INTZZ>&H@^@
M
M
M                                  "O<V_M&XQ_G]M_JB2"K"!
M
M
M
M                          5[FW]HW&/\_MO]420580(
M
M
M
M                 "O<V_M&XQ_G]M_JB2"K"!
M
M
M
M         5[FW]HW&/\ /[;_ %1)!5A @
M
M
M
M   *]S;^T;C'^?VW^J)(*L($
M
M
M                                                      !7N;?V
MC<8_S^V_U1)!5A @
M
M
M                                              *]S;^T;C'^?VW^
MJ)(*L($
M
M
M                                     !7N;?VC<8_S^V_U1)!5A @
M
M
M
M                             *]S;^T;C'^?VW^J)(*L($
M
M
M
M                    !7N;?VC<8_S^V_U1)!5A @
M
M
M
M            *]S;^T;C'^?VW^J)(*L($
M
M
M
M   !7N;?VC<8_P _MO\ 5$D%6$"
M
M
M                                                          KW
M-O[1N,?Y_;?ZHD@JP@0
M
M
M                                                 %>YM_:-QC_/
M[;_5$D%6$"
M
M
M                                         KW-O[1N,?Y_;?ZHD@JP
M@0
M
M
M                                %>YM_:-QC_/[;_5$D%6$"
M
M
M
M                        KW-O[1N,?Y_;?ZHD@JP@0
M
M
M
M               %>YM_:-QC_/[;_5$D%6$"
M
M
M
M       KW-O[1N,?Y_;?ZHD@JP@0
M
M
M                                                          %>
MYM_:-QC_ #^V_P!420580(
M
M
M                                                    "O<V_M&X
MQ_G]M_JB2"K"!
M
M
M                                            5[FW]HW&/\_MO]42
M0580(
M
M
M                                   "O<V_M&XQ_G]M_JB2"K"!
M
M
M
M                           5[FW]HW&/\_MO]420580(
M
M
M
M                  "O<V_M&XQ_G]M_JB2"K"!
M
M
M
M          5[FW]HW&/\_MO]420580(
M
M
M
M "O<V_M&XQ_G]M_JB2"K"!
M
M
M                                                     5[FW]HW
M&/\ /[;_ %1)!5A @
M
M
M                                               *]S;^T;C'^?VW
M^J)(*L($
M
M
M                                      !7N;?VC<8_S^V_U1)!5A @
M
M
M
M                              *]S;^T;C'^?VW^J)(*L($
M
M
M
M                     !7N;?VC<8_S^V_U1)!5A @
M
M
M
M             *]S;^T;C'^?VW^J)(*L($
M
M
M
M    !7N;?VC<8_S^V_U1)!5A @
M
M
M                                                        *]S;
M^T;C'^?VW^J)(*L($
M
M
M                                               !7N;?VC<8_P _
MMO\ 5$D%6$"
M
M
M                                          KW-O[1N,?Y_;?ZHD@J
MP@0
M
M
M                                 %>YM_:-QC_/[;_5$D%6$"
M
M
M
M                         KW-O[1N,?Y_;?ZHD@JP@0
M
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M:<0LRGVNI)41G_\  B3[@*L4$
M
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M1EK;*JD*VJ-M*=2U+70P5<0(
M
M
M                                                      "O<V_M
M&XQ_G]M_JB2"K"!
M
M
M                                              5[FW]HW&/\_MO]
M420580(
M
M
M                                     "O<V_M&XQ_G]M_JB2"K"!
M
M
M
M                             5[FW]HW&/\ /[;_ %1)!5A @
M
M
M
M                       *]S;^T;C'^?VW^J)(*L($
M
M
M
M              !7N;?VC<8_S^V_U1)!5A @
M
M
M
M      *]S;^T;C'^?VW^J)(*L($
M
M
M                                                         !7N
M;?VC<8_S^V_U1)!5A @
M
M
M                                                 *]S;^T;C'^?
MVW^J)(*L($
M
M
M                                        !7N;?VC<8_S^V_U1)!5A
M @
M
M
M                                *]S;^T;C'^?VW^J)(*L($
M
M
M
M                       !7N;?VC<8_P _MO\ 5$D%6$"
M
M
M
M                  KW-O[1N,?Y_;?ZHD@JP@0
M
M
M
M         %>YM_:-QC_/[;_5$D%6$"
M
M
M
M KW-O[1N,?Y_;?ZHD@JP@0
M
M
M                                                    %>YM_:-Q
MC_/[;_5$D%6$"
M
M
M                                            KW-O[1N,?Y_;?ZHD
M@JP@0
M
M
M                                   %>YM_:-QC_/[;_5$D%6$"
M
M
M
M                           KW-O[1N,?Y_;?ZHD@JP@0
M
M
M
M                  %>YM_:-QC_ #^V_P!420580(
M
M
M
M            "O<V_M&XQ_G]M_JB2"K"!
M
M                              !AV5M5TL4YUQ.CU\(E$@Y,MU##1*5X
M%O<-):GY.H#3?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #Z
MQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I
M#ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_
MI #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQ
MB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;
MYQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+
M*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]
M]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+
MQ]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?
M6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7](
M ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7
M]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.
M,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93
M?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI
M93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/
MOI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ
M>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #
MZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I #ZQ>/OI93?.,7]( ?6+Q]]+*;YQB_I
M $.R#)L;O^2>-FJ*Y@6;K,VU6\W"E,R%H2=3)(E*2VM1D6O34%6L"
M
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MJ4VA)F6O70%6L"
M
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M#X>HLZHZVW;S&1**"_,)>/U=G/*YL840FTI6B1.(B[N]PE+0G56Q)DG>KR!
M+KC;DA_&LKXBA54%_&,KMYE@C,W922.+ M9OIKZ7H:DFZ[):U6VTI*MBCV*,
MTZ&0#87W%N8V''W*>/1XT4[7*\G5<4S:GR)M<,UUYDIQ>P]B](Z_-T/R )[S
M)"QVQXSR.!E%HQ2U;T4S;M9+I,HC2VE$[%=2HS(S6A]#:T)+JHRT($5ECN#Y
MS+P?$.16XK<SD-R\7G5W1RW516I*K2$Y#.,A2R5V7&(KC2&>YT2I&BO'4BN-
MOQGR)=V%AR8NJB1<G=R*@O(F'^F(4:H>.,/1NVY,2@FBD/E(6LC(C0DDH2:C
MZF XEQIR1>Y5*RZVJ(=:Y9YEC.1N5Y3DR38KZ: <5XE+2V1*>2:4GM3YIF?F
MJZ:F%Q<D0,NM,(N8."2FH>6.M)^39#^TDDI+B%+(E+0XE*U()26UJ09(69*T
MZ BA9'!N<97.OWID1REBW&*JI8[MY=O9#..SCV3,YHY*E;TI8<V;30P9D1$H
MS3J9$"U-,EH^7>0HI39V/U>./4$BKMJ>K?FE->GV=7.;F+0Y*8026XJT([:"
M-O?O,EJ)))T,/N04?+.6R*_,7\?K:Z;B]M#M*3%G9:79,QIF-*C2DR)C9*90
MM12MT71)D@T^>?G^:&DN.-N2+^SL>37:B'#R15]CUO!Q#TM"EKA8VW):-#LU
M*>T4A_TMQ2="-"$I0DU'UT#B?&G)%]D=CE=K4PZQZVS'%,C57IG)DFQ7T<=#
M#Y*6EM*5.I[9'M3YIG[U734PV>:<:9M/N.0KRGA1I2K6RQ&UI(JI11URRQQQ
MMV0TM9H,FE*V;4*5N+]P!:F/9':W%W?U4^F571Z=<-$:8;O>1*5*BH?=26B$
MDE3*U=M6BE:]%:EKH1%*6;6;76:<W8=B='"L8V0KKJR3:2I:8OH"YM#'86X^
MT;:U/-);5O0EOSC41ITT/<171=<"Y7W;IVL[<QBMN<8N:!E4UV!)L6:&D352
M&E28^BXKJM5*:=(S\\BUT3J8%91\=\E,U%O<X]3N4%O:V585C"+()$[(9E+7
MMOH<;^5)BI#3#QJ?U:[.W:T2D]S<HM PHW$.:I8S*7-Q6'8QKVPHK*+365Y+
MF61-5T9;+QMVAJ2ZS.0LDN-N[S;(C-"3TZ@,ESBODNPH:NRM?39TO'KYZRI<
M<FW[ORJFIDP%0W6%W,8FU&^3BU/M:K,B1^26XHCZ!97$V)6./,7MK;TZ*6QO
M9;;QQ56<N\G&Q&80PTJ9+E..$MTR2>B6O,0C:G51EJ C]'C_ "AB<^VQ.GIJ
MV9C]ODDB_;RJ5(+9'@V,WTV2T["V]QR2C5;3*DJ)!ZH69IVFD!T,<9Y4W@F.
M8_V6/3ZW.4Y)*0I\E)36ED#UEJ2]OG+)E:3V_P!]T 1NBX=RJEFP\6?HSM*2
M)>G:ED4K([%%:<+Y259)5\D,NH24Q!GL26SL]PNXI1]4F$JP['N4<1;@\?Q*
MBN=QF#=R;%>6RY"7^]5RISM@;:8:4H<1,U>[6\S[:3+?JKWH#4<,<49IQ2[2
M2&F&'6+Z,XQG\(Y9NG'G1W'5PYD1:T><GMK[#C"30E);5)+4E:C4US[&<FL<
M\PK):.&U-KJR/<UELA<@H[K+=NW&2B0@E),G"0;![T$9*ZEH CE9Q=D[>,<0
M44PFVEXC&D1<A<9>+<UWZ*56DID]-%F3CR?^<!H>/^)LJJ)^'TM[CR3@X<MI
MQS()61V4^&\N#'7'CNUU8;Q(8=7OU7W4$AM.]*"5J6@3[DNBR^1E>#9?B=4Q
M<GB[UF[.KWI2(;CC<Z&<9),K6E2=^JM2W:%IT,RUU((+ XTY$IKJOY5;JX4W
M*CO+JWLL.;EI:2U#O8D6$E#$Q:>VJ2RF$TMQ2DI0O<XDC+S3,.%GQ'G.;5%M
M19)%B5%=R#?JOLK5&>1)>J8,&-&:B1HNY&UR6\N.@W9!%L06[0E'M,"K@P"-
ME,'$8=3E4:)%NZQ)UY.UY)*&^S%_)LR&VD$GM)<025&STV'JDNF@(HZLXQY9
ML+G#IV4PWI-ICF0Q[2YN)5^J1!D,(2^RHZVL;;0PPV1.)625-(<21;$FK51@
MJV.',?R3$L5DXODD)N.NOL[-<&:R^E]$V+.FO34/$DB)31EW]AH7UU3KY0-1
M-CC++&\.IZ4V8_I\//BRB07>+:5;\NNV&XE:=5]I9>9[O0!5S%X[75N(<54S
M]3;U-;GT(XUA'FFNX=:CWRYCS3M6;*'F7H^BSD.N'V^VDUD9[R!5JR.-,K<P
MBPH4-,>GR<[5DS:>\1).M/(DV9&:M/?]DO>^[T!$EXQQW)<7ML[AW,)M%7:9
M!)O:>S9?2X4AFQ))J;4UH2FU,]LB5KT5NZ> "J.0N,.7,O\ 6RKDQG+,Y=DB
M;C\]5ZJ%2LUK$QF2U'*K9;2E4G8A2%KD(6DU^?O\" 2G).+\OLN/^6\>B,1E
MVF87SEG2(6\26UQELP&R-U6T]BM8Z^FA^0!J<OXXY*;H^0\"QFFA6M/F]J]>
MQ;^5.1']%.<IA<B.]'4VI2EH4TKL+0HT[5)W;=NAAZ)!    $1O,SL*[(RQF
MGQV5=SB@HLGEL/Q(Z&VG'ELI+62ZWJ>J#\ '1ZVYK]G\_P"<*OXR >MN:_9_
M/^<*OXR Z)V<9?7PI,^3@,],:(TX^\KT^K/1#236KH4DS\" 3"IL&[>K@VK*
M%-LSH[4IMM>FY*7D$LB/34M2(^H"$YM_:-QC_/[;_5$D%6$"
M
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M'O\ 1D+^CH 1G-O[1N,?Y_;?ZHD@JP@0
M
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M8J9BR44E"3>4IU?CN[FGD(C+KJ*3.#<B=FKOF+#'I&26M=$K;Y^UI/E&.V_
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M-F?]@L!QPO\ V.Q[_1D+^CH 1G-O[1N,?Y_;?ZHD@JP@0
M
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M'Y.F?]@L!QPO_8['O]&0OZ.@!&<V_M&XQ_G]M_JB2"K"!
M
M                                            5'!XUXXJ;JJ;8R&4
M=7\JS).-XD<UE56Q<[7G9!QFDM[S6UJ\X3*G%(;5N,D%Y"MPY@. 5$; L5G2
MG$IH"D0,9AR'TDY+W5C\1YM>B2-P_1ENJ/;MTTU 8]'PE14D[&YGRY=V#>'J
M,L9A3)32HL-@XZXO9)MMEON))I>PEN[G"(B(E>.HK:UW%>,U5'A]!#7*]"PB
M24VE-;I*<-U+#\<B>5M+>G;(7J1:>0$5%B?$N9IRG$4SJ>5C])B=B[9K:^74
MV=$V2&7V29J8G;2^E#RWB<UEZ&P@C;1KJ"K.I>&L?H9\!R#:W!8]4R5SJC%5
M3-*F)(69F1H0A"75(0:C-MIQU3:->B?#05JL?X\P"HO\8[65S[=F&J=.PG'Y
MUDB9$84VDV7UQCV]YXF$/=M/>><[9*T+R:!*LBXTQW)\EC919+D^DMULNBGP
MFW$E#GU<\C[D:4VI"C4@E'O3L4A6[RF70$:_&>(J/'+BMNGK6UO9%%&<A8XU
M<2$2&ZR.^DD.%')#39FM2")LW75+<V%MW>.I73<8#A7)%M;W[-O*<5)JYV$W
MS%=)1Z,ZP2WD.-/(-"]'H[CSAI-)D:5'YVI= &YL^-\7NI421:M.RFHM-,QL
MXBW/R#U=8DR3Z'2(B4:C)A&BB46G4$8N+<8PL9M6+=Z_N[Z1!BG JF[B;Z0U
M$CK,C42$-H:):U;4I-U_N.:$1;O'4-F6"X\JYR6YDLJE.9;#BUMU%D*)R,Y%
MAH?;2@F].A*3(62^IZ@(Q X<K:9G\C:V=\W7P)5?CU+?S#?JHK4EE3/;6VTV
MA;J-A]K<^;JDM]$]06J[P?B'*U9CC,ZZKK"EQ[%8-C$1&L;I%RRE-A&]#3$J
MTH+>W';3YQ.R?RQD2$>!&!5@2^#,>=K8U/ N[NJJT4T;&K&)"EMI;GUL)KL-
MH?2XRX1+[9J0;K/;69*/KX:"LB3P=@TB19FE$IBIMZF%23*1A_9![52:3@OM
MEM[C;\;:1-.(<+3QT,^H%=4GA*AM:FZJ\DO;V_7>1&JV1.L)J>^S#8<2ZEME
M++332#-:"4M?:-:C\5 5N<JXVK\EN$9%$M[3',@*(=;(LJ1]MAU^":E+)EU+
MS3R#V*6I3:R02T&H]JBU,$:^7PWCBCJWJ6RMJ"PK(!TWRC6S3*7)KC6;IL2'
M9"7E+\]2G$N%HXA2C-*BU,%K:QN-L<B<;KXL8](3BZZUZF_RA')*+(0IM6CA
MITW$2ST/:".K(.+<5R<FV[A,AYANDF8R;*7=B5P+ V#=W&1;MY'&;-*B,M &
MD7PA1SGGY=_D%[>3Y%1/QY4J?+:-2:ZS;2TZA"&6&VTKT22NX2-YJZJ-70B+
M4GK\"HZRYI;R,I\YM#3KQZ"2W"4@X3BV%F:RVZFO6.CSM?=Z B+1."<9J*ZE
MAXS;W./SJ2 JF8MZZ2TF8]7+=6]V'S=9<;62%N*6VKMDI!GYIEU!:YN\=.8S
MDN%76'L*D0JF-+QR\8DOF[)=J;%2)'I!O/K-2W&9+*'%$9ZJ2M>G70@';2\/
M4F.6-7;%:W=U'QDI#F,TMC,3)CP52&U-&3)J0EUPTMJ4TUZ0\O8D]"T\0&?Q
MCB$W'\9G'DC+7K#D]A.OLAC(5WF$2;)>OHZ3/4EI99)J/KX*V:^4$86/<,8[
MCUC4RD6EO8U6.*=<QF@L)92*ZM6ZE39*91L)Q9M-K4TSWW'.T@S)&@+6PK>*
ML8JZ3#Z"*J4<#!Y29U*:W24X;J&7V"[RMOGEMD+Z%IUT!&;DV U.47E+D,J5
M,B6%(W,CM>ANI;;D1+%"$R(\A*D+WMJ[3:NFU1*26A@,:-Q?C$:+AD,B?=C8
M*PN)3-NK2M*VG8*JY12"VZ.:LK/W.O[P#7XUQ!38S8U<F/>7DRIH"<+'J"9/
M4Y70"=0;1$A"4H6Z33:C:9*2XZ3:#T3H"UFY'QG6Y!D[>7Q[>UH[OT$JB8_4
MR$,E*@)=4^EIPG&W-II6M9I<:V.%N/SO#0C21N"<6JJZCAXS9VV/S,?BRJV#
M;5TELIJJZ:^<AR*ZIYEU#C9+/<WN1N09$9*UU,RU]D<$XHAB/%H+*WQQA%8B
MCL$U,SMG/KVU+6E$DWD.FIPE.NF3Z-KI=Q7G]>@I9<$8A+]+B5TZUH\?M(T:
M#>T%7,[,"PCPV4QD(>):%N)W,(2PZIEQM3C9:*,_$"ON2<%8GD4RV?186M+
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M)(*L($
M
M   'Q1;DF6IEJ6FI>) /(^-4,J1&X_J(F06,:3,Y R]'RMO9>FL-LMVJ'4LF
MIO:A3Z4F:UF@S):S6G3H0*EF/9CEU=?UV,3<@780ZG-+W'_E&Q;96^]71,<<
MLF/2W$I29J:=46YQ&PU)3U\H#NXJR;*H.8T-5G5Y;.66509<B&;C]=<8W=.Q
MFVGU2JJ3"2VY%0E!J6EEQLDJ;4GQ4G4PEN<IR'(>4Z+!(.36..T,R@LK2P.H
M[#<IUZ)+ALM$AYYITV].\9F:2\XBVGT,!7&!9EGZ(O%V9VN2SK^;FS-RQ<4J
MVX[<!95E?+E1CC,M-DIMTU1D$M1*/>:E="+0B#[QWDG)]PO"LDL+.><3.B)%
MJ<ZTITURVI,1UW_W1&9UD-/QE$DTH,E&:4K[OG%J01KC+''[.IX&J(=]/K$2
MZG+'79\-;7IJ&=\1)L1W%MJ)I)JVJW$DU%IH1EKJ"IK0Y%E^63<7XWL\OF5[
M#DO+HTR_B>CQ[>S+%[)$.*PEW8:&W#:<[SZFV]RR1XEJH$8]-EF8Y??TW%\[
M+)<*M1<9/7.93 [$>TMFL=**J,RA[M]M+A>D.>D*::\_L'IH1K 3KV?S;AXQ
MD$:19)L7SRW(&BLU]M"IKI35FITDMDE&Y>AFHFRVZZZ= -6\"
M
M      "O<V_M&XQ_G]M_JB2"K"!
M
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MZ D(
M                      K[-B/ZQ>,CTZ%/M=3\G6HD@JP00
M
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M !5> 4^IZJ^C1?\ %5X!3ZGJKZ-%_P 57@%/J>JOHT7_ !5> 4^IZJ^C1?\
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MY,=PE,9#<26W$2B69=5/M&DR-L]2T K>?4EQS_(9_P \V_QL"GU)<<_R&?\
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MEG7W6"*MJJ2W,K)OH3\24RK<VXTY)94E23+Q(R,!,
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MB+);/<AQEU@UH6D_*2B,C(!(F?\ (M_]$O\ F <P
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MF1 +>SXB+%)A$6A$Y%T(OYTT"),
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M_P#D$)(UJ\[<:2VI 75F?^R-Y_,)/_9*!&Z9_P BW_T2_P"8!S
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M ;-/]H+O^AF_Z4X")*                  (U@'^RD/_K)7]*= 24
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MTD.$F,9H4:%H7M5UVJ(_ P':G'GU.+93E%H;S9$;C9+AFI)*UT,R]&U+73H
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MH9D?N .[T3-/UM7? 'OC8!Z)FGZVKO@#WQL ]$S3];5WP![XV >B9I^MJ[X
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MF[?*<*FI<O5(KH<C'8>-1YTR*EB^J+&.TI^6ME$13DIQ\S<_SAA2&V5%HHB
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M;4N+565R;;'\RC5%U1Y5()M"T5=6CN7BC=[:4I4XVVRK12"VG(5H2=I$07[
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M6TCDN?26F0RL@]/3:N-.1'VGZYM,":2$ID0EL-2:QYI*R8)"E+;?,E*W&9$
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MTW.+:NRE638JE"'4TCE5&DG'6S'2WOC*COMLL)[FOI&_=YQZ&0;B\SB+F5]
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MGP,K9L<UX0=N[!:?V8U'H(^2(R D.E#5'D/KCI:21-^_(TD1(UWFL]A)WD9
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M29-MSL$VKO$VI1HT-/ON@#(:S_%TU7ICLZ*F;'D1JMQMM+IH39SX[4AIEO\
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MTU]A+<EEMY"UQT:M')4H^R6UH]O0%3Z->87,QNRM&78AXI 5.9L9"VR;AI]
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MR;.2ZEK?M]%+73=KIJ0$>PP9            >=/;;_L*E_Z3@?XZ@7'YF@V
M+3]FS^W7!?\ 2:/\18)K]:@8     $6Y$QZVR?%7ZNB>CL6Z)4"=#5-[GHRG
M*Z:Q,)#O:\\DK[.PS3U+74!7=UP]ELZ-,C0K&N25K&RR'.4\E_\ ))R6>BP8
M4T22\XVEMDVX2M-2ZE[@+7*+PI/BYT[<F57*HW<@7E!2I?ICL]IUP^Z;+<8G
M$Q26EWJB3[Y*.FPU><!6SY7XVR[/9CS-?:1RQV74/UAULM^9':C3G5J/TWMP
MU)*4>Q1([3ZB0G;N+Q40# @\3Y=!S2JR"%80:IB*N JUL*YR6W+GQ8<,H[D*
M7%,_19!+6DC3+6DG4-DE)%JDC ;#DWC;*,MR&'=8W+@5DMB(42/>$N9$MZ]W
MO[U.MKBK)$MI2%&7HDI/;WENUT4H@&L>XCR^?8N5-C9UQ805M>VZ'([;Q6KB
M<BA38RFU;M64&RJ<LR4G7>1)Z)ZZAE0^.N1)J,4C9):5'R?B,NK=B,067B.0
MFM;>;<D+4LB-#CJ5H)+*=R$:&>Y1Z:!*L2QC),7F2F"?@R*:SM[JWL%:/)E(
M*PD$]$0U^ >TC63QJ^YM\H#6Y;QS:9!<7ME%G,,-VK.--,H<2LU(/'[9ZP>-
M1I_.(<)"-/!7CT ;;.L6NK^=C-C1OQFWJ2>\_*:F=PD.19D*1"=V&V1F3B"?
MWH(RVGIH9EX@B!W7!UO<8U44"[6*@ZK%(F/)6;3IMKGU\R#,:<,DK0HF%*A;
M%DE1+VJ\TR,@6I?QI@LS$/EN;8QJZ)87+S*UM5BI4HR:C-=M'>ES5&Z^KJK3
M5"20G1)$>FIA!:KA7,XC=A$^4:RNK7U17/DRM5.*ME2XUM'G',]#>6IN"OM,
M&WVHAFA2UFHST2D@*AT+%LIR&SK^.*Q*T8]0LY5'0_/K)423$3;19,6+Z:\[
M^1<\Z29-^BK6;S9=P]O4@58V8\-V^2()QF?$)Z)!QUN$RZ3[;2YF/2I3ZTNK
M94E:67DR=I*;/>A1;NNFADK-PCBNSQR^K,@E?)D1;)W*YT&M*4X1JL_06V#]
M(EK6X\M+</\ *NK).[4B2E*4@,GD'C:URRYG6T)=8\S(HOD8JZW9=?CN.E8,
MS#-SM*2I*30V:$N(/>TLR<3J:= &;A^&9=18-<X_*OC;N)RIIT;Y.O6B*=I]
MHFXS+;T[5V2EE1=W5[Q,S3[TB :;C3C'),5RM_*;^5%=>E4T>JDI9E3K"0[)
MCO&ZJ2N1.,U&3FX_R:222.A%KX@,>?Q3ELIO*L1CV\&/@&73K&QL9/94Y;H3
M;1U(>BH2I/:VDZKN)?W;R3YFW7SP'7]5V<W=I#O\JL*INUK44<**U6H?]'7&
MJ;1FRD/+[I$HG'C92EILM4M?WRM>@8$'!\QR:]RNKDG&KL&>S)JYD./-/IM'
MR@,0GDICGH39M..LH_+;M4D2TD1GH:0QIG"6<6V/UV,6=M4E7XO32J'')+#3
MY.R423892]-0?FH-$9C:;;2E$MQ6_4B(D@5MN1>)\TS2^LY"+:*[227:R14-
M3'IJ"KCKUH<>;1$8,F'C?4C=WW=5HW;=ID20&'=<'9#?E<0IEM"8@2)602:M
M]IMY;R?ER3%G,&^A1DD^R_'VK2E6CC?]Z8%;='&N9W&4Q<UR>;5LVS5C4O+@
M5R'G(R(%/'GI(DNNDA:WG'IZU:J024H(DEJ>IF$AQ6DR?%+%%2E$:926EAD%
MQ:3BWH<85.FE(AMH(ST49I=<2[KY4ZET 0*[PC+\NSSDFCB$Q7XGD!8^S96,
MQETWU,QV#4]Z"9)[;BC27:\Y1=M7G=?>F"]X,OI4XK>"[5SIKJ;R(]$LG9[$
M5$>VMY%I'<(X:T+<4V3YMO,K/8[Y%(\HKME<+Y:Y<U>VS@OT-)9TLZH[CDYK
MT.!3IC$J#%KVE^BM[E,N*2^K>O1>U1'M)1"L%W@;*YD.[K'+*MK*V6DGVJ^N
M.?\ )L^RC6+$^-*?A+=V0NC';>1!<+>;BE;BVI("K%XTP>7B#5S)L8]?%L+B
M2V\MJL7*D[6F&DM-D[*FJ-U]>A'U-*"2G1)%TU,(+3<+YE 7):.QK*ZL-^#)
M55UAS2K9<J';Q[ Y?H;ZU-P7#98-OM1#V*6LS4>B4D!4+@XME.065?QM6)6G
M'J!G*HZ'Y]9*B28B;6+)BQ?37G?R+GG23[?HJEF\V7</;U(%7QC^&SJ?*COW
MY++L8\?K*(F4)42R>KWI+BW-3Z;%$\6TO'H8,H9]5>:5-^WE6/V-8]9LW]Y:
M-Q)Z)"8YP;YEEO::VM5=YE3*5:$6U9&9:I\05C5/"-]6IQQ#EO$=.E/&#D+)
MIQ)NGCSE@M\TEKYO=],1L+\':>OD J5Y=A^8N9>69X/-KV+.33KH);=LVXMM
MI'?.0S*:[1&:U-J4O<RO:EPM/.3IU".Q^)<M:?BT3MI =PV!?OY6S*)I;=J[
M+?-V3Z.M"4]E"/2GEK[C9Z]O1LD%[X!KE8?R#0WV(4>+>@.3JG!G:*=:6#,C
MY-[B'8;23;-HC/>2F^X3*C+>@C+5.FX@YL<(9'55+^"U-M"=P.U>II5K+E-N
ME;-*J&8C#R&"3N:43Z8+6Q2E)[)J5H2_-T%;2=QEFA4-#4U]K%7'@V-S.NZO
MOS*Z-.;M9,B2QJ_$_+_YN;Q&IKWCO7=X$ C37L_Y.UC+.,G:UKL=-)$KW'3:
MDH+T^GNUW$0R2A9*[#N_M/$2R<3IJA1F!5D\9X/+P]NYE6,:OBV%Q);>6U6+
ME2=K3#26FR=E35&Z^O0CZFE!)3HDBZ:F$3^J#+HF)8]3TU_'K;Z@QVUI&+1E
MISS)EB[$<0ZT7BE))CK0H_?)W$I/4@*Q\?X7R&!D/R_,E0(Z%W=7=*@M.S;!
M:45L*9$<0J7-4;KKBSD(62U$DBT,MOE,5SN>#K:\QZ+CTBWCM-H9RMF0^AIQ
M1ZY+*5)CJ2DS+7M&9$Z1F6[KH9:@5)^,<#ML4F7%K=QZN-.LFXD=#=4Y.E*[
M<0G%*4[)GN*6K<MU1MMI0E+:?*HU&8#05?'>3U+]>G*9M:[@N+65YD<=$)B2
M[823LRFD3#S9D:=C;<Y_=VR4IT]J=I==P;#@3%7Z#$';&<3YR[9\_0US63CS
M$TD O1*IMYL]#0I,5M"S2KSB4M6[SM0-1IG@_+?1*W$W;:N;PVBCY#"JY:&G
M7+1QJ_CO,M&\E1);)4?O&2C2H^[IKYO@!6PA<6Y[/G5]KD]A4-S("\:0EBM1
M)-HX^.29+[BMSVBC6]Z1YI::(TT\[WQAE<)XRS%G93E3#3[=+,G/0,1:F1EP
MW6*9#SDM:4M.I2XEM<R1(V;TD9H2@_>[0-8MAQ-FMKG,;(K*XBS8%?D;5] ?
M?>F&^W7(1L* W$(RBM&WN5^722EN=-VAZF UC'"V?O8\K'+.WJ"BU>+V6*T3
MT9F23CQS)$1YF3+W'HCS8B$.-M:]34HE'T20J3EQCD$B.XN;-A(FR\OAY;,0
MPETVB98CQVG6$*/:HU[F5;%F1=- $8D<)9M98] Q:SMJHJ[%Z&=CN-26&GR=
MDIFH:C(>FH/S4=N.R25-M*42W#WZI(B2!6ZSSB[,[VRR:1C]E!;K<J<JF[>#
M*7)CJ?K:UEU+L4WHY&M*9"G"2X:-#[6Y.I&K4!IK_A;++Z<Y;O-8\4VXJXU/
M;0%JLODV$B"Z\EE<5EA;!2&U1WC2N-()*=Z2T5M-1&*W*.*LKBW4&%#G5WJ3
M RE67,FXE[Y2(WDNFN)H1&WM2XZI2'=VNS1!ETW&&XS;!LNGY)-R/#IE<V_<
MT1XW9,VS;JDLMH>==9DL]HCWJ3Z0Z2F5[4K\WSDZ'J&OJ>(+"EE5J(EFTY6U
M=U4V3!.H5WE1*J@33FA6W1/<6M/<U+S=O0"L+&>+N0,,]&9QZWJB1/JZ.LOI
M4EEYQQA=&DV%.Q&]#2X3S)[20ZI/;7Y^JM=H"/1_9VM8M;8T#+E24!N!>0J6
MW>.=)L35<-/-,FXVMPH\?MI>4E]3"5&]IX(U,@*NVI>R'Y:M8-A&8;H(C,(J
MB6WN[SSJT+]))PC/31!DC8:?=/W 10]51Y#*R"GX^JR=]7L?L\DD]R96RX\J
M.W8Q+%ADY,APO1UH[DW1E<=:E/H-*S).U8IJ=,\/2VLKJ<@38M(A0:EIJ9!0
M@]'[Z'#<KH\W4]=$HCONHTZ'KL/R"*U==PID$'&;BE^5(2IEC!Q2&R]VG>VE
M>,H92\:RUU-+IM'VR+PUZ@5H,9B9&KD3&L1BMN.8OBV07MP[WZR7%FQVIC,]
M+7I$EXSCK0;LPTL*CK4IYLTK4232L!/>0N,[O+;"\L:JQBQ'9U160H")+;CB
M4S:FT79(-[89:M+U2VK;YQ=3+R -!9<0YID*[6RN;*K8MK=ZV?<9B(D*C,E8
MX^W3,H2I>BE[%-]Q:S(MQ'T(@$SRO"[FVQC&:RJE1D6V.6%38D<HG"C/_)BT
M]Q!FC52=R=VT]#ZZ:EH KU7!&5,QH<2+;UZFTU[D"6IUMXC):+\KIE;9%J1D
M:=6G"5IH>AE[@%;;&>&K6BS1FS>.KD4,*VLKJ+-<5/=LU*LEO.H:)A;WHK*V
MER7$JD(2I3B"(MB34I0%<^6.*LSS^9;,PK:*JBLJYF'!BSGYS35=*;4ZIU\H
ML12&I2G24WHJ0K\ELZ$HC-)AG5?&V4U_);F6,3(%=4/3'YE@=:N8R[9L/1S;
M;CS(2EG$-QIQ6\YB"[JR0DMJ=5& 9IQIDU]F\;)Z&;!JG$'!25VPJ7%M6&(L
MA+K["T,*]'G,O((T)1*3HUO49;M>@1US@_*[%AO'+"VKHV*5\;)H%:]&:><G
M+9R8G"0MY#FULE1^YM-*5&3GCJGP J6QL2Y$NKK'K[,Y]0ARAL6Y;=?5-/FT
M;2:V;$=<)U[1?<==E)439EL;0C352C-0#<8-C>28G':IY3\*33&[;39#S9/)
ME'+L+-R6R225YG;2RZI+FOG;R+3H",_.\;E97CY4\-]N.^4^LF]QXE*1LKY[
M$M:=$]=5):-*?NF Q,:Q"?2TN25<B6PX]=6EO8QG>SW6FF[1Y;K:7&G#(E["
M5YZ==% *WI.%<KAL-1)<V!!IF)U3+105S\^17MJKW7URGXB):C5$4^AU+:([
M2NTWM(]3/J"U#:/&LPS]F-A*7$HJ,>Q*9CT6?+J9M:MAYV56DRU.*1HE4@V8
M:NXW%-;9&G?NVK00"Q<SX>NLAR*VR2+*A/&[:5=K7ULI4N.VXF#72:U]IY^*
MI+C9J3)4XTMO7:I)$I*DF9 -GQ]QA:XGD,2]FNUZ$HJ)<"3#KD2"04N;9JGJ
M6E<A;BUEM,DK6M6YQ9;S(M="#CGO&-KE%M<6L7Y,FQ["/2L)J[0I+:5?)4B<
MXZI,F*I+L9W26DV'V=5(4D]2-*@&QBX;G#'%4O$$90IK,WH\I$._,W)1Q5/N
MK<9;)Q\S><)E"DLD\X?<,BW^^ 8W&''EUAU[D]Y;+B)1D"*\FX<61.GN-+@)
M?2M3LN>I3KRE]U)[C).FFFGE,(90X#R)D5>[&7.AX_556191<8_*]&>5:HG2
M9-C'B+=;=T:-I!RER"6G7NIV)T(MQF&53<+94S8.6EE-@MR7U8ZM\DR;"S=<
M<H+1,]UQ<B<HUJ4\6XD$1)2@]/'J8%2<N/,B//'+Y<R$= G(VLGCHT=.9N.@
M<I76%$?Y,B(^VXA9'X;B,O !#+/@.^==.8P_564F9%LJZ<S8KGLQVVIMK+L&
M74IB.(-_1$Q;;S#NB7#(M%I+745)K#B:Q<QK(**,53.9LK>'918$]E]N-Z+#
M@0X7:)QA1.QG2]&WLO,ZFUYNA'H8#$JN(\K9CRU6UVS,FRL<N<?96\N3+<CG
M:3#D1FO2'S-UYJ,WHUO=/N+TU/W &E?P/-<2R3#OD%,2QL?E!Z2;[S;Z*]EF
M-BT.I4E]QM*U-FXY%4II6A^))T,]0%@<>X_E&&)@XG+]&G4C<*58S[AI"F5J
MN["P=DO---;C(F-'5FC\(M"U/J B,/#\UO\ *,MKE'$K\(=S&!=/O2&7RLGO
MDN-7223&/HTIIUZ,VCN[M4$3A$1GH:0T;GL^9&EIEGOTUD<VJB5%NJ>=@EE@
MX<A]7=9CQG6T2$K9D*2;+YI(EI(]QI4I(%;^1Q)FD[,8M]8V\65'KKJ19PI;
MSTUU],!]AYAF&B&9E$9)A+NAJ2E1O;?.-)J49AHT< Y0[5.PWIM="C0I%;85
M&.0Y%BJE.P@/O+>?2EU9NP4OM.]HF(BMC6A*+?IH8JR\%P67C.)V]/(16Q+&
MYDRY;J8#3TF*VN2VEE'=5,<4Y*62&T=Q;FS?X;4EH @5'PKED+T)N3-KX%/"
ML:N<B@KGY\BO0J <GTIZ(B6LSB*?2^A"([2NTV2/$SZ@5#*7&,QY 8AX0AQ+
M=1CF+/T,:?+J9M:MAWTZK4RU.*1HE4A3$%1+;BFMM)EOW;5H(!Z"Q_%I=1F.
M7Y(_(:=BY&Y7KBLH2HG&B@Q"CJ)9GT/<HMQ:>0$5Y X4OH>,Y'1JM(:I-UC,
MC'&7DMN$E#[\ZRE$XORF@DSD),BZZI5[I M2/E&OR5U6 >J[+3]K R%EY2I3
M;JXB645LYM9O*9)2FTJW;$N:'M6I.I'X (5:\(YU8UC]>NZ@O,W;-P_=P>[/
MB06+BZE*?.4RW'61RD--J[*&9*DI\WN=%*40%;U?$N1M8ADM-#L()V]J[0RX
M#CJ'2CI>H8M>T:7MFB]KJX1]4=4I4734@&0_Q'93ZHJJ;8,(:D9'<WTXV$J)
M11KJ).CFVV:BT[C9S"/<HM#V^'4"HW2<$7\2N*+,52QY<2/408LZ,4^2^^U6
M646:\MQ4IU1,)<1%228S*32E9[C69$1$*D-GQ=E$GD1S*JV;!JX$B4E^?,A*
MEL2YT),53)P9L1*CB/ZK-.DM1=U"$DE):D2@&-(X;O'ZS&8";2(E5%CU90O*
M[;FU;U?8UTQ;B"UZ(4B$I"2/KJ:?(!71@>(9G;R:B9>^BU^*8]DF0WM9$[+[
M=L\]*F6##"']^C:6R3+==WHU[I=OH1;C4$IRKCRROY.>2(TQADLMQAK'(?<2
MLS9?:*P(W'-/%!^F)Z)Z^:8"&W_#.:7=B9/VL.36,6-185CLB38$<.+5G%6J
M&S!;447SEQUJ])62EF2]#3J23(5)ZWC*U@VV'SUSHRV<<N<DMY+:4+)3K=^N
M8II*/(2V_2BWF?CUT\0$":]GO):Z)7N1Y-3:V**J12SFIZ[&)%22K&9.8?1Z
M&XE;I$4Q:'F'="7H6BT]=15GY5@=E8<9Q,)QR5"A6=8FH^3Y#T=28"54TF,^
MDCCMK,TMJ)C:2$K\W7QZ *VSW#,BKJ3),ML=LCE#);6G<Q.+1QWYD6'94Z#1
M!W+6V7FJ(WCDO/)0V3:C3Y"W!::,(ETW&)X%A]E\CV,>K57UUQVR<4W*-LR.
M0I)^*E.&;BC\=3,_$$5B?!N7O+O+),VMA6=A"J&X;+DFSMT^G45HBS0N3)FK
M[SB'E([:]NW8GP)1]3+6\5QEGDRW3E-A.J2O%916Y&Y"9*3Z(F)#K%5;L=+A
MD2S<V+-U#AHT-?0TDD!C*X*L)6)XIB,VV83$IF,BB6<AEI1..-7\67&0IDE'
MH2V_224K?T/0P*Z+WB'D#,HC!9/9TS,NJK(]/5%!9D&R\7RC F2I$C?M-!K1
M ;2TPC<E"E&9K5TT#;9MQIG-M991,Q>VA18V5.U+5DP^J3'>56UK+R9$=+\<
MC4VJ0:TH-Q!;DM[MNBM#(-);\.9?93*S($Q<>:MH5.O'/D1A^SAU+$-AXW8;
MC"XO:>/M[C2XPHMBDZ;5(,M3!9\)9?'H[O$\9L:=JBR:+4MV2WXSS*HDBJCL
M17/1&$&XGM/-QT;$+<_)*UZK\@J8<R0+^=&PP\;CI?M(F45\I)O-..QFT-M2
M-RG^V1J0WH>WN$7FF9&!B'3N#LFEV368R)-;.RN3.LY=K5K>GP:XFK-N(VA$
M>3$-+Y+9*"SJM;9D[JO5*?-VBMYCG#]C0IFDR_4-%+Q1&.)CLUZE043#ES9;
MBU1775=R.HY>BFUN;EZ*W'YP%:2KX7S2%#8>:L*^N?I9U9;8[CK4FPL:9J;!
M3(;DJW334\PW);DFA+3/FL[4J+>>H%2.CXSR=O+X.;W\^ JT<N)US:0X2'NP
MVAZI;J(K,=;FAJ4AMI*W75I3N,S(DD1$ WW'V*Y)AE=#H9,B#*J4.7$R8^V3
MR9)RK"S<F1R;(_-V):>6EW=UWD6G34$3D  4_P"U-_8#FW\U8_I; +C\H@;
M$HXT_M'P_P#TW6_TML$?LJ#            "A?; Q^^R;AF55XY5R[>R580G
M$PX##DE\T(6HU*V-$I6A>4] 7'YY_4SR]] LA^:9OZ(&J?4SR]] LA^:9OZ(
M"K)]G_BSDVFYFPRTM\-NX%;%L$.29DJME,L-(V*+<M:VR2DNOB9@:_3T&
M
M
M
M     %5^TE4VMYPAE]3207[*TDQF4QH4-I;[[AE*949(;01J5H1&?0O %Q^9
MOU,\O?0+(?FF;^B!JGU,\O?0+(?FF;^B J2<?<1<K0L]Q:9,P>_CQ(]Q7O/O
MNU<M#;;;<IM2E*4ILB(B(M3,P'ZQ P
M
M
M
M
M
M
M
M
M
M
M
M
M
H                                                  __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>px_24outlookproxy1pg02-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_24outlookproxy1pg02-bw.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !&
M  #_X0,Q:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 W+C(M8S P," W.2YD964S83<W,#,L(#(P,C(O,#@O
M,3@M,38Z-3 Z,S @(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T
M<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;7 Z
M0W)E871O<E1O;VP](D%D;V)E(%!H;W1O<VAO<" R,RXU("A-86-I;G1O<V@I
M(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.C8R.3)%149$,C(Q0S$Q148Y
M1C P1#@Q1#)#1C,Q13<W(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.C8R
M.3)%149%,C(Q0S$Q148Y1C P1#@Q1#)#1C,Q13<W(CX@/'AM<$U-.D1E<FEV
M961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z-C(Y,D5%1D(R,C%#
M,3%%1CE&,#!$.#%$,D-&,S%%-S<B('-T4F5F.F1O8W5M96YT240](GAM<"YD
M:60Z-C(Y,D5%1D,R,C%#,3%%1CE&,#!$.#%$,D-&,S%%-S<B+SX@/"]R9&8Z
M1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME
M="!E;F0](G(B/S[_[@ .061O8F4 9,     !_]L A  $ P,# P,$ P,$!@0#
M! 8'!00$!0<(!@8'!@8("@@)"0D)" H*# P,# P*# P-#0P,$1$1$1$4%!04
M%!04%!04 00%!0@'" \*"@\4#@X.%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 9R!/L# 1$  A$! Q$!
M_\0 M  !  (# 0$! 0            8'! 4( P(!"0$! 0$!
M      $" Q    8! P,# @,$! 4,"P(?  $" P0%!A$2!R$3"#$B%$%183(5
M<4(C%H%2,Q=B)+0W&)&A<M)SLS1TE'56.+'!T8*R0],EM78)DE-C@X0U5975
M-E<9DT14U"8H9(6EQ6:&ICGPPL.D)T=($0$! 0$! 0               1%!
M,2'_V@ , P$  A$#$0 _ ._@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M   ?#SS4=IQ]]Q+3#236ZZLR2A*$EJ:E&?0B(O4P&I:R_$WW4,LWU<X\XHD-
MMHEL*4I2CT(B(EZF9F W(                       /&5+BP8ZY<Y]N-%:
M+5Q]Y:6VTD9Z>Y2C(BZF U/\Z8=_TAK/^6Q_]N ?SIAW_2&L_P"6Q_\ ;@/M
MK+\3><0RS?5SCSBB0VVB6PI2E*/0B(B7J9F8#<@
M
M
M                                       *0\O776O'G+U-+4VH_P!.
M09I,TF:5V49*BZ?0R/0P6(+Y!\$<0XGPOE.2XYB<2NO(,>.Y#F,J>WM+7*90
M9IW.&7HHR E=-TJE+IJY2S-2U1F34I1ZF9FVG4S,P1G
M     "GO*A*5< 9L2B(R^+'/0^O4IC!D"Q_*,&P!*.-2(^1L0(^I'=UNI?\
MQ6V"/[*@P
M
M
M         I?RQK;"VX!RZ'5Q79DO;!=)AA!N.&VQ81W7%$E)&9DE"5*/\"!8
MJ[FWR$X^Y$XHR#",5;MY>0V[,>/7QCJY2.XZF2TO;J:/4R28+(ZLJ&G&:F R
M\DT.MQV4.(/U2I*"(R/]A@RS0                     !3_E-_F!S;_BK'
M^5L L?RB!L 2CC3_ #CX?_SW6_Y6V"/[*@P
M
M
M
M #0YGB%)GN,6&(Y$VX[2VB$-RVV7%,K-+;B72T6GJ7N00"F/]"K@7_Y%SO\
MY8/_ /=!=/\ 0JX%_P#D7._^6#__ '0-9E3X>\(4MK!N8%;-1.KI#4N,I4Y]
M22=CK)Q!F1GU+5)= -7R"
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          #5
M7.3XWCB$N9#<0:E"^J%3Y+,4E$7V-U2=0'[3Y)CN1-J=Q^WA6S2-#6N!):E)
M+7TU-I2B(!G2YD2!'7+G2&XL1K0W'WUI;;3J9$6JE&1%J9Z ,6OOJ.V<6U56
M<2<ZV6YQ$5]MY24ZZ:F2%&9%J _;"\I:A3:;:RBP%.D9M%*?;9-1)]33O46N
MFH#X7D- W!;LW+6&BM=4;;4Q4AHF%K+75*7#5M,_:?0C^@#%_G3#O^D-9_RV
M/_MP#^=,._Z0UG_+8_\ MP&5,R&@KB9.PM8<0I".XP;\AIKN(/\ >3N46I?B
M0#+AS8=A'1,@2&I41S7MOL+2ZVK:9I/123,CT,M 'N UUO?T./L)DWUI$JXR
MC,DO3I#49!F7KHIU22 >-+E>+9)N_EZ[@6^PMR_@2F96TON?:6K3U ;<!K[:
M]I*!@I5[91:R*9F1/S7VXS9F7K[G%)(!C4V78ID:C1CU[76RTEJI,"6Q*,B+
MZF32U -L\\S&9<D2'$LQVDFMUUQ1(0A"2U-2E'H1$1>IF U\'(\>LWRBUMO"
MF2C(U$S'DM.N;2]3VH49Z$ ];&YIZ@FSMK"- )[7M'*>;8W[=-=N\RUTU+70
M!\5]_16[JV:JSB3GFDDMQN*^V\I*3/0C,D*,R(S ;$!I5YAB3:U-N7]<AQ!F
ME:%3&"42BZ&1D:^AD ^?YTP[_I#6?\MC_P"W 9<3(*&P;?>@6D.4U%3W)3C$
MAIQ+2-#/<LTJ,DEH1]3^P#XA9)CME(*)76\*9*41FEB/):=<,D]3,DH49] &
M186U54MH=M9T>"TX>UM<IU#*5*TUT(UF6I@/R'<5%A&=F0)\:5#9,R>D,/-N
MMH-);CW*29D6A'J>H# _G3#O^D-9_P MC_[< _G3#O\ I#6?\MC_ .W 9TRZ
MIZYAJ586$:)%?T[#[[S;3;FI;BVJ4HB/IUZ ,'^=,._Z0UG_ "V/_MP&R@V5
M=9M&_6RV9C!'H;L=Q#R-?MJ@S(!E -,[EV*,.K8>O:YM]M1H<:7+82M*TGH:
M3(UZD9'] &Y :J7E&-0)"XDZY@Q9;6A.,/RF6W$ZD1EJE2B,M2/4!\,Y;BLE
MU#$>]KW7W#VH;;EL*6HS^A$2S,P&T??8BLN293J&8[236Z\XHD(0A):FI2CT
M(B(OJ8#3_P Z8=_TAK/^6Q_]N ?SIAW_ $AK/^6Q_P#;@,ZPNZ:I)H[2QBP2
M?U-DY+[;._;IKMWJ+734O0!ZP;"!9L%*K93,R*9FDGH[B76]Q>I;D&9:D PI
M.4XS"D+B3+J!'E-'M<8>E,MN)/UT-*E$9 /N=D6/U;Q1K.VAPI!I)9,R9#3*
M]I^A[5J(]#T]0&-_.F'?](:S_EL?_;@/:+E.,3I#<2%=0),IT]K3#,IEQQ1^
MNB4I49F 2LIQB#(<B3;J!&E-'M=8>E,MN)/UT4E2B,@&U(R,B,CU(^I&0#27
M&:8=CKQ1L@R&LJI!Z&34Z9'C+/=Z>UU:3Z@-A6VM7<Q2FT\Z/80U'HF1$=0^
MT9EUT)39F7U 93CC;+:W75DVTV1J6M1DE*4I+4S,SZ$1$ C2>2>.E2?A)RZE
M.9KI\<K*(;NOVV]S4!)DJ2M)+09*0HB-*B/4C(_0R,!^@ #%GV5=5,E)M)C$
M*.:B03TEQ#*#69&9)W+,BU,B/H ^*^WJ;=*UU4^/.0T9$XJ*\AXDF?4B,T&>
MFH#&CY1C,N2F%%N8+\Q:MB([4IE;JE%]"2E1F9@-A*EQ8,=<N<^W&BM%JX^\
MM+;:2,]/<I1D1=3 8U?>4MNIQ-3919ZFB(W2BOMO&DE>AJV*/370!D3)L.NC
MKF6$AJ)$:+5Q]]:6FTEZ=5*,B(!I:W/<&N910*?)ZFPG&>THT2?&?=-7V)#;
MAGK_ $ )"
M
M                  K+G_DUWB;B^WRR$E*[G^'"IT.%JCYDH]J5*+ZDVDE.
M;?WMNGU!8_G]Q%P_G'DWE%U:6=^IIN%VW;B^GDN8\IV2:NVVVC<C<>B%'IN2
ME)%^P@:\>?+'%&=^,685$ZMOEJ*8E<BEOZ_?$<4J.I).M.-FI6AIW(-2=RD*
M2HO7J1#UU)GG(RN6?"RYR^:VA%H]'BQ[5I!:(*;$LX[:U)+KH2S23J2_=)1%
M] 9ZJO\ ]G^1?S[E:M/<50V1']=#DHU_[ +6T_\ :#D7ZW@A_7XMCU_^&, 1
MM,&X>MN:_$?"L7IK"-6RH=U-LEOS$K4@T-R)S)I+MD9[C-TC_80'7.7-_!5U
MP=/IX%U:Q;1RX9>?:5#2XDFR86E)DKN$7KNZ: LJ:<6>(>5\JX/79S59#708
M=BJ0A$22A\W4'&?6P>XT),NIHU+3Z :D?FY4KH9O&U*\I#C];CR83CK1&E"E
M1E(;,TD?4DZD9D0)'4'B$1%X]8AIT_\ CC_Z2D@E3SEO/6N,>.L@S=QM+[M7
M&UB,+UV.2WEI980K0R/:;BT[M.NW4$?S>X]P7D/RGY#GKM;Q2I+;1S+>[G$I
MY$=E2]J&V64FDNIGHAI)H222/TT!OQF\S\$YGXWVM+D%;?JEPI;BBKKV 3D"
M2Q+9(E&A:26LTF:3U2:7#W:'Z: 2ZZ[XR\BW;;QQM.4<A0B3D.*M/P;-!:-H
ME3V4M_'49)_*3W>:WFDM"4:M"T+0&<<:X3BG(WE7R7+19W1KF]I<ZRM)FY;$
M2*2TI)#+*3(B+<LDH:1M+U/Z&8->-GS;X]9;X[OT^35]^=A6RGS9AW,-#E?*
MC3$(-Q*5)2XLTFI)*-"D.'^4]=.FHEUT]@'+-ARWXIYU-R!9/9-2TMQ5VK^A
M)^0:("W&GS270C6A9$K[K2H]"+H#/7*/B[FF/<><F/9AD\E,>LK*BP=VZEW7
MG3;(D,LD9EN=<,]J2U+\3(@:KPNK;DCRLY90U$:)<^89MUL W#*'6US:M3-2
MC+\J"/<XO;N6KT+4TI \?T5X<X:Q3AG&44E T3]H^25W%VX@DR9CQ%ZJ/J:6
MTZGVVR/1)?=1J49FU8P(_GSR!X49C71\IS9S):M4*(BPN514-R"<-IHG)!H+
MVZ$>TM/L#6J!XDXRL>7,SCX753F*^9(8?D)DRB6ILBCHWF6B",]3!79W'WCO
M>\'\:\NNWMM"M6[W')3;2(B'2V?%B2S5O[J2U)7=+T!G7,_B9DF.XGS/77>4
M64:IJF8<U"ILQQ+325N,FE);E=",]="!JKI\V.1\ S?#<:BXCDE?=3(MFXZ^
MS!?0^XAI4=2=RB29Z%KH0)&R\0TI5XX\EDHB,CD6A&1]=2_260*Y&XMPNLY!
MS6!BMQ?L8S F(?4Y<RR0IEHV&5NI(R<=93[S22"]Y>H*Z%+P^XZ49)3SC2&H
MST(B:B&9F?H7_P <034X\WZA-#Q+Q[1DX3_Z7*;@D_M)&\H\$V]VW4]NNW73
M4"*<X!\9ZCF?#+7*K+*E8^JNGN0.W\=M]O:AAI[N*4MYO3J[II^'J"VH1Q?=
MW_&7-]9"Q.V*<;%ZW3NO05J.)9Q52_C*(DD9DMMU)[D:ZZ:DHNI$8#^F_*^<
M,<<<=9%F;QI[E7#6N&A?Y5S'=&HZ#_!3JT$?X P_D<Y17UA0S<Y>;4]5(L&X
M$R<M6JCG2VW9!$>O4]R6UF9_]T'1_4KQKY _O&X>QZXD.]VV@-?I-LHSU5\J
M"1-[E'_6<;[;I_[,&*X!\L/^L'FO^[0_\@C U$@YP\98W$F!TN<1,G*R39NL
M1W:V3'*,\2I#*GMS1I<7O).W11;2T]0)5J\)9OD&5>*/*E/?2G9R<>KI\>ND
MR%&XXF,_!4LF=RM3,FU$K;KZ$HD^A$0)?7,'$/']1R5EW\MW631L3A?%>E?J
MLU*%-;VC21-Z./,%JK=_7^@*OUKPYX^D.ML,<WTSK[JDMM-(9BJ6I:CT2E)%
M8ZF9F>A$0)J0?^T"8*/'XW8UW&TBU;)6FFNTH)?]H"+8\(R(N"HAD6AG9SS/
M\3WI($KBGR7(O[_<U+0M#L$:E^UEK4&HZU\@/%7)^9,Z9R^HO8%;$371H)QY
M2'E.;V%.*-6K:3+0]Y S*X4S3#9>%YO:X/+DM2IE5,. [*:)1-+6DR+<1*+7
M3J#;LKB;PQR_CWD;'LTGY'63(=/)^0]&9;?)Q9=M2-$[DD6NJOJ#.N:?)PB+
MGG.-"T_Q])_ZK#8+';/E1R];\5\6UD;&7CBY+DAE"B34]%QHS31*?=;^RRW(
M0D_W=VXNI$#,<H<'>,N3<]5]EF%AD!5%4B2N,4^0TN?*ERR2EQP]INM^TMZ=
M5J7U/IIT,&K4LX[X=\D^%N65)PVH?MJJ%(;3/D-/(BU-G 7HHR-4A2$[MAZ>
MBE-K]-=.I-23SWS3*(UUCV#QGWHN*R(!V,E#2C0B7)4^MK8X9?F)I*$F2?35
M>OVT$515<2<,9?QS!E8AR$AGEI33*Y=!?.,UL)<A1I)YAIQY""(TD:C;7W5[
M]--$Z^TKKGQ3P3E[CFCL<=Y >CR,84EF3CG9F)F*84O=W6T&G4B:41H4DB5M
M(]3+\Q@S71 ( .8//!*3X8KS,B,TY!#-)G]#^+++4OZ#!8BG_L^B+^6\V5I[
MCG0B,_KH3+NG_9!:XCE3IE/E#]E5O+ASX$]<B%(9/8MEYEXUMK09>AI,B,@:
M=W9-S% YH\0\NN5FVWDM?%BQ,B@IT+MRTRF#2ZE/J3;I%O1]CU3J9I,&>H1_
M[/DTINL[6K0B3$K]5']"[DC4"J>Y+Y S?R3Y8:H:N2MRKFV'Z?BM0IQ2(C#)
MKV)>6DM2W*27<=<T,_4B]I$0+XG7(?A%GF&8\Q?XI;?S99-.-)EU<*(N/)0;
MBB3O8_B.&X25&6[H@R3[OH>A-=8^-*>7HF %3\OU[L:TKG2;JILJ0U(E2(2D
MZI)_MK6HEMF1IW+/<I.FI:D9F2KE!
M
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MI!&E"4GZD1$?]! P_DUSQ_U@,Q_Y]<_\-(-Q_6<&'\F_)S_/UG'_ !Y/^\-
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M
M
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M"*<X'\2[SA_D&/FD[)8EG':BR(RHC,=QI9G(222,E*69=-/L"VNJ09
M
M
M
M           $6Q/C?!L&F6MAB='&JY]T^N59R64GW'7'%FLRW*,S2@E&9I;1
MHA/T(@$I
M
M
M
M
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M$E9$YO4DFSV_E]0$IXSS9/(^"4F;H@G6IN6#D%!4X3YM:.*1IW"2C=^77\I
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M@\FJ+BW-:/ HE7^O7]FXR5BA$DHR(+4IQ*&C6?;=W+41FO9[=$Z'K[B!9%[
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M<CQ_S#H+C$J4\AR*)6QU0:9*C0<A1QY25%N3U+:@U+_H GC69URERAY(V+7
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MHA:B.>WH9E_@%^P%^.H^+K?D"[Q%B?R;2QZ#*U//)>KHBB6TEE*]&U$9.O\
M52?7W@RYJ\FC,O)KA70]-)=<9?\ RV2#4=39_P#_ #B91_S1/_R9P&7+'B/_
M -67D+_C=Q_Z)C@U7/G']3DG&^&8WY(X>IU_]'NI%5D<%1Z-''437;U-)'HV
M\EU3*S5^5>PT]3Z%= 8/DU1FGF<WEM"^4BGN<::EQ%ZEN)*X+1&A9$9[5H41
MH6GZ*+0$X\,<;9R/SQOE9&DGG*:.XNF9>+5*%QX;"6C0E734D.+=2?\ 6]Q=
M>H'%A^0'-U)C4NSP'+>-;'+,6*/'ESIR=4P#(S)U.JNV9)[:DE[MY=0218O
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MW-KY#4N&Z1FU(86EUI9$9D>U23,CZEIT!A[@
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M6MGXX<0W..\)VO'7*%.F.=M-FE*KU/,R"7$E,M-DK>PM:2/5*MNBMR3+7IT
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M\.H\ QBOQ#&VELTE8E:(C;JU.K(G7%.JU6KJ>JEF8,M\
M
M
M
M   #391BF/9K3N4&4P$6=,\XT\[#>-1-K7'<2ZC<2#3J1*21FD^A^AD9 -LT
MTTPTAAA"6V6TDAMM!$E*4I+0B(BZ$1%Z$ ^P
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M:5E;L_49K$/NZ]OY#J&MVW37;O,M=-0'BQD%#*>1'BVD-^0X>B&FY#2UJ/\
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M/'KU+1"UDK_6 ;&1*BQ&%2I3[;$5!$:WW5I0V1&>A&:E&1%U,!K_ .:,9_\
MDS!_Y4S_ +8!E0K:JLE+173H\M;9$;B8[J'321^AF2#/34!C6>3XU2/(CW-S
M!KGW-#0U+DLQUJ(_30G%),P&QCR(\ME$F*ZA^.Z1*:>:42T*2?H:5)U(R 84
MC(*&(\N-*M(C$AL]'&79#2%I,RUZI4HC+H ]85M56*E)KYT>6I!:K3'=0Z:2
M_'89Z ,A]]B*RN1)=0S':(U..N*)"$I+U,U'H1$ UU9E&-7;RX]-<P;&0WJ:
MVH<IF0M)%ZZI;4HR ;4
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ME@
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M]3(LUW)Q6[D3_&N)/9;W#R5RIAJLS?U[YOFRDU&[KU[A_OZ_O:@REX
M
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M0&K&.HG&'GB<E=M9>BD)D+<2E1?0R+4OH"ZLT$
M
M
M
M
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MB,M?0RT,NAD#*5@
M                                        #CCSN_X7Q;_SA._\*$#4
M=2Y__P#.)E'_ #1/_P F<!EPEXRXWY'W&!SY/$.755#C2+5YN3#L6T..JFE'
MCFMPMT*2>TT&V7YR]#Z U6]XA@YU6^9LF%R39Q[C,VH#OZE80B)+#FZL:4UM
M)+3!%M:-"3_AEU+^D#B3\$OL1?+;F23)<2S&98LW'G7#)*$(18QS4I1GT(B(
MM3,"^->7 >3L75SG'BCR5$53R)2TS*MB9_!:?+^+\<G&B>9>2@G"-!/)+:D_
M4_4QJ7\'<U\D%RL_PUS541F\R<96[$N&&F6GW%,L=[:Z;'\)Q"V4FI"V]---
MID>OM)8ZL!'\ZN&<CYHQ[D+E)?#^*P\F>D6:BMOG+)!1R1*E]@TZR8^NXS<U
M+4_R_0&JN+BOAGF')^:6^<.;&XM3,KFS36T\1QIPS7V5,-I(F5NI0TVE:E^Y
MTUFO37IJ!JK*TN6/]*GD\^'3@?S,GYQR4V>SM*A?)C;B1OZ;]_;T_#4#AC!9
M9Y*<KPL+YTR-JFL,2?<4WB"891W9BFSWR4-K3[-QI;3N,U*/M^Y!:;C \3'E
M\VVO-KCQ5YHFM[-:4 W?[/?W9),[=>FOR/3_  @..S9ZH:(,E=B:"KTM.'+-
M[3MDR23W[]>FW;KJ#+C[P"[AUW(*F"65,<Z#\(EZZ;MDC=_3L[>O] -5S[Y+
MR\6O>9<JM,"AR5T,0V499,AZG%=FD\3;[R5)2:4(6X:$;EZDMXC66NX@6/Z-
M<4V&&VG'.-R^/TI;Q X+3=8RG3<TAHMBFW-#/^*A9*2[J9GOUU,_4&'&GEYA
M$WCGD%C+L%L%52.38TRIO8;)]M+CBS9*5NT+3MR"<;4LO7>2E?O=#4=C<2\:
MU'$^"5F&5.CAQ4=VPF$G:J5.=(C>>5]?<9:)(_RH)*?H#+&YQ^;_ '-YY^G[
MOE?H5CM[?YMOQU[]/^]U!8JWP=5 /@Y!0]OR$VTXI^W37OZ-F6[3Z]KM_P!
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MKA7_ (W7?^ED@L7MY(_#_N*SKYVWL_ICFW?IIWMZ>SZ_7N;=/Q!(B?AB4HN
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M*?\ .!S#_P =C?Y5. KQ\Q]I\O\ $)5W_P ?/DIV]O3O:?/C]C3Z_GW[?QU
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M@&0
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M\^\XHUN/.&1$1J6HS,].A>A:$1$#*4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MAM]R.YJ:='$H,S3U29?M(_L UJN5>,TWW\KJR^G+(=_9_3CG,=_O:Z=O;O\
MSZ_N?F_ !%O)+-<DX]X@N\KQ*44*]ANPD1Y"FFWR23\MII?L=2I)ZI49=2!8
ME5?R9@,NX:Q0LIJG,LT2AVI1,8.3WM"W()LEZFLOZA=?P!&]EW]%7VD&DG6<
M6+<6G<.MKWGFVY$GLEN<[+:C)2]A=5;2/3Z@/VVO:6@99D7EC&K6)+[<2.Y,
M>;82[)>U[;2#<,MRU:'M274P&P 1_*,[PO"6FGLNOX%(A\]&"GR6V%.:>NQ*
MU$:M/KH0#94]U3Y#7LVU#/CV=7(+5B;#=1(867^"MLS(_P#5 1ZRY6XSI[K^
M7+7+Z>'>DHFU0'YS#;R7#/0D+2I9;5&?HE6A@)'9VU72U[UM<36*^JC))<B;
M*=0RPV@S(B4MQ9DDBU,NIF C\KE#CB#>MXS,RRI8R!W:2*YR:PE_<X1&A)I-
M>I*41D:4GU/7H D=A80*F$_96DIF#71DFY)ER7$LLMH+U4M:S)*2_$S :#&>
M2>/\SDNP\3R>LN9C!&IV-"EM/.I273=L2HU;?\+30!7V7<\4^,\T4/'4JXIH
M-"Y"E2LAGS)3:'H\I*#./&4:G$H:4O5*]%^Y1&6FGU+B8S)=\GEBOA-956L8
MXJG<<>PY9-?JK\GO+(IB#,NYV4D24=#VZD?]!$-QKGBHON;,FX[<N*=JCJV(
M3%&ZB4VJ1864@MS[:%&O:I32OX1M-D:B,NOV(N+;B7E+86,^H@6,:5;51M%9
MP67D.2(IOI-;7>;29J1O21FG<1:EZ CX;R&A=L9U.U:1%VU8VAZR@I?;.1&:
M=3O0MYLE;D)4GJ1J(M2 55Q-SG6<BYIFF.NVU1VZRS.%BL2');<D3H3#:E.2
M4'O,WB5INU;3M27W]07%@Y/R)@>%/,1\NR2MI9,DMT=B=*:8=6C73<2%J)6W
M7INTT!&]@6$"UA,6-7*9G5\E).1I<9Q+S+B#]%(6@S2HC^Y& B\SEGB^ONU8
MY.S&FC7J5]E<!V?'0ZAW73MJ(U^U>O[I]0$Q 8\Z?!JX;UA926H<".DW)$J0
MXEEEM!>JEK69)27XF8",8_RKQIE=E^CXUEM3:VNBC3"B3&77ED@M5&A"5:J(
MB]33J WMAD5!42F(-K:1(,V4V^_&CR7VV7'&8B.X^M"5J(S2VGW+471)=3 :
MO&>1<"S21(B8EDM;=2XI;I#$"4U(<0C73>:4*,]NIZ;O0!FY)EN+X= *SRNX
MATT U;$2)[[<="E_U4[S+<K\"Z@*M8Y2G7?/V.XQC5W%LN/+7%I%L?P^Q(:=
MFM2W&MZ9""4KVI2DC02M"^I:@JZP1%\HY'P#"GFX^6Y-6TTIY.]J/-E-,O*1
MZ;B;4K<:?QTT ;BEO:7(Z]JVQ^QC6M6_KV9L)Y$AA6GKHMLU%J7UZ@(]8\L\
M7U$:'-LLQIHT2P4XF"^Y/CDAXV5FVYL5OT,D++:L_1)]# 2<[.M*M.X.8Q^D
M$R<HY_<1\?XY)WF[W-=NS;[MVNFG4!&9O+'&%=*@P9^8TT>59M-R(#;D^.DW
MF7RU:<2>_0TK_<5Z*^@"8$9&1&1ZD?4C(!$(7*W&5E>%C5?E]/)OS7VD5[,Y
MA;RG==.VE)+]RR_JIZ@,;E*5?Q*2M<QW*JW$9:K6(A^?<$T;,B.HU;XK?>(R
M[KO3;IUZ'IIZ@J36&14%1*8@VMI$@S93;[\:/)?;9<<9B([CZT)6HC-+:?<M
M1=$EU,$:O&>1<"S21(B8EDM;=2XI;I#$"4U(<0C73>:4*,]NIZ;O0!7F3\[U
M&/\ -U-QQ)N*>%CRJZ1*O)TJ4VAYJ?J:6(JC4XE+2C+1>U6JE$HM-/J7%EY1
MFV'X5&:EY=>P:2.^9ICJGR&X_=4GJ9-DLR-1E]=NH(RZ#(\?RJN1;XS:1+BK
M6HT)F0'VY+.]/JG<V:B)1:]2]2 ;,!SI79CRSSS;W3G&-]&P?C*EF.5C&2*A
MMV=C:R&-.XMEMXR;0R6I;5=%=2ZF>Y*"LVKO>:.+<\Q_%<\GGR%A.4NG#B9+
M$KOB3ZZ87Y2E-1B4@V3U+5:C]-5:EMVF%_ @ YYY(R7E>TY[K.+,#R]K%:V3
MC?ZTZ\[61K(S?;E/M*+1XB5[DI3^_H6GIU!6)FD3R9XTQFQSHN1*O+8E$RJ=
M/I)E)'KTNQ6/>[M=CJW;B21GIN3^!Z@?%R4'(F.VN TO(5I+8HZ6XAQ9AN6#
M[;#;*Y:4F32G'#2G4E*V%]S] 1O[BZI\>KGK>^L(U751]O?G3741X[?<42$[
MG'#2DM5*)):GZGH ^;2]I*.L7=W-E%KZ=I)+<L);S;$=*5>AFXLR3U^G4!K,
M7S_!\V)[^4,BK[M4?K(;@26GW&R,]"-:$*-22/Z&9 &49_@^$DS_ #?D5?2*
MD]8[<^2TPXX1'H9H0M1*41?4R+0@&UJ+JGR"O9MJ&PCV=7(+5B;"=1(861?U
M5MFI)_ZH#0WO*''&+VJ*/(\LJ:JX7M/X4R:PR\DE]4FM*UD:2/Z&K34![9]=
M2ZCCS)\BI'T)G0*6?85THB2\V3K$5QUI9$>J5%J1']C 4QF/*F=5/BW0\DU]
MDAK,IL:G=DV!QV%I4N8\TAT^T:.V6XE'Z)Z?30%ZZ-!%49MA_.=OD<F?A/)$
M3'<<<0T4:I>IHTY;:DH(G#-YWW*W*U5^'H"JCXCE^2W+>'_S;$Y2AU39RY,+
MXBZ&$\9'%7LW;R0G\WKIH"NC9^;8IBT-YO*LEKHDVJC1WK=<A]F.I"7C)I#J
MVS5JA+KG1'3J?0@9;$LGQLZ LJ_5X18RIHI)7)R&BA=@^A+[QJV;?QW ,#%^
M0,&S8WT8CD5==N1NLAJ!):?<;(ST)2D(4:B29^AF6A@,RSRS%Z60_#N+J#7R
MXT15G(8E266'&X*%]LY"TK41DT2_::S]NO34!CXOG6&9LV^[B%_ NT1C),GX
M$AN0ILS]-Z4&9IUTZ:EU ,GSG#,*::>RZ_@4C;^I,?/DM1U.:>NQ*U$:M/\
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M-B64*-8P'DR(,MI$B,^@]4.-.I):%)/[&1D9 CW
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M:IO.IJS+5MV;8I)-8A7KHMM)]]/X&8#H<$<X<2X]29]RWR[F&90&+BYJ+O\
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MF:NI'IZ G7[S$_(R;&N#<*N)+BJ',K.J3DJC6I*I;;,=IWL.*(R,R=6K4_\
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M4JGFPY1;)*(AZKBFM/TVI)3)%]FP2N@00
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MM)I0P1*<09:D9>\U&?3Z@:R\MXQ_FCDG!>0OU3XO\E_J'_F_L=SY7ZBR3/\
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MTE/<;T-9I21JU]-2T/4")?5UL.FK(=17-$Q7U[#42(RGT0RP@FT)+]B2(@1
M(/$ZJCF:RY9J+?XT:]KFX%]0G'W(D/L$1-24O$X6U220A.G;/][K[@5O<2QC
M)J&[R>QO,I?OZZYF%)IZU]A+**M@C<,V&U)4HUD9+26ID7Y2Z>H(EH
M                  #4Y1D5?B..6N4VI.'64T1Z?+)A)+=-F.@W%;$F9$9Z
M%T+4!YXME-7EV+UF7UAK;J+6*W.CG)(FG$LNIW$:RU,B,B]>H"-X%R[B_)=I
M<0L/8G3:JE<.._D1L$BI??2>AMQGC7JZHO4]J--NAZZ*3J7$^!
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M*(ED9:Z&9?L ;EMMMEM#+*$MM-I)#;:")*4I26A$1%T(B(!]
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MT,!B-9[3N\@/<;I8EE>L5A7*Y!LZ0CCFZEG:3N[JYN5^7;Z?4!*
M     !$\!Y#H.1X%I8X\F0B/46<FEE%+;)I1RH9(-PT$2E:H]Y:'_K )8
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M6N0\K\'9'BSN<96C.^/LGLFJ.;+>KV*V=6S99'V7$_&/:MHS2HU;O0BT+KH
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MY/:<IP,-RQC"\=CYK;NO635>U9V$J:M9)-K;(43;;+:$MKU(MRC5IKH"U<O
MF=Y=E,/*\:SQV/,RK";E^DEVD1LF6YC;9:MO&VG1*5*]VI)(BTTZ$>H)5O@B
MG\.SZ_B<K\E8-FL]#M=3LQ<AQMXVFV=E/(;5WTF:$I-265[4;E:GKKU!4.X
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M:/C]GV39]A<Y[,DL'D^/W$['[.3$3L9D/0#1_%2@NB=261'ITU+4B+70A5K
M@ IO.D\R7F8S:VIR"+QSQO61V5(R=QF'82[*6\G<MM")"]K"&_RF:DDHS+4M
MQ*]I6BX4Y%RR9R7E/%N1997Y["IX+-G6Y3 ;CL.:+<2VY'?1%-36])K+TZEI
MU/KHD5J,<O><N4<TY&Q6HS"-BV.8K?/Q8]PW6L3;!;:M4LQ&T+VMDALD&M;J
M]7%&HB(]-= F'!^=YE8/9UA_),V/8W6 ST17;^.TF,B7$>:4ZAQQI'M2LDH,
MU;2(NI%ZD9F*B^$6O.7-54]R=CF81L-QM^3(3BF-+JV)[<F-$=4UOGO.&3I=
MU2%(5VC]OYD_0!E>'R[!S!,M<MF$1;9686ZI\5LS-#4DT1S<0G4S/1*M2+J!
M70P(IC-D\RWV96-?79%&XUXWJV&#CY$MF%83+62\@U.$A,AS:PVT?M/<DE&9
M:EJ2O:5I^$.1LJL>0\MXPR/*:_.XM%%CV%;E=>VPPI:'E$AQAY$4U-;T&HB]
MO4M#U,]>@J3\+YKDF76_)D7():93&.Y9.IZA*6FVNS"C[>VV9MI(U&6OYE:F
M?W K7<=9;FV:Y%S%C;]TF*NBM#K,8F%$8<. 3K#FQ9HT23VQ1)7HZ9ZZ::Z&
M A'AU2Y;&I\CLI^4?-QY-W:PUT7P&&=UBAUDUS?DI/N%O(C+LZ;2UU J*^/.
M,\QY3Q[.1B>:1L(QZ%;V:8)L5S5E,FRE.[UK?5)5L;:09DA*6RW*]QJ^FI:M
M;C7FRTD\+9'GF?--.W>$R+.ON?@D3;<N16$1I[9'T2;N]"/ZN[KT+H1,:>BK
M/);-,3B\D1L[A4EM:1DV=/A*:J.]6E'>3W6&'Y3AF\2G$&G<OU09@/:VYRO+
M_P 8+;EC'231Y?"9)B2T;:7T1I[$QN.^24/$HC2HC-2"61Z$HM>I 9]2#CN/
MS4[&D9_G650WJFXISG0\1A04(1727&T.LZ25:N.;$:DX2NAK/IT(@&'Q+?<D
M\L^/M)>M94BESNS7)-S(?TZ-+2E$6Q>:V_%/MM'N:;)&O3[^H" 938>0=3G%
M/QIBW++>39M8Z2;**C'*Z+%JJLB]TJ6\1NFDS,T]MO;JK_OD;BK"YDY-R/&+
M?$N,<5MH%9EN3(<>G95;DVF+7P8B/XD@FEFEM3KBB43:#/;J6GU(R)$7B\CY
M7QEF>*UV0<C5G)6'99/;I7WFFH,6RK9\DM&'"3"69+86KHLUE[/OZ:AF<J<E
MY$7+D?B]K-XG&%&56W9(R"9%8D.V4AYTV^PRY+,F6TIT]3]QJ(RZ@+ XJ/E.
M,];UF>V4')Z%DV7,9S&$EB.[.9<3_$2]&8,T)-!Z$2D]#Z^H"RP0
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ME=[@]+<8QPO-A,M5M3>=YHY%J3A*7)C,2%*<0TE!*3JH_=N+[:)%=, @
M                           #399"R*QQV?#Q*S;ILC=015]D^PF4TRX2
MTJ,U-*Z*)22-/X:Z@(MQ/QF]Q[!MI=W;KR+-<EF?J.1WSC26#?>))(;;;;3J
M2&FD]$)^FIZ:%HDBK"!   -2UT^OV :-.)U!9:O-7"=>O3@E5L*==6IF/%-S
MNN)9:UVH4ZHD&XK356Q)>A -X
M           *]Q[C1VCY9S'DQ5DE]K*HM?$16DSL5'.O:2T:C=WGOW;==-I:
M JP@0           !HI.(TTW+8.:2TNOW-7#>@5J7'#./'1*42GG&VORDZX2
M4H4YZ["V^FH#>@     !J1^@                       *^YEXU=Y6P]&+
M,V2:I:)\2?\ *4S\@C*(YO-&TEH_-]]06+!! S(NIGH0
M                       /PRU(R]-?J7J TN)XI4893-T=,3IQTNO27Y$I
MU<B5(E2G5///OO.&:G''%K4I2E?]@!NP
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MBK*J3<E%*:PAUUQH_@MJ;:VI<4K:>BU&H_51GJ>I@B:@
M        --EDO(X.-V<S$8#5IDK+"EUE?(<)EI]\ORH4M2DDDC^YJ+]H#)HG
MK:325LB_C-PKUZ*PY9PV5]UIF6MM)O-H61GN2E9J22OJ0#/)1*_*9'].@#]
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MGDC.74T:KJXD]3.-28SZ7US8!:Z/.I)2MBCZ>TR+]GU,)0:DD9$9D1GZ$?U
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MNS-A$RVR5U2MBB4>I1H[)GM9:95_#V$DE:IT/30DI)5P @
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M^.6*NR=A53M#95ML\[&_@N/J>)QM;:5=?>?[-/0]>@;F-QYD#7D1,Y06<?\
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MUDGU ^)_C7$6.8IQ4]Q14+<14R8$N!+G*T.0ZY/;6AY]7TWF:S,B]"+1)="
M5108+Y'5^!EPTL\>B8ZQ$>J49HTZ^]*.N4E24I1$,DD3QI5LWJ,B3Z]3+4PE
MM1Q#?J\:D\/6<B-&R-=0]7G(0I3L5$A3BW&S-1))1IU-.XR3]^A@-5/P'EK+
M?':XXRR6%4PLK3%B550N')<5%>BPCC:..J4@S0M7;7T(M/3T 2/DOBB[R_&,
M2D8Y8LU/(>#NQI]%.?)3D13[326W6'MI&KM.[2W&2=>A=--2 13)<&YKYI16
MXIR5"IL5P&/*9F9 W5RW9TRS.,K>AEK<A*6FE*+4]QFHNA]=-#"6\K<:9/<Y
M%C/)/&\R)#SS$R?8:B6)+*!85\I.CD9TVR-2-.O;41=#4?IT401U[ >5N5LN
MQBWY5BU>.8?B$UNXB8_5R7)\F=:,?V3CSRD(0EI!^B2+4]5)/UU(),?'=^KR
M'5R<HXYXLO%?T!;9K,Y!RCF=_JWMTV;?KN]?H P^+N-LIXJS/(Z6H5&?X<N'
M%6E-$-U12JJ<[IW8[;9IT-A9ZFG17MT3]349A<0(
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MCT!<3P$1K.L#QOD?'UXQE<=<FH<>:D+::=6PKN1UDM![FS(_4@$E
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M@(5EM?QQ>9[AL+))2/YXJER+3%H/><:=5HC1Y>Q)DE9$EOT5]@5/00
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M47E3C5E8LQKV][WZ1!<,R=D_&3O=V%I^Z1ZF W(
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MIA<J<MXCGF,XMR[04K=1F;[D.GM<<?DN?&F)22D,R4R2U4:M2+<@B+ZEKH9
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M^['4XA*S;<(M-R#,CVG^) /R9"AV,9R%81VI<-XMKL=]"76EEKKHI*B,C_I
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M:$J6VI1:&:#,M4F9>N@#&M:&BO4-MWE9$LVV3-3*)K#<@D*/34TDXE6A]/H
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M'&T)0IQ9%IN69$1J/3ZF _6H<1AYZ2Q';:D232<AY"$I6X:"T3O41:JT+TU
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M OKC)^',2OL@F.6%Q.AJ<ES'M.XXHGG$D:MI$7H1$"UZ\[WEOC7$&77U#+7
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MK4<S3>0K7A&Z@R.(ZK#,'K8;*HKUC8L/S6&6W&TM?'C1FB-IW71.BUE]2/[
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M0"6^.^#X5/\ '^@AR*R+81,CA+DWZWD)=7+DR%K)XWEG[E*2>J",SU3M(B]
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M KX%7%1!K(K,*$V:C;C1FTLM)-:C6HR0@B(M5&:CZ=3,$9(
M           #5Y)CM/EM#8XSD$9,RFM&%Q9D=1F6YMPM#T,M#2HO5*BZD>AE
MU 4NOQPOI%0G")_*5])XO0264XV;,5$I41LRVQEV"4]U31)(D;-NFWH"ZG&?
M\/T.;X% X\BOKH:.L>A.PDPD(7VVZ_\ LVR)S7IH1=3Z@:S^6..87*^#6&#6
M$UVNB6"XZURXZ4K<3\9]#Y$1+Z=31H")HE.U*4^NA$6O[ %><I<31.2'*.VB
MW$K&\OQA]R30W\$D..,*?2E+J%MN>UQ"R2G<D]/3[&9&5"[;QPGY8]576=<A
M6]_EE'-CSJBP-B+#A1?C.$X:6X+"2;U<-*>XM1FH]J=-.NHU8%YQK#O.2\5Y
M+=L'F9N+1YL5BO0A!LOIGM*:4:U&6XMN[4MOV ?64<;PLHSO"L[?G.QY>%*L
M%18C:4J;D?J;*&5;S/J6TD:EH"*E\J\BQ#)<4<XD@R$V'*5A85J<?IHYJ^2Q
M,<=2I,A9D1DV@F5.:K/Z*^GJ18O3#,7@X5B=+B5:7^)4T-F$VK3::^R@DJ<,
MOZRU:K5^)@C> (-Q7QI"XLQ1S%(-@]9,.3)4XY,A"$.$J6K<I.B"(M",%>/'
M7%D#CKC5KC6%8O3(33<QHI[R$(>TG...*/:GV^TW#T :)OQ]QASA>)PM8SY<
MJK@;W(=NG8S,:D?*<E-NHVD:2-"G#3Z=4_MU UH[?QWO\THY..<E\FW&35':
M4BNB-QHM:VT^2=&GI'QRW2E-GHM).JT-74P-2_+.'J[,N*(G%MO:R21!C068
M]TPE#<DGZTD$V]LZIU/9[B+[GIIT,@\+[AU>8<4/<8YID\ZZDNJ)W^9%MM,S
M"=:?[[*C2G5)[-"1]S3]2/J!KTG<.1,HXU_N[Y$O)N4K)TY#60.DB-8-/H6:
MF76U((R);1'M(SUU+4E:D9@:BSGCQ=9&NOK^3.1[;,L/K'VY+&/2(T:&V^MG
MJ@IC[.KDA)?7?U/[@:GF9<9P,PR;"<E>G.PG,)EO38D1A"#:?-Y"$;%[BU21
M$CIM^X#)Y+XXH.4L8<QC(#>90EYN9 L(BB;EPYK&O;?969'HM.JB]/0S($0)
MK@2^N["J7R;R+9YG04DIJ? HG8D6OCKD1_[)4I;!&I_;Z^XRU/UZ:D9=7:"*
MSY3X@3R+:8YDE9D4W%<KQ=4G],MZ]+;BB:G-DV\A2'.AZDG0CU]#41D>H*SI
M'&#$SD;&^295M(=M,>JWJCXYMMDU)^02M[RS(M4J,U:Z)Z /7(N-(.0\CXAR
M.]/>9FX@W.:C04(2;3Y6+)LJ-:C]Q;2/4M 1%\@X0M3SBUS[CG.)V$7&0H81
MD,=F)&LH<M45.QMSLR2VH<)/3=U]3,M-RM2Z]<'X&K\'Y!>Y'8R2TMKZQKEU
MUZY:+1(5-<6ZEWO&HB3V]O;;;0VV1)2A)$7UU&LI'#2Z_EB;RACV4SZI%TJ,
MO(\?;0TY#GJA,FRWN-1;DD23UZ:GKJ9'U U:0(@^%\:P\+RG-,HC6#TM_-)C
M,^3&=0A*(ZF$+026S26ID9+_ 'OL"OO!..8>"VN7VL6>],<RZV=NY#;R4)2P
MXZ6G;0:?5)?<^H(T^-<)X[1X_G6,SI+UK4Y[96%I:-.DEI3?ZFDD+;;4CK[=
M-4J]2/J"ZBU;X\Y"S3-81=<H7=EQFPTF(WC;;$6&^N&@MJ8SL]I)OJ9V^Q2$
M[2-'MZ$!J7X;0XWP!Q@Q37.0?_<O0J<,K>Q)#/:;FRC4E"S1T_M'MJ3_ !(@
M%7>/6+X_?\J<E\TXZTO^5;2<NNQAY9*2AY2^V[9RFDK(O8[(06Q1%_62?H9
M5TP".:O)>ABY3R;PICLJ9)KTSK"W[<VO>*/,8=:8C+:>9<,E;5MN$A1'IZ@L
M3;'^$)I9769ER/F<_.[7'S6>.,2X\>!"AN.%M-[L1RVN/:$6CBOVZ:DDR&I/
M+XUAR^6*_E=5@\F?7TZZ)%:2$=A3;CRWC<-6F[=JO33TZ /WDSC"BY/JH<*T
M?DUUK4R4V%%>5SG9G09C9>UQI>A]/ZR3Z'H7H9$9$1"LX'L9^14^1<HYS89V
MK'72E45;(C1JZ S)3^1]UF,7\9U&FJ5J/]NH+J$<TXRUF'DCQO1_JDNFFG36
M<F!:5SB6I4:5'WNMK3N)1*+5!DI"BT4G4@(L?#^%WZO,&>0<]RN9G.906%Q*
M>7+88@Q(#+I&EPV(L<MB7%I,TK7]2 UZYYPRUD^41L_Q3(IN%\@1X_P5W->A
MN0U)B$>XFI49XMCI)/0RU^Q:ZZ)VC7U@'#3&*9-.S[)[^9F7(,]@H2KRP;:8
M1'B)/7LQ8[);&4F?56W^C356HUM\+XUAX7E.:91&L'I;^:3&9\F,ZA"41U,(
M6@DMFDM3(R7^]]@'TOC>$OEEOECYSI6#=%_+A5VU/9-DY1RN[N_-NU/33T!%
M'>1B\)YGR/#>)<>F%89Q'OEHME0]V^LJ6VE)LN\O31.J201)U]RDZ?@98ZBC
M1H\.,S#B-I9BQT):8906B4-MD24I(OH1$6A CYF0XMC#D5\YE$B%+;6Q)CN$
M2D.-.I-*T*(_4E$9D9 **1XVVT&K?PNDY,O*WBV2;B'<62U&=>1&?49N1V9[
MB3=0TK<I.W0^A]=>NI=3C*N%<(RC J[CXF':JKH^PYCTNO<-J97R(A:-/,NG
MN/>6I[C5KNU,S]W4#48C\!VES:U4WE//K+.JNAD(F5-(_&C5\+Y+/]FY)3'+
M60I&IZ&L^O774C,C&IED_&D')^0,,Y ?GO1YF&?.^+#0E*FG_P!19)E6]1]2
MVD6I: /2YXYAW/).,\DN3WFIN-19L-F A*#9>3/0:%&M1^XC3KJ6@(^+#C6'
M/Y4J>4UV#R)U35O4[=:2$&PMM]:UFLU&6XE%O]/P!4<RSA%Z?F,KD'C[+)V"
MY=9-(8NGX;#,Z%.2T1)0MZ+(]AN)(M"7_K:F9F-;7C7B"LX_L+?)9MI+R;.\
M@-'ZSDMEL^0XVT1$AII"")+322)/L3]BZZ)21!8P(H:)XXVF-V=_>8!R+:XU
M<9-92K&W6F-%FQ7&Y3AN);*.\6U*VC4O8\1[M%&"ZL7C;C*AXSH9%-6./V,N
MRD.S[RWL5]Z9/FR/[1YY6FAZ^A)]"_$S,S(KUKQXNL;7/KN,N2+;#</LGG)#
MV.LQX\UN.I[JLH;SW\2.1_3;J9?<%U.\6XFQ?"^.Y7'&-D[%K)D>4S*G+-+L
MMY^:V;;LEU1D1+</4OIIH1)(B21$ ]L2XSI,:XTB<6S5*NJ!B$[72#EI)"I$
M=]2S6E1-Z:=%F73K_2"*X;\<+YBG5@\;E*^9XN4E3!XV3,4Y11%F>Z,FP-/=
M)K:>S9MTV]-- 74TS;AC&LLXI/B* XNBQM#<5F,J*DG%M-PGD/)+^(9[C4:/
M<I1ZF9F9]0-3UZMARZMRGG-)E5[\<XDEATB4AUE:.VM*T^ADI)F1D"*.:\<;
M^HK9&(XERC>4?',GN(/'4L1I+S+#YFI;,::Z7=:0>X]-"_;J>I@NK>PS#J#
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MR(B[BC_'34DF0U(<;XPKL=SW-<[1-=E2,V*$F9 =0CLLI@,FR1),NJMQ'UW
M('2^/&08HR_CF'<GW=#QT^\ZZ6.QH\1R3'1(6:UMQ;!U*G62U,]#2G4O74U&
M9F-2;CSA"EXUQO*L2HK*4NBR61)DM,ODE;D,Y;!,*2AP]3<T2E.AKZ].OU U
M*>.<*C<=833X5#EN3HM.R;#4M]*4.+)3BG-3)'0M-V@(^^0<.C<@X7<X9+E.
M0HUS'.,[*92E;B$FHE:I)70_0!$L_P"#Z3D'C&HXTLK"1':I$P?@6[24')2[
M7L]@G-O1.JT&I*M/ZP+K*S/ANDRW",;P1F:]55.,2JZ5!5'0A:U)JFS;:;5O
M+30R/J9 :S.3^*:3D^%6_,ERJ?(:*1\W'\@K5DW-A2.FIH,R,C2O:G>D_70O
M0R(P1%:C@>?*RFGROD_-IV>2\<6;]!!DQ8U?!CR.FU]3,<C)QU)I(TK4?J6O
M4%UO.2.'H.=W%5EU3<S,4SVD0MBNR*M)"W/CN:FIA]IPMKK6JE&23T]3^AF1
MA@X;PFNHS%'(F=91,SC-HL=4.KG36&(<:"RYJ2_CQF"V(6HE&E2M?0S^Y@:]
M<CX:<M.3X7*>/Y3/QVX1'CP;>'&;:>C3X<9XGB:<)SJG=IM49:]---#UU&MW
M1\:PZ/DO*N2VK!YZ;E,>%%?KUH03+"8#26DFA1%N/=MU/=]P'YQMQI!XW_F?
MX4]Z=_,]W+R!_O)2CLNS=NYM.WU26WH9@//$N/8W'\C.+J"^_<2,KL9%Z] <
M2TC:ZX@_\7;/H1D?Y2-?](#F:DF<(%C5C-@\HW> X<^Y)=ON*URFF)D=XE**
M1$8;-*I"$.&1D:&==25IJD^A%71XG8Y88YPO5-V4%RM<LI4RSCP'M2<:BR7C
M-@E;NON;)*BUZZ&0)5PW%16Y!4S:.YC(F5-BPY%FQ7-=CC+R30M)Z:'U(_4N
MH(I!OQPOF*=6#QN4KYGBY25,'C9,Q3E%$69[HR; T]TFMI[-FW3;TTT!=33-
MN&,:RSBD^(H#BZ+&T-Q68RHJ2<6TW">0\DOXAGN-1H]RE'J9F9GU U8D=HF&
M&F"/<32$H)1^I[2TU!&OR3'JO+,?L\9NVC?J;:,[#F-$9I4;3R30K:HNI*+7
M5)EZ'U 4[6^/.0LTS6$77*%W9<9L-)B-XVVQ%AOKAH+:F,[/:2;ZF=OL4A.T
MC1[>A NMW X)KX7"4CA']<E.T[J'F6K-33126VGI1RC3M+VJT49EK]C U++O
M 8EWQI(XU>FNMPI%2FE5/2E)O$VEDF>YM_+N,BUT] 1X/W.&\-8'1P<LO&H-
M)518E(Q8SO:;[D:-M21I01ZK6AE2MJ2^^@"J?$;!*^DQS(\[@PW8<#,;1]['
M8T@C)UG'XSSA0DF2NJ=V]:NG12=J@6NC 1RSR/BCN8^6E37P[N;CMO#PKYU5
M<5JD$\Q*;L)"-5(<2I+C:D+6A;:NBDF"\6O@G#O\MY._GV7Y),S7/G8WZ>S<
M3FVHK,6&:MQM18K!=MK<?51D9Z]=--5;@Q<OX4=L\P>Y"P+*YN#9G.81%MY<
M-AB;$G--$24&_%D%L4XA)$E*]>A?0#6TXXXBK<!L;7)IUK,R;.KXD)N,DLS3
MWW&FOR,M-H(DM-)T+V)^Q==$I(@B9>/]YCUA:JXNY$LL*QVZDN3IM U#B3XS
M;[^G<.*;Y$;&[3IM]/V$1$-33%^(L5Q7CR=QO$.3)J;=J8W<SI+N^;,>L4&W
M(?=<TT-Q1'ZZ=-" 59E_&MAQ;XY\@8](RN;DE2W4*:J&;!MIOX,=I)I)IM2.
MJB/5/KZ:="(!BX1P-:Y)QCC%3_>-=1^,[FH@39V*-(C*4HI<=M]UAN>:>\F.
MM2C_ (74MIZ :NG)N+\,RO CXVL8!-8JAAF-#CQE&VY%3%V]A3*SU-*F]I:&
M>NOHK4C,C(KIWQWNL@:A4G(O)-SEN#5[K3S6.O,1X?R.P9&A$V4R7=D)(R(S
MW&1Z]=2,%U/,[XQKLYGX;-=FNUR<,MX]U#8C-MFAU4;3:RHE%[4&1:>WZ /3
MDCC>%R.UC34V<[!+&KV%D;!LI2ONO0"<)+2MWHE7<ZF74$87)O$E5R,[47#=
ME+Q[,L><6[19)6*),F/W2(G&U)46UQM9%[D*_P!70U$96DQO@Z0UF%?GG)&7
M3<\R6E0M%"<N/'@08)NEHMUN+'+8;ID1>\S^A'IJ23(:DT3C6'$Y8L.5TV#R
MI]A3HHEUIH1V$MMO(>)PE:;MVJ--/3J ^ZKCF'5\F7_):)[SDV_@Q:YVO4E!
M,M(AZ;5)47N,ST^H(\\=XT@X]R/E_([,]YZ;E[<%J3!6A)-,%7,DRDT*+W'N
M(M3U 0Z9P'9U-];W/%F>6."Q<A?5,N:=B+&L8*Y3G]H\PW)+^ M?U-']&A$1
M$74IP3B''./\5M,<J7Y,J=?*??O;Z:LGI\R9*2:5O.K,B(S+<9I3Z%U]3-1F
M-;+C+ (G&>!U6!PIKMA$JD/H;F/I2AU92'W'SU2CI[3<VE^! C4X-P_2X9Q4
MOB54Q^RHWH\^'(DN$EI];-FIU3A%MU(C(G3(C!=:3&> X5;QY;\799D<[+,0
ML&FHL"--0TRY7L1^K9,+01GJE1(6DU="-!=--2 UI7/'7(KBMCXEF?*-U?\
M'<?M)/'E1XT5Z0S',E-M29S1=YU&J2UUT,_H9'H8&KV889BL-1HS:6H[*$MM
M-(+:E*$%HE)$7H1$0(A')W%=+R=!KDS)<JHOZ.1\Z@R"N63<V%)Z:F@S(R-*
MMJ=Z#]="]#(C!46IN"ITC**C+>3LUGYY88ZYWZ"')C1J^!%D=-'S8C%HXZG0
MC2M1^O7[:#4LM.-8=GRC1<H+L'FYU'7R*QJN2A!L.(E&LS6I1EN(RW?3[ B<
M                              "$\L<DU_$V%3,VM(3]A#ANL,KC130E
MTSDNI:(R-9D70U:@,O*\S?QFRQBO8H;"W1D4Y,!V5 ;[C4!*B(^_)/\ =;+7
MJ?X& E8    # .DICM2O3KHIW:6^RFR-AOY1-?U"=V[]O7TUT 9X
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M0_3IJ58E/,EV%3 GSX*ZR=*CM/R:YY27'(SKB"4IE:D&:34@SVF:>G3H",T
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M;(C6:V^YL+3U-((I-K+%NXK_ #F]Y&MM\H*C?J":-,J'_+Z7C3WB@G#V=?\
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MX(YJYIQ.V+F.ASS(L)F<D<:Q:=R BA@-MS7(-FIXUG(."ZI*'B6C1.I]/O\
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MEY'R?69_D>5S)]-0/_-Q[%$L,LQ8LHV4M&M3J=5N=2[A;NI*^NW4C+JT@0
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M2),:(T;\IY##):$;CJB0DC/H751D0#T0M+B4K0HE(41*2I)ZD9'U(R,@'Z
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M1P"KW!                        %?\YI4KAC/R26I_P OV9Z%]BBN&?\
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M-V/'.MNWK6$BB@XVU"F1%.-[TOLPR87$-HSU-PUD;:4:>[IIJ1@BJH+3KO\
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M#->.,(Y%8B1<UIF;F/!6MV(V^:R)M;A$E1EL4GU(OJ AW^C%P+_T'@_^Z?\
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MZ[MWN4HU'[M=0&1.PS%[+$RP:;6-/8D45F 54>XF2BQR2339:&2M$DA.G7Z
M%YAF+Y)C*L-O*QJ;C"VV655J]Q-=N*I"VD^TR/VFA)EU^@#SR?!<1S.GC4&4
M5+%G3PW6I$:&_NV(=82:&U%M,C]J5&7[# 2$  0K.>(N-N25-.YMCD6UDL)V
M-2U;V9*4:Z[>\PIMS;K^[NT >F"\4\=\:(>3@^/Q:AR2DD2)#>]V0X@CU)*G
MGE+<-.O7::M &9FG'^%\B5J*C-:6/<06U&XRF01DMI9EH:FW$&E:#,NAFA1
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M;A8]*P6REL0[@Z+Y2)=*J6K:VXM3REH>:09D3AEUU_+]-0Z$(R,M2ZD?H8(
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MX?"R>,Y'>AK=3MEQ6U+4YJWW/<V@EGHDM3]RC,R5T8"
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MMMLFCWI6;DB2?\-&J>KBR]/H%D5*IJZJ"NS3LLE1VCF)Z%H^:"-PO;T_-KZ
MC, 53RWQ%.SBRH\TPV[/&.2<8-95-OVR>8=CO$9.1Y#9_F0>IZ>NFY7M/<"H
M;;8%Y09[6R,1S7*L8I<4GH.+;3,>CRW;*3$7[7&R*2E*$=Q.J5&DR]?J70#X
MFO(7"M;E7$\7C+'I9TB:5,->/3#+O$P_6Z=DW"Z&O<1&2S]=3W=3Z :KK.^(
M?(7EK%3Q[.<FQJN1!=CR(,:E8F&U.DLN)U=FN/$2D)2C>:6V4:&LR,]"(@%F
M\E\<6V:Y;QWD%=+CQXN'6R[.>U(W]QYI2$IVM;",MWM_>T(!I>4^-.0;C/\
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MM[-K6PC+=_LM" +'CNUF<WTW)[<N.FGK:&12NPE;_DJ?>?4Z2TZ%LVZ']3U
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MN=Y=,*PR.S;;[4<S0DTLQV4'U)II*E$G7KU^A:$006JXLYOXTC6F(\1WF/\
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MU'-UNI@M,D:6V(;#AGHDB/W+,B4K0M2U(S4%C@@
M         ([D^<XUA\RB@9!+5&E9+/;J:="6G'>[,>_(@S0E1)(_ZRM" 2(
M     1S',[QC++7(*6BF')L<7E% NFC;<;)F0HE&224M)$K\I]4F9= $C
M    !'<SSG&N/ZIFZRJ6J'72)3,!IU+3CQG(DF9-IVM)49:Z>NFA )$ CF89
MUC.",U4C)Y:HC5U8L4U<:6G'NY.E$HVT&3:5;2,D*]RM"+[@)&  (7F?$W'G
M(=I4W.9T3-O/I-WZ<I];I-I)PTJ4E;2%I0XG5)'M<2HO]4P$T(B(M"Z$7H0
M  ([,SG&H&95N RI:D91;179\&(33AI7'CF9+4;A)V%IM/H:M0$B     ?AH
M2HTJ4DC4@]4F9:F1F6G3^@P'Z      -!FF9X]Q]C4W+LJE*AT-?VBE2$MN/
MFGONH91[&DJ4>JUI+H0#=QWVI3#4ED]S+R$N-JT,M4K+4CT/\# >@
M                (Y#SO&)^9V7'\68:\JJ8K4^?"[;A$B._MV*[AIV'KN3T
M)6O4!(P             !')^=XQ69C4X#,F&WE%W'?EUL/MN*)QF,2E.'W"2
M:$Z$E712NN@"1@ #\4A*R(EI)1$9*(C+7J1ZD?\ 0 _0 !'LVS;'./,<E99E
MDI4*BA*:1(D):<?-)ON):1[&DJ4>JE$70@$@(R41*+T,M2_I ?H    ".4V=
MXQ?Y1?X;5RU/9!C'QOUF,;3B":^:@W&M%J225ZI+]PST^H"1@
M /PTI4:341&:3U29EZ'H9:E_08#]              %57OC9PCDEV]D-MB,=
M=G)<[\I3+\J*R\Z:MQK<98>;:69JZF:D=3]=075E5E974M?&J:B(U!K(;:68
MD..A+3+32"T2E"$D1$1?@",L!^+0EQ)H6DE(46BDJ+4C+\2,!^@
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M=/0#XUO.^=UG)GB#;9Q4-J9AVS5<X<99[ELO-VT=IYHS(BUV.(4G=H6NFOU
MGJ3M\E99F.3P./>(?AJA4+4?^=\PE(.7!B*-LO\ $HI-K2EZ2?JKW;4>A]==
M V_*7).5UF68_P 6<;1H;^=W[#M@_/M=_P &NK&#-"I#B&S)2U+42DMI(]-2
MZ@-369[R;@&>X[A?*TBKO:3,%NQ:3):AE<-QBQ:3O*/)84I:=KA&26U(^OK]
M= QLOY+SRZY<L>)L'N*3$U4T*-+D65ZVJ3*GO3$DM*(3.]M*D(2HB</JK=Z
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M0S674_IH>J0Z.!
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MWN>^%F.4E)#5*O8##-E'K%DI"I/Q);BG&2+H>Y39JV%^\>A%Z@O4-E)\1)%
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MS81)XFXQCSK//,F=CPIM9(@R8JJ=IN0AR0Y/-UM*6^WVS0>U2NO4M2]1C?\
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M?KU@U4P_@L=_8^_^53ON3M1]SZ_L!$M
M
M      !^$1$9F1=3]3^X#]   !^$1)+1):%]B ?OKT/T ?A$22T26A?8@'Z
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MI6G6ZNO@]SO+)"G_ .*XM:]?<LBTU/UU+:%N@@  /S:G7=H6X_4_J _0
M
M
M
M
M
M
M
M
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M!ES'QS;6LCS&Y0JWY\EVKC4["HT%;SBH[:C37&9H:-6TC]RNI%]3^X+QTX"
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M+T!95J<K<9Q>'/';D%O'<AO)[\SX$CYEI.-Z0RIN;'1HTMI#1I(R,]Q?7Z]
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MZ1MN2TF:WW(C2%JVQTI)M*5+(E*4:OH0"X 0
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MXGLVU9)9<84Q,:(B<)).D1FVK4EMJZ^TRUZZD#*;
M
M                                    T&*X?3X>Q.:J^\[(M);MC9SI
MCRY,J3)=T3N<<7U,DH2EM"2Z)2DB(@&_
M                      'E*8^5&>C=QQGO-J;[S*MCJ-Y&6Y"OHHM=2/[@
M-5BF+4^&44;'J)M;<"-O6:WG%//O//+-UUYYU9FI;CBU*6M2CZF8#=
M
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M)S3D?%9E4S 8P>S*MC26G5.+DI-^4SO6E22))Z1R/I_6_ #%N@@
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M,OFZTMM&Y7?<TV*42RT3ZI($:?S._P P-[_QJN_RML"+7XT_S<8?_P R5O\
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MNK+6Q5;V<.WCQYEJXGMKE/M2;!"WU)U5M-Q1&HRU/34"NN 9
M            :W(:.!D]#:8W:DM59;Q'X$Q+:C0LV)+:FEDE1=2/:H]# :[
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MGN6KJ?51@C>@(/+XGQ"?R5#Y7FMR9&6UT<X=>MQ]2HS#1MN-F2&?0CT=</\
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M3Q.E;R+([B+743RFT,V#SA$PM3Q&IO:LM2/<1:EI] 1#S\B>#B+7^>ZGI_\
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MT2U(U+J6XBU Q)<=R;'LNJVKO%[2-;U+QFE$N&ZEYO<GU29I,]%%KU2?4OJ
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M KUK*:NX=\R:K%L(:^!B^<4ZG[*FCF?QVG4-REI-#>NB2)<7>G^J2UDG1)Z
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M;[:?KZ?<#U^2L7/&_ YV2ZC9,R"QCW$C7U,GI[;+1F?UU::;/^D#K[PO)[G
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M]R+)^#L 8<F4/)ZVU82]W3)<%<MPH\A*#/7WD@^RI9K(TDEMW4CU(%=@</\
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M!.Y'S761R3GBSL[20Z1=QB*^HW6F"_JFK=W'$EIH>U.GL($J_ 0
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M0WCZ>T^XT1[4Z(W$Y[DI+<G4B,%2CB/AC/$<CSN;.9K")*S>3'.'555=J<6
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MBL,O$D]Q;VVTI5H?UZD",\
M
M
M
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MD3RCEWZ=Q+,XQR)R@BY[*2CYA--._P "<F*;*G$N)7^3O&9D1@D17E2U\AN
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M  ;F6NRZOL,BYC8RFBBFXN=1M08[2GT*;4A/O;49I)*U)5K^&@"]P0
M
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MHSU+MD"KB\)#2?!<7;]+.?TUUT]Z3T!*T7&:D_Z:O*R=2W'2L&1?70DUFO\
MV0.)#Y)Y[18Q9XQC_)6&L7O$UXXI-G>.DZZ[!EHW)(T):3N0HDJ2HE)62U)W
MDGT CG]F'QOC_.6 %XN7%A.G3YR"R. TI]V BN[B#<)2WD)6:.T;IN$HU[2(
MCU)0*_H.#+E?RT4DN0^"$F9$H\D,R+ZZ%*KM3_UP6+!\LE$GQ\S0U&1%VH1:
MGTZG81B("*<J_&SAJ3X[M<@2*-S^9CQ%5TY-.=+)/SDUYR.YVR=)LBWEKMV[
M?IH"ZT,4R+_V>\G4_P#QQE_^T*0.L7"XG@NK#\?5ECK192=;#.[)3EZ1_/-A
M'R-29/M_VF[\GM^W0#ZE7EK+Q7).-N*G<<>*1B$ZV8:@.-]QLE0NQVBT[I$L
MM$EI[BU B*<P\'8UX]97C_*%50_S5QBF0W&OJ&S,Y1Q'5&6UQ"C,M4K(O9W=
MR2<+:K4EI(A*E?F+=XGDU!Q)>?*;EX;9V9R79#9JVKKW$L&X?L]Y:(,R,B]Q
M'T]0(^Z"3X%T-[67=)*88N:Z4Q*KGU*O5DW)9<2MI>CNJ#VJ(C]Q: ?69S%+
ME<,^2V/\UW$)^3@%Q *HM)\=!NG$?[:F3W$6NFA=MPB]5D2R3J9 -?Y'<V8E
MR_B<+B3B-UW+,FR2;%-28D=Y#;++"^[[E/(1HHU)3KTVH1N-9ITZB1C>1>$5
MBLP\=N.;P_E51&BAG;%J:-UI*Z^,K11&2BW$70_4"+MQWACAO@/]6Y)IH,BM
M_3JZ1^H2ER),S;"3M>=T:4I>I_PB]"U!-61AN7T6>XU RW&GU2:2S2M<1Y:%
M-*43;BFE:H61&6BD*+J"-Z
M
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M7J1@/F%!A5L5N#71FHD)DM&8T="6FD$9ZZ)0@B(NI_0@'N
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%-9;DQG2]%M/)):%%^TC(P1D
M
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MT]VNH)/5P<&?+_N:P+YN[Y'Z#7:[_P VSXR-FO\ WN@%6 "
M
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MM= BU5?$JX*.U"A,MQHS1>B6F4DA"?Z"(@1D@
M
M                              #\,B,M#+4OL8#]
M
M                  'YH6NNG7TU ?H
M
M
M
M
M
M
M
M
M
M
M
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M
M
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M&8+*64K<^2E)*42=-3T+34%XZ.(R,M2ZD?H8(
M
M
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M0RT(_H"598(
M
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M6A9[BTR9@]_'B1[BO>??=JY:&VVVY3:E*4I39$1$1:F9@/ZQ P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
*          __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
